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Abstract 
 
Measuring the Return on Marketing Investment (ROMI) and marketing’s impact on sales 
has initiated a great deal of discussion in the field of healthcare marketing research, 
with some researchers identifying such measurements as a necessity and others seeing 
them as an impossible task due to the complex nature of marketing projects in the 
healthcare industry. The key objective of this research is to develop a systematic 
approach to guide pharmaceutical industry managers in deciding how and where to 
invest in the sales and marketing of their Over the Counter (OTC) products. This 
research aims to identify how to optimize sales and marketing investment decisions, 
with the goal of improving marketing’s impact on sales and the Return on Marketing 
Investment (ROMI). Achieving this aim would help executives meet the challenges 
resulting from on-going changes in the healthcare sector. This research was conducted 
in an emerging market, looking at a range of pharmaceutical OTC products from the 
researcher’s organization. A quantitative method of data collection was used, followed 
by an action research (AR) approach. The quantitative method consisted of a survey 
targeting pharmacists working in pharmacies in the Kuwaiti private sector.  The AR 
methodology was used to analyse the research data and to develop the intervention 
plan. Results from the AR phase reveal that the ROMI achieved through indoor 
promotional activities was higher than the ROMI achieved through medical detailing. 
Reducing the amount of free-of-charge goods supplied to pharmacies had no significant 
impact. Pharmacists’ recommendations were found to be the most influential sales 
driver. This was reinforced by additional findings in which the medical detailing of 
pharmacists at community pharmacies achieved a 7% ROMI, higher than the set target 
of 3%. The strong influence of pharmacists in polyclinic pharmacies was also 
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considered, with polyclinic pharmacies achieving a 30% ROMI, greatly surpassing the 
set target of 4%. The use of action research in this project facilitated the learning 
process by generating innovative and creative solutions to real-life challenges.  
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1.1 Introduction 
  
The present research took place in a healthcare company with a diversified business in 
pharmaceuticals, consumer products, medical equipment and medical devices. The 
organization has two core functions: (i) importation and distribution and (ii) sales and 
marketing. This research focuses on the sales and marketing arm of the organization 
and on developing the learning process and know-how in that area. The organization’s 
activities have been limited to markets in the Gulf Cooperation Council (GCC) region— 
mainly Kuwait and the rest of the Middle East—which is considered to be a key 
emerging market in the pharmaceutical industry. 
This research focuses on identifying optimal marketing investment decisions 
that will generate the highest possible return on investment (ROI). This will aid 
healthcare companies in meeting the challenges from on-going health reforms, which 
are forcing these companies to reduce both expenses and marketing investment 
(Narayanan, Desiraju, & Chintagunta, 2004). The marketing elements used in the 
pharmaceutical industry include detailing, direct-to-consumer advertising, pricing, and 
other marketing efforts. However, not much is known in the literature about the best 
use of the different marketing elements, nor about the ideal mix of these elements 
within the pharmaceutical industry (Narayanan et al., 2004). There is also a scarcity of 
literature discussing managerial decision making in marketing. Osinga, Leeflang, 
Srinivasan, & Wieringa (2011) recommend that marketing academics place more focus 
on what executives really need in order to improve their marketing efficacy through the 
use of optimal marketing instruments.  It is thus highly important to conduct evidence-
based research on how to improve the marketing decision making process and on 
identifying the most efficient marketing instruments  
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It is also crucial to understand how to support executives in improving value to 
the firm in the face of challenges such as cost cuts (Seggie, Cavusgil, & Phelan, 2007), in 
finding ways to improve the measurement of return on marketing investment, and in 
optimizing the use of tools such as customer relationship management (CRM), the 
economic value added (EVA) financial ratio and the balanced scorecard.  
1.2 Research background  
1.2.1 The researcher’s background 
 
The researcher is a pharmacist who graduated from the University of 
Portsmouth in the UK in 2003. The researcher worked in the clinical field as a 
pharmacist for two years and then moved to work in the sales and marketing field in the 
pharmaceutical industry. In 2006, the researcher obtained a post graduate degree, a 
Master of Business Administration, from the Maastricht School of Management, in 
Strategy and General Management. The researcher has held different executive 
positions, starting from the role of medical representative for a Haemophilia product 
line and later being promoted to oversee the tender business. Three years later, the 
researcher was promoted to handle the trading division of the pharmaceutical business, 
which had a revenue budget of around 200m USD and a total number of employees 
exceeding 250. In three years, the researcher was able to double sales and triple the net 
profit of the pharmaceutical division. The researcher then moved to a healthcare 
company in 2013 as managing director. The total number of employees in this 
organization was around 70, with revenue around 20m USD. The researcher joined the 
organization as a partner and executive and took on the aim of developing the sales and 
marketing arm of the organization.  
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It was this organization where the researcher decided to conduct this research. 
The researcher has the authority to facilitate the research work was able to obtain gain 
the consent of the other partners and key executives at the organization. The researcher 
and the organizational management wanted to build a clear financial structure that 
would clearly differentiate between the organization’s trading projects and have each 
be considered its own profit centre. Hence, the management team decided to create 
trading projects rather than trading departments in order to provide higher dynamicity 
for the decision making process. In line with that, the management was interested in 
developing Key Performance Indicators (KPIs) to ensure that performance could be 
monitored closely while authority was being given to the commercial directors and 
sales managers. With the KPIs, the management team was keen to develop a model that 
could reflect the return on marketing investment and could be applied to all the sales 
and marketing projects where there existed a proportionally high amount of 
investment.  The researcher, as managing director, offered to conduct a study in the 
organization to determine the best way to measure the return on investment for one 
particular project related to the OTC analgesic line. The success of that project would 
encourage the organization to apply the model to the remaining trading projects. The 
researcher proposed an action research approach toward developing the ROMI model 
and would play a dual role as both scholar and practitioner in order to bring academia 
and actual business practice together.  
1.2.2 The research setting  
 
This research has been conducted in a healthcare organization that specializes in 
two core functions: distribution; and sales and marketing. The researcher is the 
organization’s managing director. Prior the researcher’s joining the organization, a 
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conventional distribution model was used as the company’s core operation.  A key 
challenge for the researcher was changing the mind-set of employees who were familiar 
with the conventional business model and introducing to them an advanced business 
model that relies on sales and marketing functions rather than just the distribution 
function. The sales and marketing functions require more sophisticated knowledge and 
are associated with a higher risk level. The managing director hired employees who had 
worked with the managing director in the past and who had good experience in the 
sales and marketing functions. These employees played a major role in facilitating the 
transformation of the organization and the introduction of the sales and marketing 
functions.  
 As indicated earlier, the new structure of the organization has an unusual 
characteristic, in that it uses trading projects (rather than trading departments), each 
with its own authority as an independent profit centre. The organization has support 
departments that handle human resources, finance, accounting, quality assurance, 
tender administration, trade administration, logistics, business development, IT and the 
supply chain. The trading projects are managed by two commercial directors.  There are 
sales managers who are responsible for one or more trading projects, depending on the 
feasibility of the project.  
The chosen project is managed by a commercial director who participated in the 
research as a head of the commercial team. The choice of the project for the research 
was agreed upon with the commercial director. It was considered a potential long term 
project and when the research was conducted, it was in the ideal phase for research and 
would enable the team to observe an evidence-based study outcome. The commercial 
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director agreed on the research methodology and participants, as described in detail in 
Chapter Four.   
 
1.2.3 The pharmaceutical industry 
  
Several unique aspects distinguish the pharmaceutical industry from other industries. It 
is considered one of the most dynamic industrial sectors, responsible for the discovery 
of new and improved therapeutics to meet unmet medical needs, with approximately 
300 billion US dollars in yearly revenue (Dogramatzis, 2002).  The industry experienced 
dramatic growth over the span of a decade, reaching a market size of 752 billion USD in 
2013 (IMS, 2013).   Other associated industries are present within the pharmaceutical 
industry, as shown in Figure 1 below. The chemical industry is associated with the 
supply of raw materials, while biotech, OTC (over the counter) and generics 
manufacturers provide different forms of pharmaceutical products (Dogramatzis, 
2002).  The pharmaceutical industry is known to be a well regulated industry; this 
poses many challenges for pharmaceutical companies, including cost containment 
initiatives, patent regulations, health reforms, changes in codes of ethics, and other 
changes related to consumer and industry dynamics.  
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Figure 1: Associated industries within the pharmaceutical industry (Dogramatzis, 2002, 
p.25)  
 
The major stakeholders associated with the pharmaceutical industry are diverse and 
come from both the pharmaceutical companies’ internal and external environments. 
Figure 2 shows the different stakeholders within the pharmaceutical industry, divided 
into internal and external stakeholders. The external stakeholders are categorised into 
inputting, mediators and consumers, while internal stakeholders are company 
employees, unions, and task forces (Kotler & Clarke, 1987).  Inputting stakeholders are 
stakeholders who play role in the company’s success; mediator stakeholders include 
drug prescribers, university professors and other healthcare professionals; and 
consumer stakeholders include patients, patients’ families, the media, the general public 
and competitors.  
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Figure 2: Internal and external stakeholders within the pharmaceutical industry 
(Kotler & Clarke, 1987, adapted from Dogramatzis, 2002, p.29)  
 
 
1.2.4 Over-the-counter medicines 
 
Over-the-counter (OTC) medicines include the medicinal products that customers can 
purchase from supermarkets, pharmacies, retail stores, and online sources without a 
prescription (Bond, 2002). The US Food and Drug Administration (FDA) and a number 
of other health authorities from different countries have approved them as safe for use. 
These medicines are effective in cases of common, self-treatable health conditions such 
as allergies, the common cold, minor pain and many other ailments that affect many 
people in almost every country (Aronson, 2004). The number of OTC products has 
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increased over time; there are currently about 700 OTC products that were not 
available without prescription three decades ago. The market is expected to further 
increase in the coming years, as the FDA is planning to make some birth control, 
diabetes and asthma medicines available over the counter (medicines, 2011).  
Some of the important factors enhancing the OTC market include the availability 
of consumer treatments for insomnia, allergies, overactive bladder, yeast infection, 
diarrhoea, smoking cessation and heartburn. With a greater number of safe and 
effective products available over the counter, consumers are able to better manage their 
own health. Many researchers have shown that transferring products to OTC status 
results in greater utilization of the medicines; this is especially true in places where a 
large percentage of the population suffer from poor health and have remained 
untreated (Oborne & Luzac, 2005).  
OTC medicines aid in improving the wellbeing of consumers by providing 
convenient treatment options. The importance of OTC products has increased in the 
preceding years, as they provide self-treatment to consumers, and save time, health 
resources and money. Consequently, they have become an important part of consumer 
self-care. Nonetheless, in critical cases, professional advice should be sought out in 
order to avoid complications (Bradley & Blenkinsopp, 1996). The importance of OTC 
medicines is evident from the pivotal role they have played in providing access to safe 
and effective treatments in many underdeveloped countries. In these places, it is quite 
difficult to access healthcare services. OTC products thus play a central role in 
healthcare by providing effective self-treatment options to address many health 
complications (Okeke, Lamikanra, & Edelman, 1999).  
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Recognition and a high level of awareness in any field provides a sense of 
empowerment to consumers. This is especially true in healthcare, where OTC medicines 
play a positive role in improving self-care on the public level. People are now more 
aware of minor illnesses and their available treatments. They do not have to go to the 
physician to seek solutions; instead, they are able to find treatments in their local 
pharmacy retail store. A number of healthcare companies and regulatory authorities 
provide knowledge to the consumer about the variety of innovative medicines that are 
available over the counter. Consumers can access numerous treatment options when 
they have self-treatable health conditions (Wazaify, Shields, Hughes, & McElnay, 2005).  
In this study, the researcher assessed OTC analgesics; the reason for this selection was 
that this type of medicine is commonly used. Famous brands that fall under this type of 
OTC medicine include Panadol and Tylenol. According to AC Neilson (2013), the 
analgesics category achieved sales of 220 million packs in Kuwait, significantly greater 
than other types of OTC medicines that fall under different pharmacological categories.   
1.2.3 Value of over-the-counter medicines. 
OTC medicines can be purchased from both pharmacy and non-pharmacy outlets 
without a prescription and without direct supervision of a healthcare professional. OTC 
medicines are considered to be less expensive compared to prescription medicines, as 
the majority of pharmaceutical molecules classified as OTC medicines have off-patent 
status. Therefore, the entry of the generics has already occurred, providing the OTC 
medicines at lower prices. 
OTC medicines provide easier access to treatment options for common 
conditions, offering timely treatment that helps in relieving the symptoms of minor 
ailments. In a study in the US of the 7 most commonly occurring health care conditions 
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that are treatable by OTC medicines, it was found that 92% of consumers would seek 
more expensive treatment alternatives if OTC medicines were not available ("The value 
of OTC medicines to the United States," 2012).  A survey tracking the opinions of EU 
consumers found that 9 out of 10 consumers in Europe view self-care as a vital part of 
preventing both minor ailments and chronic health conditions (Tisman, 2010).  
The World Health Organization (WHO) promotes the change in classification from 
prescription to OTC only if the pharmaceutical molecule has solid, proven safety and 
efficacy data. It has been found that 75% of primary care physicians would recommend 
an OTC medicine prior to prescribing a prescription-only medicine  (Tisman, 2010). 
This accessibility to medicines has provided greater convenience and enhanced access 
to medication. In the United States, many studies have confirmed that access to OTC 
medicines has reduced the time to treatment for deadly parasitic and infectious 
diseases (Gurwitz, McLaughlin, & Fish, 1995).    
1.3 Measuring ROI 
The importance of measuring ROI increases with time and improving the way ROI is 
calculated is becoming even more important. Munoz (2005) emphasizes the challenge 
in calculating marketing ROI, since the traditional methods are not working as they 
previously did. Woodburn (2006) stresses the importance of developing appropriate 
frameworks for measuring marketing effectiveness through the systematic collection of 
data for objective and informed analysis.  One recent finding by Osinga et al. (2011) was 
that the evaluation of marketing should not just focus on the relationship between the 
sales team and consumers but should also consider multiple stakeholders and what 
should influence the size of the marketing budget. The work of Rust, Ambler, Carpenter, 
Kumar, & Srivastava (2004) touches on the importance of measuring marketing 
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productivity and the impact it can have on firm value. They also stress the importance of 
continuously developing methods for assessing marketing productivity. Rust et al. 
(2004) suggest that marketing assessment should be done using a conceptual 
framework that draws the marketing productivity chain from the firm’s strategies, 
marketing assets, market and financial positions, the value of the firm and marketing 
actions as they relate to tactics, impact on customers, financial position and the market. 
The end of the chain in this conceptual framework is the impact on firm value. It is also 
important to consider both financial and non-financial measures when calculating ROI 
(Doherty & Dickmann, 2012) and to measure the outcome over time. Thomas (2002) 
recommends measuring ROI on a multidimensional basis; the meta-analysis approach 
allows marketers to measure ROI over time. 
It is important to consider that there is no accurate way to obtain a precise 
measurement of ROI, nor is there a set of solid data to use for this (Duboff, 2007). It is 
advisable to use reasonable estimates of the likely outcome of the desired investment.  
Duboff (2007) emphasizes that despite the challenges in calculating ROI, it is essential 
not just for accounting purposes but also for future learning. In the healthcare market, 
measurement of ROI is not as common as it is in other industries (Thomas, 2002). 
Because of the complexity of the industry and the uniqueness of the healthcare market 
in general, increases in brand awareness (or brand equity) should be reflected in the 
ROI. The common term used in the healthcare market is the ROE (return on 
expenditures) (Thomas, 2002).  
It is important to emphasize that a good marketing ROI not only considers the 
financial revenue coming from the marketing investment but also incorporates the 
psychology driving consumer behaviour over the short and long terms. Hence, it is 
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important to consider both the qualitative and the quantitative effects of marketing 
efforts to obtain a good measurement of ROI (Thomas, 2002).  
An interesting research approach presented by Woodburn (2006) suggests 
developing a measurement system for return on marketing investment (RoMI) by 
collecting and capturing data within a defined framework. This framework would 
enable the marketing department to develop business cases for marketing activities that 
could then be considered in a more objective manner, helping reach a better 
understanding of the cause-and-effect relationships of certain actions. Known as the 
action research approach, this can help the organization develop a RoMI measurement 
to understand the effect of marketing activities and how to adapt and improve.   
Measurement of RoMI is an important aspect of marketing, and in the case of 
OTC products, it should be done to ensure campaigns will not result in losses. There are 
many means by which ROI can be measured, for instance by dividing net profit by the 
total assets of the company or by dividing income by total capital. In the case of OTC 
products, the hospitals are accountable to their communities, stakeholders and the 
board of directors for the RoMI. In this context, call centres can help greatly. Patients’ 
calls can be used as a record. Furthermore, the calls can be used to justify the dollars 
spent on marketing efforts and to channel economic support to the marketing activities 
that have been proven to increase revenue. The call centre can execute both inbound 
and outbound telemarketing functions to provide information to consumers about the 
hospital, its affiliated physicians and its programs (Dickmann & Baruch, 2011).  
Some hospitals use a call centre system to provide services and technological 
capabilities to support the interaction with consumers through the internet. For 
instance, New York Hospital Queens (NYHQ) employs a call centre for three purposes: 
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to reduce the probability of error for in-house record keeping, to measure ROI, and to 
ensure that the call centres are doing their work properly. The patient calls the hospital 
to request referral to a physician. Along with providing the requested information, the 
call centre collects important data about the caller, such as where the caller heard about 
the physician. This information helps the marketing department assess which 
advertising processes are most effective. It also helps the department invest in areas 
that return the greatest revenue and more lucrative customers.  
Knowing ROI helps organizations understand the effects of their marketing 
efforts. In the case of hospitals and pharmaceutical companies, once the finance 
managers have the ROI, they can determine the effectiveness of the marketing 
campaign. The figure helps understand which marketing campaigns attract the most 
lucrative business, or which need more effort or a redesign. Call centres not only help 
determine the ROI but also show how many callers become patients and the percentage 
of revenue these patients bring to the hospital (Dickmann & Baruch, 2011).  
1.3.1 Challenges in measuring ROI 
A significant gap in the literature concerns the calculation of ROI. It has been thought 
that lack of advances in measuring ROI reflects the limited progress in the practice of 
calculating ROI  (Doherty & Dickmann, 2012).  According to Thomas (2002), there are 
multiple reasons that measuring ROI is a challenge for the healthcare industry. The first 
is the business-to-business nature of most pharmaceutical companies, which don’t have 
direct access to the end users, as most sales are done through pharmacy outlets. Second, 
marketing is not well developed in the healthcare market in general and is considered 
to be a young discipline within the industry. Third, few of the decision makers have an 
educational background in marketing. And finally, there is lack of interest among 
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healthcare marketers in identifying the ROI. Despite these challenges, identifying 
marketing ROI is no longer a luxury as much as it is a necessity for modern business 
(Spiegelman, 2003). 
1.4 Action research  
Applying action research to the measurement of the ROI can help bring active 
engagement to the process and extend existing knowledge, adding practical value to the 
ROI calculation (Doherty & Dickmann, 2012).  Action research aims to generate 
actionable knowledge that is useful for the organization. According to Doherty & 
Dickman (2012), when it comes to measuring ROI, the challenge is determining the 
causal linkages that satisfy both the needs of the practitioner and scholarly rigour, with 
a high enough level of accuracy to avoid misleading information. 
1.5 Problem statement  
Due to the strict regulations applied in the pharmaceutical industry, promotional efforts 
in the industry have been dominated by traditional marketing programs in the form of 
push techniques that encourage physicians to prescribe the promoted drug; this is done 
through detailing the medical information for a particular drug to the prescriber 
(Parker & Pettijohn, 2006). Despite developments in pharmaceutical drug promotion in 
developed markets like the United States, where direct-to-consumer marketing through 
the media is allowed, such methods are still prohibited in markets like Kuwait.  Despite 
this, over the past two decades, changes have occurred in some emerging markets with 
regard to regulations on the promotion of pharmaceutical products. With the advent of 
OTC products, for example, main supermarkets in Kuwait were allowed to promote OTC 
medications through direct interaction with consumers.  
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An index ROI can be used to measure the effectiveness of a marketing program 
and can provide a key performance indicator (KPI) to measure the outcome of a 
marketing investment. It can also help in evaluating which marketing activities increase 
the trust all company departments have in marketing activities and which allow for 
proper evaluation (Solcansky & Simberova, 2010). Measuring ROI is no longer a luxury; 
it is a necessity. However, due to the amorphous nature of many marketing projects in 
the healthcare industry, the determination of the return on marketing investment 
(RoMI) has been considered impossible (Spiegelman, 2003). Many studies have 
suggested that scholars and managers should focus on developing the RoMI measure, so 
as to help marketers and executive managers reposition marketing expenditures in the 
way that best serves the organization and the business (Seggie et al., 2007). Considering 
the maturity level of pharmaceutical marketing in emerging markets, the current 
necessity of measuring ROI, and the lack of studies that have worked on developing an 
instrument to measure ROI in the pharmaceutical industry, particularly with regard to 
OTC products, the current research aims to investigate RoMI and to measure the impact 
on sales of various marketing activities.   
1.6  Research questions 
This project attempts to answer the following research questions in order to meet the 
study’s goals and objectives: 
 How do pharmacists perceive the OTC promotional activities? 
 What are the most effective OTC marketing activities in terms of sales, from the 
pharmacists’ point of view? 
 What are the most effective OTC marketing activities in terms of ROI, based on 
data collected from the survey distributed to pharmacists? 
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 In the post-intervention phase, what are the most effective OTC marketing 
activities in terms of sales? 
 In the post-intervention phase, what are the most effective OTC marketing 
activities in terms of RoMI? 
The intervention phase is the phase in which the action research is conducted.  
1.7 Research goals and objectives 
The long-term goal of the study is to provide a practical solution that can assist sales 
and marketing managers in finding the best approach to investing in the marketing of 
an OTC business in the pharmaceutical industry. The research aims to build on the 
agenda presented by the 4th annual Pharmaceutical Marketing Conference, where it was 
concluded that measuring marketing ROI is on the agenda of many marketing managers 
in the pharmaceutical industry, and that the difficulty in measuring the RoMI is present 
at both the company and product levels (Agterberg, 2005). The conference also stated 
that ROI should remain a common focus for marketers as they are asked to cut 
marketing budgets and deliver higher profit margins. It has been concluded that the 
best way to achieve that is by building a better understanding of ROI analysis(Rod, 
2006).  
The first objective of the study is to examine pharmacists’ perceptions toward 
the new marketing trends related to OTC products and to determine the most effective 
marketing tools to be used inside the pharmacy channel in terms of impact on sales.  
The second objective is to determine the most influential factors in terms of RoMI from 
the survey data collected. This data includes pharmacists’ assessment of the impact of 
different marketing activities such as point-of-sale materials, detailing to physicians 
through the generation of prescriptions, and detailing to pharmacists. 
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The third objective is to determine, based on survey data, which action plan is 
most effective for generating the highest possible RoMI and which marketing activities 
for analgesic OTC products have the strongest impact on sales. The reason for selecting 
analgesic OTC products was because analgesic product pain lines have the highest 
market share in terms of volume and value, according to AC Nielson data, achieving a 
total sales value of $4.5 million and around 220m units sold in Kuwait. The significant 
size of the analgesics market reflects the marketing spending power that this line 
possesses versus other lines. That justifies the selection of the analgesics line as the 
subject of study in this research. At the post-intervention stage, the most effective driver 
of sales and RoMI in terms of marketing activities can be determined.   
1.8 Structure of the Thesis 
This thesis is divided into eight chapters that can be summarized as follows:  
Chapter One provides the study background, elaborating on the pharmaceutical 
industry, the market for OTC medicine in general, and the challenges pharmaceutical 
marketing executives face in measuring marketing’s impact on sales and return on 
marketing investment in such a highly regulated market. The chapter touches on the 
problem statement, research questions, goals and objectives. Chapter Two covers four 
key aspects related to this research. The first is how the literature has tackled the 
challenge of calculating RoMI, particularly for the pharmaceutical industry. The second 
aspect is how the OTC medicine market has evolved and how the related regulations 
have changed from a marketing perspective. The third aspect is related to the 
importance of emerging markets. The fourth aspect is related to marketing in the 
pharmaceutical industry, including which options are currently available for marketers 
in that industry. Chapter Three consists of the conceptual framework development, 
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which models were used for this research, and how the framework was adapted to the 
research goals and objectives. The chapter touches on the background of the survey 
used for the research and elaborates on the RoMI model used for the action research 
component. Chapter Four elaborates on the quantitative and action research 
components. Most importantly, the chapter highlights the inclusion and exclusion 
criteria and sample selection for the quantitative component. The chapter also 
elaborates on the metrics of the ROMI model utilized in this research, and how the 
model has been customized to serve the research goals and objectives. Chapters Five 
and Six provide a detailed discussion of the results and analysis of the research. Both 
chapters highlight the limitations and challenges experienced during the research. 
Chapters Seven and Eight highlight the overall conclusions of the research and the key 
findings after combining the results of the quantitative and action research 
methodologies. Chapter Eight touches on the necessity of continuing work in this critical 
research area in order to achieve better practical and theoretical implications, and 
discusses the key limitations.  The final chapter, Chapter Nine reflects on the journey of 
the research in the scholarship of practice.  
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2.1  Introduction  
 
This chapter covers an extensive review of the pertinent literature regarding key 
aspects related to the study. Four important aspects are covered in this chapter. First, 
the chapter provides an overview of the recent literature, some of it specific to the 
pharmaceutical industry that touches on the evolution of the RoMI calculation and the 
key challenges that have been faced. Second, the chapter gives an overview of the global 
OTC market, including why OTC medicines are becoming more important and how they 
provide greater economic benefit and welfare to nations around the globe. Third, 
emerging market perspectives are covered, including why emerging markets are 
considered important for all main industry players. Fourth, the chapter looks at how 
marketing in the pharmaceutical industry has evolved, how it can trigger revenue 
growth and how it differs between regions.  These four key aspects are essential for this 
study, which aims to measure marketing’s impact on revenue and RoMI in an emerging 
market for the fast-growing OTC pharmaceutical product category.  
 
2.2  Overview of RoMI measurement  
 
Measurement of return on marketing investment is important because it helps measure 
performance outcomes through real life examples. Although cases are complex and 
there are a number of factors that affect the statistical analysis, the average result of the 
analysis will help managers determine how to reallocate expenditure on promotional 
tactics (Wittink, 2002). Healthcare organizations are now considered to be more 
accountable for measuring RoMI for particular markets. As this information is needed 
by the board of directors and executives of an organization on a regular basis, the 
importance of measuring RoMI has become more essential than ever. Marketing 
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personnel are now required to justify the money and resources they spend on 
marketing efforts. They must also present the entire dataset in order to obtain efficient 
sales channel support from their firm, which can help enhance revenue generation 
(Spiegelman, 2003).  
Spiegelman (2003) writes that market investment decisions at many 
organizations are made with the help of sales data regarding market resource 
allocation. In many cases, no attention is given to the impact of investment allocation 
rules, and as a result, resources are allocated to sub-markets.  It was previously thought 
that the level of investment was much more important than resource allocation. 
However, different submarket sales examples have shown that aggregate sales response 
functions are significantly affected by investment level decisions. Aggregate sales are 
more sensitive to improvements in investment allocation rules. Therefore, the resource 
allocation budget requires more attention to market budgeting with sufficient 
justification to ensure that the return is satisfactory and meets expectations.  
Phillips (1997) states that there are always some financial and non-financial 
issues that need to be assessed by qualitative and quantitative data measurement. 
Strategic issues are usually based on both technical and non-technical perspectives. 
There is always a need to collect information through conventional means of data 
collection and to incorporate such information into current models so that the impact of 
future activities can be predicted and assessed through more developed measures. 
Measuring RoMI more accurately is critical for implementing a planned action. It also 
helps boost confidence through better information as well as facilitating its application 
by solidifying the decision making base. Knowing RoMI helps in determining the 
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business impact by incorporating a technique that affects the strategic planning in the 
long run (Phillips, 1997).  
According to Seggie (2007), there is no shortage of measures for use in 
marketing field; however, disappointment often results from the use of these metrics. 
Marketers face the challenge of defining suitable measurement metrics that can be 
successfully applied to all industries. In the case of return on investment, measuring the 
success of product strategy, advertising campaign and distribution strategy is a 
challenge. The problem is that in these areas of marketing, the money that is spent is not 
directly correlated to measurement metrics. Hence, the need for information about the 
outcomes of marketing efforts becomes greater. As marketing is a field that influences 
most corporate functions, any process that can help in measuring and tracking 
quantitative data is of great importance (Seggie, 2007).  
Seggie (2007) also asserts that nowadays, industry specialists and academics are 
willing to find ways that can help them evaluate value-added measures within 
organizations. Most of the accounting measures that have historically been used are 
currently not capable of measuring performance in every unique case (Seggie, 2007). 
The process of determining RoMI is complex, and many healthcare organizations have 
been challenged with finding the right method for its calculation. The amorphous nature 
of this process and wide range of influencing variables have made it difficult to measure 
the success of a marketing investment. That is why RoMI has been considered virtually 
impossible to measure.  
Determining return on investment helps identify brands that are high in demand, 
making reallocation less uncertain. For example, Wittink (2002) studied 20 brands of 
asthma treatments and measured their ROI. It was found that medical journal 
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advertising (JAD) provided the highest ROI, meaning that its ability to bring in a return 
was greater than that of any other studied marketing instrument. The information 
received from ROI can also be used to determine patient loyalty, the profitability of 
hospitals and revenue generation (Wittink, 2002). The literature stresses the 
importance of measuring RoMI in the healthcare industry, and some literature assesses 
marketing and sales activities in terms of ROI for certain therapeutic areas, like asthma 
and chronic disease therapies. While the majority of studies look at developed markets 
like the United States, there is a clear gap regarding the assessment of ROI for OTC 
medicines in emerging markets.    
2.2.1 Difficulty of measuring ROI in the healthcare industry 
 
Up until now, various techniques have been described for measuring return on 
investment. However, healthcare industry practitioners agree that measuring RoMI is a 
difficult challenge. One reason is the complex nature of the healthcare industry, which 
requires a lengthy process and a delay in time between introducing a product and 
obtaining the regulatory approval for promotional activities to receiving an assessable 
sales outcome. It is now a widely accepted fact that healthcare promotion cannot be 
done through marketing only. Decision makers need evidence-based results to develop 
trust in a given service. At the same time, measureable return on marketing efforts is 
not easy to obtain in the case of the healthcare field (Thomas, 2002).  
In addition to the above, there are other challenges as well. For example, the 
actual sale of a given product does not occur when it leaves the pharmaceutical 
company; it happens at the pharmacy after a physician has prescribed the product to a 
patient. Therefore, many transactions are required in order to complete the actual sale. 
Many pharmaceutical companies do not track the average length of time that customers 
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use a particular product because aggregate data would be needed for this measurement; 
such information is held by the pharmacy where the sales took place. Due to privacy 
issues, the lack of access to the required data makes it harder to measure return on 
investment, and thus the incremental value required to enhance marketing efforts 
cannot be easily determined. There are ethical issues as well. For instance, patient-
related data cannot be shared freely. Furthermore, many ethical issues can arise if 
patients are segmented on the basis of the medicine they use (Thomas, 2002).  
Thomas (2002) adds that marketing is also a young discipline in the healthcare 
field. Hospital management often does not have sufficient knowledge about marketing 
issues; the same is true for administrators. Thus, healthcare providers do not have the 
advanced expertise in marketing that would allow them to try different methods for 
measuring return on investment and finding the best one (Thomas, 2002).  
2.2.2  Evolution of RoMI measurement 
 
The measurement of ROI has evolved over time. This development is still in progress, as 
conventional measures are in most cases historical, and the long-term performance of 
the company cannot be measured. Assessment of marketing’s impact sometimes takes 
time to reach to an assessable level and cannot be done through conventional means. 
Nowadays, the past performance of a firm cannot be used as the sole predictor of future 
performance. Hence, marketing investment decisions might require additional 
information. Long-term perspectives need to be considered in order to form the true 
picture (Seggie, 2007).  
According to Phillips (1999), measuring the return on investment has been an 
evolutionary process that has redefined itself over the last 25 years. Hundreds and 
thousands of studies are conducted every year and many of these studies are also 
 
 
26 
published. More than 20,000 workshops are conducted each year, attended by 
managers and specialists in the field. Almost 4,000 people have received certification in 
ROI measurement and many books on the topic have been written in more than 40 
countries. Many researchers now agree that ROI helps align business needs with targets. 
It also aids in earning respect from senior management and support for future projects. 
During RoMI model design and implementation, the overall process can be enhanced 
through the accumulation of knowledge and utilization of the most recently developed 
industry-specific ROMI model, which can be adapted to the particular firm’s investment 
plan.  
Stewart (2009) proposes that knowledge intensive environments nowadays 
require competencies and skills that can help determine a company’s intangible assets. 
The intangible assets of a firm create almost 69 percent of its total market value. In the 
past, these assets were thought to create only 17-18 percent of a firm’s market value. 
Marketing expenditures serve as investments and hence there is a need to ensure that 
the value of these assets is measured by metrics. However, if these metrics are not 
correct, they can be misleading, giving rise to a number of issues.  Along with this, the 
accuracy of subjective performance measures is also under debate. There is always an 
immaterial difference between the financial performance of a company and subjective 
measures.  In the past, marketers relied largely on subjective measures, such as product 
attributes, customer satisfaction and associated segmentation.  These subjective 
measures have more to do with marketing plans and actions. On the other hand, relative 
metrics such as those showing competitors’ actions and maintaining focus on firms can 
provide good information that can help in improving resource allocation and return on 
investment. Sustained differentiation and continuous ROMI model development can 
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help firms position themselves in the market favourably compared to rivals (Seggie, 
2007). 
The above paragraphs have shown that corporate drivers require the continuous 
development and identification of metrics to measure the effects of marketing 
investment. There is also a need to develop the technological components that facilitate 
the development and use of such metrics. New metrics can begin with new technology, 
such as the Internet and various forms of media. Necessary monitoring can also be 
performed via customer relationship management, organizational resource learning 
and the monitoring of electronic cash registers. Information technology can further help 
the firm and provide it with new metrics. The creation of a database starts by tracking 
the activities of customers, thus providing marketers with the possibility of creating 
new metrics. For instance, the British tourism company Thompson Holidays used this 
procedure to determine the profit per customer trip.  The data obtained from customers 
helped the company understand how brand loyalty was maintained. This led the firm to 
target customers who were loyal to the firm. Many other firms have also used customer 
relationship management (CRM) programs to gain the same information (Seggie, 2007).  
In the area of efficiency, major breakthroughs and better control can be obtained 
if independent metrics are translated into causal chains, or models. With the help of 
such models, marketing strategies can be evaluated and their effectiveness can be 
determined in terms of their effect on the bottom line. This will help in selecting the 
most profitable course of action. In addition, intermediate variables are generated from 
the model and these can help determine market share and customer attitudes, and can 
be used to measure performance. These performance indicators can be monitored and 
controlled, and corrective action can be taken to enhance financial performance. 
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However, there is a limitation as well. According to Seggie (2007), the effect of strategic 
tactical actions on intermediate variables has only been studied by a few researchers. 
This is the reason why the relationships between financial performance and marketing 
actions cannot be completely understood. In the case of physical science, formal 
experimentation can be used to explore such relationships. Here, systemic manipulation 
of variables and interests can be done. However, such controlled studies are unrealistic 
when it comes to the marketing environment. The reason is that the external 
environment in which a company operates is not under the control of the researcher. 
This means that causal analysis will develop slowly and conclusions will be tentative in 
nature (Seggie, 2007). 
Seggie (2007) identifies seven elements that should be taken into account in 
order to create a useful framework. These include the financial, long-term, forward 
looking, relative, micro, objective and causal elements. It is important that mangers 
learn the importance of these elements and make sure that all the dimensions are fully 
satisfied. Repositioning marketing expenditures can be done using the elements, and 
return on investment can be calculated. In several cases, when marketers link financial 
outcomes to marketing efforts, the challenges faced in implementing a strategy can be 
reduced. When rigorous metrics are created, measuring return on investment can be 
done more easily (Seggie, 2007).  
Phillips (1997) adds that input measures, including efficiency in marketing 
planning and actions, and precise market data collection, help determine the reactions 
of participants and/or stakeholders to the marketing program. Learning measures that 
are adopted from such data help determine changes in attitudes and behaviours. 
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Business impact measures help assess changes in customers’ behaviour and ROI 
outcome in order to compare costs and benefits (Phillips, 1997:139).  
Mantrala (1992) conducted three case analyses in order to determine how 
allocation decisions are affected by dynamic problems such as sale-specific functions 
and parameter value. Simple, cross-border changes in submarket allocation can reflect 
investment level decisions. Mantrala’s (1992) studies show that simple, cross-border 
changes cannot be obtained with submarket allocation. Operational as well as 
behavioural difficulties are present that can affect allocation changes, but the ultimate 
payoff is high. In order to find the right solution, close coordination between allocators 
and investors is needed. Mantrala (1992) shows through his research that aggregate 
sales response is affected by resource allocation rules and that the optimum investment 
level can be determined by the investor. These results show that there is a need to 
maintain a correlation between investment levels and allocation decisions. Many 
normative models such as these have been prepared by marketing specialists, but the 
use of such approaches remains limited. The increased variability of aggregates—for 
example, single source, scanner and scanner panel data—can change this situation. In 
short, directing more time to resource allocation decisions is required before increasing 
the level of investment. Moreover, advertising allocation decisions and pulsing decisions 
should also be examined (Mantrala, 1992:138). 
Spiegelman (2003) devised an accurate method for measuring the return on 
marketing investment. According to the author, call centres can act as a marketing 
channel. Hospital call centres, for example, can execute an inbound or outbound 
telemarketing function to obtain the information required to sponsor a particular 
program. The calls are generated as a result of marketing efforts made by the hospital; 
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these calls primarily include requests for health-related information and service 
referrals (Spiegelman, 2003).  
Measuring RoMI through call centres is a recently developed technique; more 
studies are still required to assess whether this technique provides accurate results. 
Despite this, the process is already being applied by some hospitals. New York Hospital 
Queens (NYHQ), for example, a 439-bed teaching hospital, is employing this procedure 
not only to measure return on investment but to ascertain whether the call centre is 
performing within the required limits (Spiegelman, 2003:147). Chances for inaccuracy 
are still present when measuring ROI through call centres. This was found by Paul 
Pickard, a senior marketing officer at NYHQ. In order to reduce confusion, Pickard 
factored some amount of duplication into the equation. The formula errors were 
reduced by removing factors that hinder accurate patient tracking, allowing the 
measurement of ROI with considerable accuracy (Spiegelman, 2003).  
Khaled (2013) created a technique using a balanced scorecard that includes 
different dimensions of the organization’s future performance. Financial performance 
measures are used to give a clear picture of what the company can achieve in the future. 
Performance indicators are combined with key success factors and the sequence chain 
of goals. Most of these goals are dependent on one another, connected by relevant 
procedures and actions. In this way, the balance scorecard is used as a tool to help 
revitalize company performance in several business units. The four most important 
dimensions in this regard are growth and education, and financial, customer and 
internal processes. This model is called the Balanced Score Card Model or BSC. The 
information obtained can help determine the effectiveness of the strategy being used. 
Based on the given environment, the needs of the company require appropriate 
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strategic execution, since the organization can go in the right or wrong direction based 
on financial perspectives, internal processes and learning growth (Khaled, 2013).  
Stewart (2009) suggests a process for determining causal links amongst financial 
performance metrics such as outcome and financial performance. In this research, a 
number of surveys that were done for marketing accountability were taken into 
account.  The American Productivity and Quality Centre did surveys with the ARF 
(Advertising Research Foundation). At the same time, ANA (The Association of National 
Advertisers) also conducted surveys and a great amount of consistency between these 
surveys was observed.  
Stewart (2009) stresses the importance of cash flow, calling it the ultimate 
marketing metric. It is important to identify the actual source of cash flow and the 
development process through which it takes place. Cash flow acts as the main financial 
metric for businesses, allowing them to assess products, the business and customer 
activities. Customer retention can be determined using information about cash flow. 
Business models can also be prepared from cash flow movements by using elements 
such as margins, categories and leverage.   
Stewart (2009) further adds that standard measures are required to improve 
marketing outcomes over time. There is a need to assess how the business is 
performing in relation to the past. This tells managers whether or not their performance 
has improved over time. In a competitive market, standard measures and metrics can 
fulfil this need and provide solutions to relevant problems. However, the providers of 
metrics should ensure appropriate transparency if a company is investing in metrics. 
For this reason, companies should share information about the validity of the metrics 
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provided to the organization. This might be considered similar to giving away trade 
secrets, as such information is of competitive value.  
Phillips (1997) created an ROI framework and described its various levels. The 
first level is reaction and planned action, in which the satisfaction level of participants is 
determined according to program and project. This level assists in starting planned 
actions. The second level is learning that measures frequent changes with regard to 
skills, activities and knowledge areas. The third, application level, aids in the 
measurement of changes in job behaviour. Finally, the business impact level helps 
identify changes in business impact. With this framework, the costs and benefits of a 
program are identified and return on investment is determined. Some important 
elements while measuring return on investment include the life cycle of the program 
and its linkage to the operational goals. The importance of strategic objectives is 
considered and the visibility of the program is taken into account. Finally, the size of the 
target audience and the investment time needed assist in determining return on 
investment. On the basis of these elements, the ROI process includes some integral 
steps. First, evaluation is done to develop solution objectives and plan baseline data. 
Collection of data is done during implementation of the solution and then again when 
the project is completed. The data are then analysed to isolate effects and convert them 
to monetary values. The data are tabulated and solution measures are identified. Then, 
the impact of the study is assessed. According to Phillips (1997), building an ROI 
scorecard is a process that helps in gaining a macro-level perspective of the success of 
the company. It can be seen as a brief report from a detailed study that can be used to 
find connections between business objectives and training contributions. The process 
involves integration of various kinds of data that can be used to determine alignment 
amongst different programs, operating goals and strategic objectives. Phillip’s (1997) 
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scorecard includes seven kinds of data. At level one, reaction and satisfaction are 
measured. Then, learning and business impact are assessed. After this, application 
barriers and enablers are observed and business impact is checked. Finally, tangible 
resources are used to measure return on investment.  
The RoMI club model presents a framework that is tailored to fit the needs and 
demands of a company (Woodburn, 2006).  The RoMI model starts with the calculation 
of the company’s performance. Then, its profit is calculated and a forecast is made for 
future results. The market segment is another important aspect of this model. 
Measurement of return from each segment is needed so that better strategies can be 
developed. In the case of the RoMI model, today’s competitive advantage factor is seen 
as tomorrow’s qualifying factor. According to this model, communicating decision 
making and clarifying expectations are two methods that can help in quantifying pre-
declared assumptions. This is the main reason that quantification of assumptions is a 
necessary element. Here, data collection alone is insufficient, and valid predictions 
about the future can only be made by capturing real-life observations. Such 
observations are then quantified and methods for improvement are suggested to the 
company. Testing of the RoMI model is required in order to ensure its validity 
(Woodburn, 2006).  
According to Reinartz (2000), focusing on customer loyalty can help reduce costs 
and obtain better return on investment. Loyal customers show a tendency to spend 
more money with the firm, as compared to those who are not loyal. Differentiated 
analyses can be made more fruitful when clear-cut, positive, profitable, lifetime 
relationships are created. Loyal customers provide rigorous empirical evidence of the 
benefit of lifetime and value-added relationships. Short-term customers, on the other 
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hand, do not provide valuable data, as they do not have a tendency to create a lifetime 
relationship with the company. It is unknown whether they will buy the same product 
in the future. Expected revenues can be forecast more easily when situations are 
contractual. In other words, when continual use of services is assured—for instance, 
with magazine subscriptions or cell phone services—revenue can be forecasted. When a 
contractual situation is in place, cumulative profits can be gained and this can be 
expected for the lifetime of the contract. In the case of non-contractual situations, on the 
other hand, it becomes imperative for the company to keep the relationship alive for as 
long as possible. Another method for relationship marketing that can help in collecting 
data is catalogue marketing. This includes preparing catalogues for selected lists of 
customers based on the products they buy. Catalogue marketing also creates a 
differentiated lifetime profitability analysis, which can further reduce the cost of 
marketing and increase the return on investment. According to Reinartz (2000), there 
are techniques that can help with identifying long- and short-term customers. The 
database created from the customer list can be used to determine the time that elapses 
between purchases. The general nature of the customer can be identified with the help 
of such information. Lifetime expectations as well as an individual’s specific priorities 
can also aid in finding dynamic characteristics that can allow managers to create better 
customer relationships and achieve a good return on investment (Reinartz, 2000).  
2.2.3 Managerial implications of measuring RoMI 
 
Several marketing examples have been used to determine the marketing mix as well as 
which interactions can affect return on investment (Narayanan et al., 2004). Narayanan 
et al. (2004) elaborate on the impact of marketing mix variables and how these 
variables interact to impact return on investment. Their study focuses on feasible 
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promotional tools that are accepted by regulators and which can be employed in the 
market.  In this context, managers from the pharmaceutical industry need to understand 
a few things. First to of all, it is important to note that the interaction between prices 
and detailing is negative. In most cases, high prices negatively affect sales, especially in 
free markets like the United States. At the same time, managers who focus on higher 
detailing make their product even more price sensitive. Marketing efforts have a 
tendency to raise prices, while detailing efforts can help in reducing price. Several other 
elements can also affect managers’ decisions regarding investment and price 
management. The fact is that without suitable metrics, it is impossible to accurately 
measure return on investment and determine the effectiveness of sales efforts. The 
concept of ROI is an ongoing process and pharmaceutical companies need to measure 
their performance in various market segments. Practical studies can help in 
determining the validity and usability of these ROMI models. In addition, the idea that 
ROI is only necessary in companies with high profit margins is untrue; smaller 
companies must also contribute to this field. In short, there is much to do to understand 
why it is important to measure marketing performance and how it can be done 
successfully. Thus, this study should contribute toward a better understanding of how 
to select effective marketing activities based on their impact on return on investment by 
offering a model that can provide guidance on this. This is important, as the literature 
suggests that more work needs to be done and smaller companies need to contribute to 
this field.  
2.3 Overview of the global OTC market  
  
The global OTC market has seen an almost 3.4 percent growth over a period of 10 years, 
and as of 2013, the pharmaceutical market was worth 752 billion USD. In most 
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developing economies, consumer awareness regarding certain medicines and their uses 
has increased to a great extent, and the credit goes to information technology. The 
introduction of the latest blockbuster drugs and the relaxation of rules and regulations 
related to the sale of OTC products have also rendered the area more attractive for new 
entrants. In 2009, about 60 percent of total OTC sales were seen in Europe and the US. 
These countries still account for the highest sales globally, and despite strict rules and 
regulations, the market is growing quickly. The same is true for developing countries. 
The market is now maturing and the scope of growth has reduced to a considerable 
extent. Easing of advertising restrictions has also made it possible for pharmaceutical 
companies to shift growth to other distribution channels. In many countries, quick 
switching from Rx to OTC has added to this phenomenon (Greene & Commission, 2007).   
Novartis, GSK, J&J and many other names offer OTC drug products because of the 
attractiveness of this market. After the pharmaceutical and medical device markets, OTC 
remains the most lucrative option globally. This attractiveness has resulted in a series of 
acquisitions and mergers in the field. The high-profile merger of Pfizer with Wyeth, for 
example, took place in 2009. Many other companies have also changed their consumer 
health businesses to adapt to the market. Some mergers have proven very successful 
while others have been less so. When undergoing downsizing, companies often prefer to 
retain their OTC manufacturing unit. For instance, the Indian pharmaceutical 
manufacturing company Piramal sold its formulation division to Abbot but continues 
business with its OTC department (Greene & Commission, 2007).  
The OTC drug market is characterized by multiple local players throughout the 
world. Multinational companies sometimes pursue mergers and acquisitions with these 
local companies to take advantage of their strong distribution channels in local markets. 
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Global pharmaceutical companies have utilized the over-the-counter platform to drive 
business, and transferring Rx products to OTC remains a main strategy in these firms. 
Because of the emergence of new competitors, the OTC market has become challenging. 
Higher marketing and advertising budgets are being allocated by multinational drug 
manufacturing companies in order to maintain their place in local markets.  
The perception of OTC products has changed over time and manufacturers of 
these products now consider OTC an important part of their business. Since OTC 
products are facing intensified competition, it has become crucial for companies to 
employ serious marketing and advertising plans. Funds should be allocated for 
improving penetration into deeper market segments. The OTC market must be carefully 
studied before finalizing the plan. This is because in most developing countries, product 
sales are driven by both doctors and pharmacists, who can increase or diminish the 
popularity of the product. However, in other countries, pharmacists should remain the 
focus of attention for OTC marketing campaigns, as they have direct contact with the 
client who is deciding whether to buy a particular product on the basis of the 
information provided to them. The pharmacist is the central figure at the point of sale, 
having direct interaction with the consumer as the receiver of the prescription and 
distributor of the product. Therefore, the survey in this study was distributed to 
pharmacists. Pharmacist perceptions have not been studied in the context of 
organizations similar to the one in this study.  
OTC manufactures use the FMCG (Fast Moving Consumer Good) approach to 
connect with consumers at a demonstrative level. This approach increases awareness of 
the brand and can help in building brand loyalty. In the current market culture, 
television advertisements and print media are not providing satisfactory results when it 
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comes to product marketing. Companies are now seeking out and testing innovative 
mediums for advertising. Most pharmaceutical companies know their target consumer 
and are placing their marketing campaigns on social networks (Kaplan & Haenlein, 
2010). It is very important in marketing to access the consumer for whom the company 
is making its product. The first brand to employ such innovative ideas on new mediums 
for advertising was P&G Vicks. In the early eighties, almost all companies enacted the 
idea of mass sampling by providing product coupons in newspapers.  
2.3.1  Efficiency and market benefits of OTC products  
  
OTC medicines are less expensive than their branded counterparts; hence, they have a 
positive impact on the economy. Approximately 86 percent of consumers believe that 
using OTC medicine helps lower their healthcare costs. One study by Paul (2011) 
estimated that consumers in the United States can save $5.2 billion annually by 
increasing self-care through the use of OTC medicines. At the same time, OTC medicines 
can help consumers reduce frequent and excessive visits to prescribers (Paul, 2011). 
The World Health Organization (WHO) has also sanctioned the switch from 
prescription to OTC status for medicines that have shown positive results. When 
medicines are used wisely after safety has been proven, they can be delivered for 
consumer use. A great example of a positive outcome from OTC medicine can be seen 
with nicotine replacement therapy (NRT). The therapy greatly reduces the burden of 
diseases caused by tobacco use. Internationally, it was noted that 37 percent of smokers 
have used OTC-NRT to quit smoking (Wakefield et al., 2008). 
OTC products are not only useful for providing greater access to healthcare, but 
they also show positive economic benefits. Medical treatment using OTC products is 
very affordable. These products save money for both consumers and the healthcare 
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system by reducing redundant visits to doctors for self-treatable conditions (Paul, 
2011) 
2.3.2 Categories of OTC medicines 
 
A number of therapeutic categories of medicines are sold over the counter; the leading 
among them are antipyretics, ophthalmic drugs, analgesics, dental products, smoking 
cessation products, gastrointestinal products, dermatology products and first aid 
supplies. When dietary supplements and OTC medicines are combined, they make up a 
multibillion dollar business. OTC medicines have spread to more than 80 countries and 
the market is still expanding as more and more companies are seeing the success this 
area can offer. Easy access to OTC medicines in both developed and developing 
countries helps people to take a more active role in managing their own health. They are 
enabled to easily treat common illnesses without having to make expensive visits to the 
doctor (Engel & Straus, 2002).  
Along with the OTC categories discussed above, health supplements, 
contraceptives and energy boosters have also become a focus for many pharmaceutical 
manufacturers. This has happened because people are now more interested in 
improving their lifestyle, either by performing well at their jobs, or using energy 
boosters or contraceptive medications. Similarly, brain boosting formulations have also 
entered into the OTC market (Engel & Straus, 2002). 
2.3.3 Policies on the delivery of OTC products 
 
The delivery and classification of OTC medicines mostly depends on the national drug 
policies of a given country. It is the responsibility of the nation to decide which self-care 
medications need to be regulated. Companies need to encourage the trend of making 
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safe medicines accessible to the public without a prescription. Policies and regulations 
vary from country to country. Some countries like the United States have well-
developed policies and regulations that encourage OTC medicines, whereas other 
countries continue to take a conservative approach regarding self-care and are reluctant 
to approve OTC medicines.  
At this point in time, when expansion related to medicinal products is occurring 
in most developing countries, many OTC producers have shown strong growth in 
emerging markets. When it comes to emerging markets, sales of OTC products have 
shown steady growth compared to prescription-only products. Although many attempts 
have been made by some governments to reduce self-treatment around world, the 
practice remains prevalent. Russia and China are at the top of the world’s emerging 
markets with regard to the sale of OTC medications.  
2.3.4 Competitive environment 
 
The OTC market in most countries is dominated by multiple multinational 
manufacturers. However, local players also hold market share due to strong distribution 
channels and deep penetration in local markets. Many multinational companies agree 
that OTC products have been a source of growth and profit, bringing immense benefits 
to the business. Novartis, GSK and Bayer are some leading multinational players in OTC 
products in emerging markets. The growth of the market has increased since these 
major players began to consider OTC medicines as an important aspect of their 
business. This is the reason why all the large manufacturers in the OTC market have 
invested significantly in research and development activities for safe, over-the-counter 
treatments of minor illnesses (Greene & Commission, 2007).  
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2.3.5 OTC medicines and the pharmaceutical industry 
 
The pharmaceutical industry has received immense benefits from the sale and 
marketing of OTC products. Many public healthcare professionals, consumers and 
marketers value the efficiency and expediency of OTC medicines. The pharmaceutical 
industry recognizes that OTC medicines provide easily accessible treatment for minor 
illnesses. Novel medicines that are available through the prescription-to-OTC 
transformation process increase the opportunity for greater self-care and patient 
liberation. 
Media reports have predicted that in the leading markets for OTC products, 
revenue will double by 2023. These markets include countries such as the US, the UK, 
Japan, Germany, Italy, Spain and France. Along with these countries, nations such as 
China, India, Brazil and Russia will also gain economic benefits from the marketing of 
OTC products such as analgesics, dermatological products, allergy medicines and 
products used for the treatment of GIT infection (Custodio et al., 2014).  
2.3.6 What drives the growth of the OTC market? 
  
 A number of factors drive growth and productivity in the OTC market. These factors are 
diverse and can range from relevant stakeholders interest to population growth and an 
awareness of the importance of preventive therapies. Amongst these, awareness is the 
major factor that encourages people to take initiative regarding self-medication. 
Although there are certain risks associated with self-medication that have hindered the 
growth of the OTC market, many benefits exist. Regulatory bodies in both developing 
and developed countries are attempting to reduce these risks, which can include 
incorrect self-diagnosis, delay in treatment and drug misuse (Rajan & Glorikian, 2009). 
One important element highlighted by Greene and Commission (2007) is the increased 
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focus on wellness instead of illness.  Information about medicines and their positive role 
in improving wellness should be shared. As the cost and complexity of seeking medical 
treatment increases with time, it has become easier for people to turn to OTC products. 
At the same time, increased disposable income and changes in lifestyle have also 
resulted in a positive impact on OTC sales. These elements should be understood in 
depth in order to ascertain proper marketing strategies, because these are the factors 
that will ensure a healthy growth rate for OTCs in the coming years (Greene & 
Commission, 2007).  
Another factor that affects the growth rate of the OTC market is the speed with 
which the Rx is converted to OTC status.  In the UK, where additional clinical trials are 
required for this process, exclusive rights are given to the prescription manufacturers to 
enable them to sell their products in the OTC market. However, the potential for growth 
is greater in emerging markets, where additional clinical trials are not required (Rajan 
& Glorikian, 2009). Some of the important factors for consumers with regard to the OTC 
sector are the following: 
1. Time and money: People now have less time to see doctors and do not prefer to 
spend money to visit them for minor illnesses. Both the lack of time and the lack 
of money increase the importance of OTC medicines, which can be used to 
manage seasonal health issues. 
2. Belief: People now have enough health awareness that they want to treat minor 
diseases on their own. Thus, the belief in self-medication and the indirect belief 
in OTC products have increased. 
3. Pharmacists: Individuals now prefer to take the advice of pharmacists for some 
very minor and seasonal health problems such as the cold, cough, influenza, 
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headache, minor pain, etc. Thus, the importance of pharmacists has increased. In 
some ways, they are seen as doctors, as they are able to write prescriptions for 
chronic diseases.  
4. Awareness: The awareness related to some medicines has increased and people 
have come to realize that some medicines should be present in the home at all 
times. After this realization and awareness, some OTC medicines have become 
major grocery store items. These include cough syrups, Crocin, pain relief tablets 
and balms.  
5. Lifestyle: Changes in lifestyle have also increased some of the lifestyle diseases 
that require herbal medicines with fewer side effects. For example, obesity has 
become a major health issue in the urban lifestyle and thus the demand for 
slimming products has increased (Greene & Commission, 2007).  
 
2.4  Emerging markets in the pharmaceutical industry 
The pharmaceutical industry is considered to be an operational stage of the healthcare 
environment, where it is involved in discovering and meeting medical and consumer 
needs. The pharmaceutical industry is also considered one of the most dynamic 
industrial sectors, consisting of 200 major global competitors who focus their resources 
on areas of expertise, in which they have invested in the development of know-how 
(Dogramatzis, 2002). According to the IMS (2011), the global pharma market is worth 
over $700 billion per annum, of which research and development accounts for around 
16%, manufacture around 29% and sales and marketing around 36%. 
The emerging markets have been evolving with regard to the pharmaceutical 
industry, and according to Mackey & Liang (2012), regions like Africa, Asia (excluding  
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Japan) and Latin America have experienced higher pharmaceutical industry growth 
rates compared to other regions, with high growth projected to continue into 2020.  The 
expectation is that these emerging markets will account for 20% of total global 
pharmaceutical sales by 2020. These markets are thus considered to be the future of the 
pharmaceutical industry in terms of sales and marketing activities. The key drivers of 
this expected growth are high population growth and unmet healthcare demands.  
According to Campbell (2010) and PricewaterhouseCoopers (2007), marketing 
in emerging markets is considered complicated due to undeveloped anti-corruption 
laws in these markets coupled with stringent anti-corruption laws in the United States 
and United Kingdom. Serious fines can result from breaches of these laws. High market 
growth rates and ambiguous regulations in emerging markets may represent a good 
business opportunity for cost-effective pharmaceutical marketing if done using a well-
studied approach.    
Considering the unique and positive economic indicators of emerging markets 
and the literature’s suggestion of the importance of emerging market evolution, it is 
important to conduct study that assesses the impact on sales and return on investment 
of marketing activities for OTC medicines in an emerging market. 
2.4.1 Emerging economies and OTC medicines 
  
The demand for affordable medicines will only increase with time in developing 
economies. Emerging markets have always been a focus of attention for pharmaceutical 
companies. These companies have put time and effort into research in such markets in 
order to achieve better financial results. However, such research has been done with 
caution and thus a number of opportunities still remain. It is believed that emerging 
markets will account for almost 15 percent of the total global OTC product sales by 
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2020 (Jefferies, 2013). In this context, the BRICMT nations (Brazil, Russia, India, China, 
Mexico and Turkey) have remained a focus of attention for most multinational 
pharmaceutical companies. Algeria, Saudi Arabia, Nigeria and Colombia are other 
prominent countries of interest. All of these markets are assessed in terms of their size, 
future outlook and potential prior to investment (Kyle, 2007).  
Despite the opportunities that the emerging economies of the world offer to 
pharmaceutical companies, there exist some challenges that are inherent to the process 
of introducing new products. For example, the choice of either the direct or indirect 
mode of entry remains a main problem. Most companies currently use the indirect 
mode, but its efficiency is unclear (Kyle, 2007). The advantage presented by emerging 
economies is evident from the fact that the Asia Pacific region contributes about 46 
percent of total pharmaceutical sales, as compared to only 5% from the US (Jefferies, 
2013). In emerging economies, the line between prescription and non-prescription 
products is not as clear as it is in developed economies. The roles of consumers and 
pharmacists are also different in these economies; hence, similar principles cannot be 
employed in both cases.  
Another area that requires attention when introducing a product in emerging 
markets is the interplay between consumer medicines and prescription products. In 
most of the emerging economies, people do not have access to a well-trained physician, 
resulting in greater reliance on OTC products. Thus, along with the business aspects, it 
is critical to take into account the healthcare situations of the people consuming these 
products. In addition, pharmacists play a central role in most underdeveloped countries. 
This is due to many reasons, including the lack of appropriate healthcare infrastructure, 
geographic remoteness and lack of coverage. In these cases, the pharmacist becomes the 
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custodian of health and can serve as a bridge between pharmaceutical companies and 
the patient. For this reason, the first component of the current study focuses on 
pharmacists as the target group. The potential cost of an expensive physician can be 
reduced through marketing OTC products in undeveloped economies and hence, 
positive financial results can be obtained at both the national and consumer levels 
(Kyle, 2007).  
The number of OTC medicines that are available through different outlets such as 
warehouses, discount departments and grocery stores is expected show a marked 
increase in the coming years. This increased availability will provide greater 
convenience to consumers. An important way to introduce new products into the OTC 
market is by transferring a product from prescription to OTC status. Nowadays, there 
are hundreds of OTC products containing the ingredients and dosages that were only 
available through prescription a few decades back (Custodio et al., 2014). 
A significant reduction in the use of alternative healthcare services and 
medications, along with increased access to OTCs, can critically reduce the cost of 
publicly-funded healthcare systems. Adoption of the self-medication approach also 
helps healthcare providers use these medicines more efficiently. Easy access and 
reduced costs are some essential benefits present in emerging economies. In diverse 
global healthcare settings, OTC medicines have greater economic value. A number of 
countries are taking advantage of this by improving their systems for the marketing and 
sale of OTC medicines. The use of OTC medicines and self-care saves billions of dollars 
by reducing physician visits and healthcare costs (Paul, 2011). 
2.4.2 Pharmaceutical market in the GCC 
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The Gulf Cooperation Council (GCC), which includes Saudi Arabia, the UAE, Kuwait, 
Oman, Bahrain and Qatar, has experienced rapid economic development since the rise 
in oil prices in 2003 (Sturm, Strasky, Adolf, & Peschel, 2008). At the macroeconomic 
level, major economic developments have been driven by the high oil surpluses 
resulting from this increase in prices. Reports have predicted that the GCC’s economy 
will grow at a higher rate than the global economy (4.5% real GDP growth vs. 3.5%, 
respectively) until 2020 (Kinninmont, 2009). According to Kinninmont (2009), the key 
driver for this expected growth in GDP is the continuous growth in global demand for 
the GCC’s oil and gas. Additionally, GCC countries are considered to be key players in the 
global energy industry in terms of exports and production, and this role is expected to 
become more vital in the future due to the vast oil and gas reserves present in these 
countries (Sturm et al., 2008). The same report identifies key economic features 
common to the GCC countries, including a young population, high dependence on an 
expat labour force, high dependence on oil and gas industries, and a rapidly growing 
young national labour force.  
According to the GCC Pharmaceutical Industry Report (2013), the GCC’s 
pharmaceutical industry has shown progressive development as an emerging market 
due to key growth drivers such as an increase in population from 37.5 million in 2007 to 
nearly 50 million in 2017, an increase in the aging population from 1.9 million in 2012 
to 17.8 million in 2050, growth in income levels, and the development of the insurance 
system. The report also indicates that branded pharmaceutical products will continue to 
dominate the market due to high brand preference among consumers. 
The same report estimated the size of the GCC market to be around $8.5 billion in 
2012, compared to $7.7 billion in 2011, when it represented less than 1% of the total 
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global market of approximately $755.5 billion. The report also indicates that 
pharmaceutical sales represented around 0.6% in 2012 as a percentage of gross 
domestic product (GDP). This is considered to be on the low side, compared to 3.3% in 
Lebanon, 2.2% in the US, and 0.8% in India. The report confirms that the GCC 
governments are both the regulators of the industry and the main source of healthcare 
funding, with a consolidated contribution of around 70%. These governments allocate 
between 6-12% of their annual budget to the healthcare-related spending. According to 
the IMS Prognosis report (IMS, 2010), the GCC’s pharmaceutical market has enjoyed a 
growth rate of around 10%, making the region the 3rd fastest growing region in the 
world.  
2.4.3 Pharmaceutical market in Kuwait 
 
According to the National Bank of Kuwait’s quarterly report (NBK, 2013), the macro-
economic indicators for Kuwait look positive, with expectations of moderate growth, 
low inflation, and the generation of high budgets and trade surpluses due to high oil 
revenues. The report predicts that the mega projects currently underway to improve 
the country’s infrastructure and services sectors will boost investment levels and serve 
as a catalyst for activities in the private sector. The NBK report also touches on the 
consumer sector, predicting that it will remain strong. This sector is considered the 
backbone of the non-oil sector, and it will be supported by increases in salary, low 
inflation, and increased debt release measures. The report indicates that employment 
growth will be maintained at an average of 3%.  
 Kuwait’s market is considered to be the 3rd largest market among the GCC 
countries. The size of Kuwait’s pharmaceutical market size was around 1 billion USD in 
2011 based on sales and is expected to grow to 2 billion USD by 2020 (BMI, 2011). The 
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OTC market in Kuwait is considered small, presently accounting for only about 15.5% of 
total pharmaceutical spending (BMI, 2011). The BMI report predicts that the spending 
in this sector will increase from KWD 28 million (US$99 million) in 2010 to KWD 41 
million (US$146 million) by 2015. The number of operational pharmacies in Kuwait was 
around 376 at the end of 2012.  
The GCC pharmaceutical industry report (2013) states that domestic population 
growth in the Kuwaiti market is slow and that more than three-fourths of 
pharmaceutical products are imported. The report also indicates that Kuwait’s 
pharmaceutical market is half the size of the UAE’s, and that the key driver of demand in 
Kuwait is the high public spending on healthcare and free-of-charge medical services. 
Based on data collected data from the IMS (IMS, 2012) related to the market in Kuwait, 
prescriptions are the main driver of pharmaceutical product revenue, dominating the 
vast majority of sales. Weeks, Wallace, and Kimberly (2001) similarly found that 
physicians control more than 80% of healthcare expenditures. Healthcare consumers 
rely mainly on physicians for information. Cockburn and Pit (1997) found that 
prescribers are the strongest determinants of the choice of drugs, even when patients 
have expectations about receiving a certain medication. In Kuwait, there are two types 
of pharmacies. The first is the community pharmacy at the street retail level and the 
second type is the hospital/clinic pharmacy that is linked to either a hospital, polyclinic 
or medical centre.  
The literature reports different findings regarding the use of promotional 
activities and it is important to consider the different factors—like the market 
environment—that can cause variation in the effectiveness of promotional activities. 
Narayanan et al. (2004), for example, found that detailing has a larger effect on sales 
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compared to direct-to-consumer media advertising, and that direct-to-consumer sales 
have a greater effect on general category sales compared to detailing activities. 
Conducting research in an emerging market like Kuwait can narrow the research gap of 
having limited studies in this regard and positively impact managers’ decision-making 
processes in the future.  
2.4.4 OTC market in the GCC and Kuwait  
Due to an increase in public health awareness, the Kuwaiti pharmaceutical market has 
seen increased demand for OTC medications such as vitamins, supplements, weight loss 
formulations, smoking cessation treatments and pain killers ("GCC Pharmaceuticals 
Industry Report," 2013). These OTC products can be purchased through different sales 
channels, such as pharmacies, supermarkets, specialist outlets, and convenience stores.  
Significant characteristics of the OTC market in the GCC and Kuwait include the 
high accessibility of pharmacies and medicines for both healthy and non-healthy 
consumers, limited adherence to regulations, and a large role of the community 
pharmacist in influencing consumers’ choice of medicine. Goel, Ross-Degnan, Berman, & 
Soumerai (1996) elaborate on four important intervention factors that can alter the 
pharmacy prescribing behaviour in developing countries: information, persuasion, 
incentives and coercion. Based on the above OTC market characteristics, pharmacists 
can play a highly influential role in the consumer decision making process and this role 
is usually considered heavily in pharmaceutical marketing plans for OTC projects in the 
GCC and Kuwait.  
2.5  Marketing in the pharmaceutical industry 
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Munoz (2005) stresses the importance of a cross-functional approach in marketing to 
ensure that frontline marketers understand what the brand is all about and 
communicate through action when dealing with customers. Moreover, Homburg, 
Jensen, & Krohmer (2008) assert the importance of having a strong link and 
collaboration between marketing and sales, which will allow market knowledge to be 
reflected in marketing activities. This link can be created through teamwork, joint 
planning and job rotation. In addition, joint meetings between the sales and marketing 
teams can be effective in improving the use of market knowledge in marketing 
activities. The importance of the market knowledge for the marketing function is even 
greater when it comes to multinational companies. Kumar, Sharma, Shah, & Rajan 
(2013) elaborate on the risk of multinational firms using sets of standardized strategies 
and adapting them to foreign markets. In this case, due to limited market knowledge, 
the marketing activities would have inconsistent results in terms of strategic successes 
and failures.   
Physicians can no longer treat consumers as passive participants when it comes 
to healthcare decisions. This is due to the high accessibility of information on medicines 
and disease, reflecting the importance of direct communication between 
pharmaceutical firms and consumers (Manchanda et al., 2005).  An important point 
worth considering is that while the direct marketing of pharmaceuticals to consumers 
has produced impressive sales, there remains a lack of evidence regarding the impact it 
has had on the health and welfare of the public (Lyles, 2002).  
 Weitz, Sujan, & Sujan (1986) found that detailing the medicinal information of a 
pharmaceutical product tends to convey a marketing message that can meet 
prescribers’ specific need to understand the particular medicine or therapeutic area, 
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giving detailing an advantage over marketing communication with customers. While 
Gönül, Carter, Petrova, & Srinivasan (2001) found that detailing has a positive effect on 
physicians’ decisions, Chintagunta & Desiraju (2005) found that marketing efforts by 
pharmaceutical firms have greater positive effects on prescriptions than detailing 
activities. An interesting finding from Janakiraman, Dutta, Sismeiro, & Stern (2005) is 
that persistent or uncooperative physicians are not responsive to detailing or 
symposium meetings, while non-persistent or cooperative physicians are responsive to 
both.  
Pharmaceutical firms believe that promotional activities for pharmaceutical 
products are necessary in order to compete, with the extra revenue collected as a result 
of these activities being allocated to research and development for the discovery of new 
blockbuster drugs (PhRMA, 1994). Pharmaceutical firms find detailing valuable, as it 
offers a customized service to healthcare professionals with the aim of enhancing social 
welfare. Gönül et al. (2001) found that detailing and sampling are informative but that 
they increase price sensitivity, mainly due to competition, as physicians are being 
detailed by representatives from different firms and price is a critical factor in 
determining the physicians’ preferences.  
In addition to detailing and direct-to-consumer marketing activities, it is 
important to consider the role of the community pharmacist in the dispensing of 
pharmaceutical products. Stremersch (2008) supports the idea that the pharmacy will 
have a greater say in treatment decisions as more medicines become generic and OTC. 
That may indicate that the interference of financial intermediaries in treatment 
selection has increased over time. The pharmaceutical industry has features that 
distinguish it from other markets, and the sector has always been considered especially 
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challenging for marketers who have worked in other industries (Dogramatzis, 2002). It 
is important to consider how the characteristics of pharmaceutical products are 
defined. A good example of this can be derived from the work of Dogramatzis (2002), as 
presented in Table 1.  
Table 1: Characteristics of pharmaceutical products (Source: Dogramatzis, 2002, p.xx).   
Product components Economic Components 
Core values Augmented values Price related Non-price-related 
Efficacy Ease of use Actual price 
Distribution 
channels 
Safety 
Temperature 
stability 
Competitive pricing Channel intensity 
Tolerability Shelf life 
Price value 
relationship 
Channel length 
Speed of action Patient education Discounts Channel integration 
Quality 
Physical 
information 
Return on 
investment 
Promotional level 
Cost 
Patient association 
support 
 
Promotional 
channels 
 Mail delivery  
Advertising 
intensity 
 Company website  
Personal selling 
efforts 
 Branding   
 
 
2.5.1 Marketing in the OTC market.  
There exists a clear gap in literature related to marketing activities for OTC products, as 
most of the research revolves around marketing strategies for fast moving consumable 
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goods (FMCGs). This is mainly due to the recent switch in pharmaceutical market 
regulations that has opened up the sale of OTC products from being pharmacy-only to 
being allowed through both pharmacies and mass market channels. This switch in 
regulations has had a positive effect on the general OTC business and on investment in 
marketing activities for OTC lines. According to Venkataraman and Stremersch (2007), 
there is a gap in the literature regarding how the marketing actions of pharmaceutical 
firms and patient preferences influence the prescribing decision made by the physician. 
This is extended to how drug characteristics influence patient requests as well as 
physician behaviour. In addition to the marketing aspects of the OTC business, it is also 
important to consider consumer behaviour and how fast it is changing as today’s 
consumers become more informed. More and Srivastava (2010, p. 3) refer to the myth 
that “as long as the patient trusts the doctor and the pharmacist, he or she can swallow 
even the bitterest and ugliest pill.” They argue that this is a misconception, but 
surprisingly find that limited focus is given to the sensory attributes of pharmaceutical 
products, such as colour, shape, packaging and taste in the promotion and positioning of 
pharmaceutical OTC products.  
With regard to direct-to-consumer media advertising, Lavidge and Steiner’s 
(1961) “hierarchy of effects” model describes the experience of the consumer across a 
sequence of effects starting when the consumer is first exposed to the advertisement, 
when an awareness of the product is first created, and continuing with a series of steps 
culminating in the ‘action,’ when the product is purchased. According to More and 
Srivastava (2010), limited attention has been given to assessing the aesthetic or sensory 
attributes of OTC pharmaceutical products, which can be defined as the product’s 
outward appearance, feeling of comfort, style and utility. The authors also found that 
factors like shape, dimension, proportion, colour and the finish of the product play a 
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major role in both the emotional connection between the consumer and the product, 
and brand loyalty. Improper assessment of these attributes can lead to a product’s 
failure, even in the early stages of the product’s life cycle. According to the study, 
aesthetic attributes influence consumers’ desire for OTC pharmaceutical products and 
thus should be considered in the promotion and positioning of the products.  
The present research was conducted with the aim of evaluating the return on 
investment and impact on sales of different types of marketing activities related to over-
the-counter (OTC) pharmaceutical products in Kuwait. The demand for building a 
successful brand is growing in the OTC market. According to Dickov (2012), an increase 
in the number of loyal consumers helps in achieving market goals by increasing the 
brand owner’s bargaining power, establishing a link between price and quality, and 
protecting the brand owner from pricing-orientated competition.  
It is worth noting that the financial management of OTC medicines differs from 
that of prescription-only medicines in terms of how it affects the decision making 
process (Eggleston, 2003). Blackett and Harrison (2001) support this argument with 
their finding that corporate stock market value depends greatly on shareholders’ 
confidence in intangible assets like the brand. For example, the stock market value of 
the Coca-Cola Corporation is around US$113 billion, while the book value does not 
exceed US$7 billion. Therefore, building a brand in the pharmaceutical industry can be 
considered as an alternative way to increase corporate value, rather than depending on 
research and development (R&D) or healthcare professionals’ influence on the choice of 
OTC medication. In addition to the financial aspect of investment, Solcansky and 
Simberova (2010) touch on the importance of measuring and assessing the non-
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financial outcomes of marketing investments (e.g. company image and customer 
loyalty).  
According to More and Srivastava (2010), OTC medicines have different 
characteristics from prescription medicines in terms of margins, advertising and 
distribution. The authors add that the drivers of sales for prescription medicines are 
their effectiveness, side effects and onset of action, while for OTC medicines the key 
drivers are taste, convenience and a satisfactory effect. Different factors affect the 
consumer decision making process, but what seems to be most influential is the brand 
packaging. Clement (2007) showed that 90 percent of the consumer purchase decision 
is made based on a visual examination of the outer packaging of the product. According 
to David Gascoigne of IMS consulting (cited in Lam, 2004, p. 104), “'Pharma marketing is 
about all forms of promotional activity working together across disciplines to develop 
synergy for the brand by leveraging and coordinating communications channels."  
Gascoigne adds, “You'll see more people testing that approach and asking about 
leveraging channels simultaneously or concurrently rather than independently. The 
more weapons you have and the bigger their impact, the more flexibly you can handle 
competitive threats and changing market conditions." 
2.5.2 Factors affecting marketing initiatives  
Marketing plays a significant role in making consumers aware of which products are 
beneficial for a particular health condition. It also informs them about the quality and 
nature of the product. In this way, pharmacists and marketers have the chance to 
promote new medicines and their uses and side effects. However, managers must take a 
number of factors into account when finalizing the plans for strategic marketing 
initiatives like improving service quality, investing in advertising and investing in a 
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loyalty program. The associated factors that must be considered for such marketing 
initiatives are discussed as follows:  
a- Customer equity 
Marketing revolves around the customers, reflecting their viewpoints from the 
marketer’s perspective. Marketing concepts and theories have become consumer-
centred over the last 4 decades. The marketing field has lessened its aim of gaining 
short-term transactions, moving towards the formation of long-term customer 
relationships. The viewpoints of the customers have been reflected in the metrics and 
concepts that come from marketing management, such as customer orientation, 
customer satisfaction and customer value. The customers and their equity are more 
important for many organizations than the brands and their equity. This shift in 
marketing from the focus on brand equity to customer equity has led to the need to 
transform product-based strategy into customer based strategy (Harris, Brewster, & 
Sparrow, 2003).  
b- Economic Factors:  
The economy of a country defines the ability of the customer to spend on a given 
product. If the marketer is not aware of the spending ability of the customer, all of the 
planning can turn into a total waste of time. Economic cycles should be studied, and the 
different stages (e.g. recession, recovery and depression) should be identified so that 
appropriate measures can be taken to align the marketing campaign with the current 
economic cycle (Harris et al., 2003).  
c- Demographics: 
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Demographic challenges that significantly affect marketing are always present. For 
instance, if a large part of the population does not know English, the marketing should 
also be done in the local language. Similarly, other factors such as disease outbreaks, 
aging and the most popular media tools for marketing should be studied to improve the 
chances for success (Harris et al., 2003).  
2.5.3 Marketing strategies for OTC medicinal products 
A number of marketing strategies can be used to embrace the OTC opportunity. There 
are various ways to adapt and enhance the marketing of OTC products. These are 
discussed in the following paragraphs:  
a- Branding: 
Branding strategy companies consider whether the product will be a new product or an 
existing one. On the basis of this determination, they can revitalize the brand or an 
acquired product. It also helps to develop understanding about the areas where the 
brand will be global, and where it will exist only in one or a few places. While employing 
the brand strategy, the company needs to make a proposal and then discuss it with the 
concerned decision makers. During the process, it is also important to ensure that the 
company has alternate options in case the proposal is rejected  (Cockburn et al., 2005).  
b- Leading the field: 
In order to lead the field, it is important to develop an expert team that is aware of the 
importance of ROI, the time spent in the market, development costs and the cost of the 
product. The ROI remains zero unless the product is introduced into the market and 
sold. The time until the product is placed on shelves represents losses in sales, and this 
time can never be recovered, no matter how long the product lifetime is. OTC marketing 
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activities help companies enhance the position of their non-prescription medicines. The 
ability to successfully advertise an OTC medicine eventually supports a prescription-
only medicine of the same brand. Thus, the company needs to lead from the front and 
build teams that can achieve a competitive position in the OTC market by enhancing 
awareness among customers and compelling them to buy OTC medicines (R. Cockburn 
et al., 2005).  
c- Franchises: 
Franchising has become the most successful business technique for introducing 
products into the market. While adopting the procedure, companies need to consider 
franchise opportunities within both new areas and existing ones. A number of factors 
can be considered when developing franchise assessments, such as sociological needs, 
prospects for innovation, issues in a specific therapeutic area, and above all, the need to 
improve the ROI (Cockburn et al., 2005). 
d- Government support: 
Government support is necessary when advertising or marketing any product. There 
are a number of health organizations in the UK and other countries that receive 
complete support from the government when adopting OTC medicines. In the EU 
especially, generic and OTC medicines are recognized and acknowledged by 
governments and consumers equally (Mitzen, 1999).  
2.5.4 Promotion of OTC medicines in the pharmaceutical market 
The pharmaceutical industry is creating new initiatives for the recognition of OTC 
products. Promotion of OTC medicines accounts for a large part of marketing efforts and 
the results have been positive. OTC lines use two basic approaches for promotion, 
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namely “push” and “pull” strategies. There are advantages and disadvantages to both of 
these strategies. The main job of the marketing team is to adjust the strategy to suit 
each specific product.  
a- Push strategy:  
The push strategy uses trade promotion and the force of the company’s sales to increase 
consumer demand for a product. First the product is promoted to wholesalers, then it is 
promoted to retailers by the wholesaler, and finally, the retailer promotes the drug to 
the patient. Using the “push” strategy, the company can focus on pre-wholesalers, 
wholesalers and pharmacies at the same time or only focus one of them. In the past few 
years, pharmacists have also been seen promoting OTC drugs. The use of pharmacists to 
endorse OTC products is a good idea, as they can easily influence which drug the patient 
chooses, thus increasing demand. However, as a result, the patient’s visits to the 
pharmacy increase and retailers are rarely visited. This can negatively affect the 
demand for the product. At the conference, “Kongres OTC,” held on 29-30 March 2007, 
Pfizer US National Trade Marketing Manager Tomasz Baralkiewicz stated that “the 
number of medical reps at present working at pharmacies is too much sometimes that it 
takes the consumers from the other markets.” Using a push strategy, the pharmaceutical 
company may also promote the drug directly to the doctor, who in turn recommends 
the OTC medicine to the patient. This strategy is widely used by Berlin-Chemie 
Menarini. The total cost of the push strategy includes the trade conditions as well as the 
discounts given to wholesalers and retailers. The strategy should be comprehensively 
analysed, as discounts are sometimes not beneficial. Companies use the push strategy in 
cases where brand awareness is low. For example, with hydrogen peroxide, smoking 
cessation patches and vitamin C sales, the push strategy works well (Parker & Pettijohn, 
2003). 
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b- Pull Strategy: 
The other strategy that companies use for the promotion of OTC products is the pull 
strategy. In this strategy, the product is requested by consumers and made available 
through delivery channels. High expenses for endorsement and promotion are required 
to carry out the pull strategy. If the promotional strategy goes well, the drug is 
requested by the patient, and the pharmacist gets it from the wholesaler or dealer. This 
strategy is extensively used by OTC drug manufacturers who market their products 
intensively in the media. The absolute leader in terms of drug advertising is Pfizer US, 
which spent nearly PLN 140m (€34.8m) on OTC drug advertising in 2005. GSK is the 
second biggest spender on drug endorsement. However, there are companies like 
Herbapol Wroclaw, Herbapol Poznan and Polfa Warszawa that do not spend a large 
amount on drug promotion but still attract customers (Parker & Pettijohn, 2003).  
Marketing of over-the-counter medicines is a complex phenomenon that requires a 
great deal of attention in some cases. If appropriate measures are not taken by the 
manufacturing or marketing departments, the result can be poor product sales (Guido, 
Pino, & Frangipane, 2011). Therefore, the ability to develop tools that can help 
executives better measure return on marketing investment is crucial in the 
pharmaceutical industry. There are some emerging trends that can be applied to almost 
all areas of marketing; these are discussed below:  
i. Influence of pricing on customer choice:  
Pricing has a great deal of influence over people’s choices and can in many cases 
determine customers’ preference for one product over another. It has often been 
observed that when people see a product that can treat their ailment but is much less 
expensive, they might believe that the product is of lower quality. However, it was also 
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noted in a study conducted by Edelman Berland (2014) that over-the-counter medicine 
with too high of a price—for example, $250 or more—are not as popular due to being 
very expensive. Sometimes the reason for not being willing to spend a large amount of 
money is that people are unsure whether the product will actually treat their condition. 
This research is interesting from the marketing perspective, as marketers need to 
understand that price affects the acceptance and popularity of a product (Berland, 
2014).  
 
ii.  Patient education:  
Sometimes the unmet education needs of patients keep them from relying completely 
on over-the-counter products. Some patients believe that they cannot prepare a health 
plan or regime based on their own knowledge, although this seems strange in an era 
when the internet educates people and makes things understandable for them. 
However, this can prove a rewarding opportunity for marketing companies. Marketers 
should be trained regarding the uses, side effects and benefits of the medicines. These 
marketers must have enough knowledge to educate patients and in this context, the 
pharmacist can play a pivotal role. It is also critical to tell the patient about the 
condition and the point at which he must see his doctor. Social networks and certain 
apps that are made to educate patients can also be useful in this regard.  
2.5.5 Physician decision making process in the pharmaceutical industry  
The medical prescribing decision is a process that is an attractive target for marketers 
in the pharmaceutical industry. The primary providers of healthcare to patients—the 
physicians—are considered the customers of the pharmaceutical industry. 
Pharmaceutical companies promote drugs of different pharmacological classifications 
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to physicians of different categories, ranks and specialisations (Dogramatzis, 2002).  
The medical prescribing decision involves a primary and secondary decision. The 
primary decision involves the selection of the therapeutic area that is relevant to the 
case and the secondary decision involves the selection of a particular brand among 
those offered within the same therapeutic area. The following steps are involved in both 
processes: first, problem recognition; second, obtaining information on the available 
treatments; third, evaluation of existing treatment alternatives; fourth, the actual 
prescribing decision; and finally, the post-prescribing evaluation of the benefits of the 
selected treatment (Dogramatzis, 2002).   
The benefit of promotional activities comes when the pharmaceutical sales 
representative relates the benefits of the pharmaceutical product to a specific group of 
prescribers that are directly relevant to the patients’ needs. Framing is an important 
part of the detailing activity, which helps define how the sales representative presents 
the information to the physician (Smith & Wertheimer, 1996). By framing the 
information and the benefits of the promoted pharmaceutical product in a positive way, 
the chances of the promotional activity affecting the physician’s decision are increased.  
Prescribers form attitudes about pharmaceutical brands based on elements like 
past experience, branding, approach, framing and relationship marketing efforts.  
Another important element that can influence the physician’s prescribing behaviour is 
persuasion from the sales representative, including the message of the sales 
representative’s proposal and the prescriber who receives the message (Smith & 
Wertheimer, 1996). The goal of persuasion is to influence the prescriber to prescribe 
the pharmaceutical product being represented by the sales representative.    
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2.6  Limitations in the literature 
Many contradictions and examples of vagueness have been found in the evolution of the 
ROMI calculation. Thomas (2002) noted the crucial finding that there is a need for 
evidence-based results in order to develop a trustworthy ROMI model, but that few 
studies have provided evidence-based outcomes. The studies that are available in the 
literature have focused on the short-term outcomes of the ROMI model. The ROMI 
calculation, however, requires a long-term perspective (Phillips, 1997) and should have 
an ongoing nature. So far, few scholars have contributed toward recognising the 
ongoing and long-term characteristics of ROMI calculation. Additionally, no industry-
specific ROMI models can be found in the literature. With the evolution of a more 
competitive and challenging environment, the importance of developing industry-
specific ROMI models to aid in decision making is increasing. Scholars like Wittink 
(2002) have been pessimistic about the possibility of measuring ROMI and have even 
concluded that it is impossible to measure ROMI, thus rejecting the growing demand for 
its measurement. However, managers can no longer rely on subjective measures to 
assess the success of a marketing activity. The need for the efficient execution of 
commercial excellence by industry practitioners is growing day by day and that 
requires an effective decision making process.  
Considering that the pharmaceutical industry is one of the most highly regulated 
industries, the marketing activities allowed in this market are limited. Hence, there is 
limited literature tracking the performance of marketing activities in the 
pharmaceutical industry. Despite the development of regulations governing the 
marketing activities related to OTC medicines, little work has been done on marketing 
in the pharmaceutical industry and in particular, on OTC drugs. While there have been 
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many success stories that have contributed toward the expansion of the OTC market, 
they have not been captured in the literature. Furthermore, the majority of the 
literature found in this particular area has been focused on studies conducted in the 
North American market; limited literature is found for the emerging markets, which are 
currently driving the growth of the pharmaceutical industry at the global level. 
Emerging markets are challenging and thus an intensive amount of research needs to be 
done to improve the understanding of the market characteristics and how consumers in 
these markets react toward marketing activities. A good amount of research has focused 
on direct-to-consumer advertising in the pharmaceutical industry and the literature 
clearly shows how this marketing tool has evolved over time. Researchers should also 
focus on different marketing tools in different parts of the world to work toward 
improving pharmaceutical industry specific marketing practice.  
The above limitations made it difficult for the researcher to base this research on 
past studies that developed ROMI measurement models, as these were not evidence 
based and not industry specific. The researcher’s aim was to continue the work on 
developing an ROMI measurement model for the pharmaceutical industry in particular 
and to include the ongoing, long-term and evidence-based aspects of the industry in an 
emerging market.  
2.7  Conclusion  
The pharmaceutical industry has received immense benefits from the sale and 
marketing of OTC products. Many public healthcare professionals, consumers and 
marketers value the efficiency and expediency of OTC medicines. The literature suggests 
that the value of OTC medicines is not just increasing in developed markets. Emerging 
markets are observing significant improvement in the growth of OTC medicines, which 
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have managed to achieve the highest growth rate among all other markets globally 
(IMS, 2012). Changes in regulations have removed many restrictions on OTC medicines 
compared to prescription-only medicines, and that has been reflected positively in the 
economic benefits of OTC medicines, including cost savings and improved public 
welfare. Emerging markets are considered the future of the pharmaceutical industry; 
although many major players struggle to achieve high business growth in developed 
markets, they are able to do so more easily in emerging markets.  Kuwait is part of an 
emerging market and is the focus of this study. Considering the market structure in 
Kuwait, it was important to consider the role of pharmacists in this study due the role 
they play as key observers and perceivers of marketing activities related to OTC 
medicines. The literature suggests that pharmacists’ perceptions should be taken into 
account. Hence, this study contributes to filling a gap in the literature, where few studies 
have been done in the context of pharmaceutical companies with a similar business 
scale to the researcher’s organization.  Many limitations exist in the literature, and thus 
there is a need for a long-term, ongoing and industry-specific ROMI measurement 
model that can be used in different markets, particularly emerging markets.  
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3.1 Introduction  
 
This research attempts to assess marketing’s impact on sales and the return on 
marketing investment. Having the ability to measure the value of marketing 
communication is critical in all industries. Marketing addresses the external 
environment, which marketers have no control over. They must therefore try to build 
an understanding of the relationship between the resources allocated to marketing and 
the benefits gained. The theoretical and practical importance of this research is that it 
seeks to develop and implement an effective intervention to help in measuring the 
impact on sales and return on marketing investment of marketing activities for OTC 
pharmaceutical products. More specifically, this study investigates what influences the 
sale of OTC products in pharmacies in different practice settings.  
The role of pharmacists in creating awareness of the appropriate use of medicine 
is of fundamental importance. Pharmacists also act as self-care consultants who provide 
health information to customers in various instances. A number of elements can 
influence people’s choice of medicines. These include self-care trends, the observable 
effects of a medicine on other people, and advice from friends and family members. 
Studies have shown that pharmacists’ recommendations influence people to choose one 
medicine over another. The situation is different in different areas of the world. In the 
US, a pharmacist’s approval is needed for the purchase of items that are not listed as 
over-the-counter drugs. Since the purchase of OTC medicines is not always free of the 
influence of the pharmacist, the societal influence of pharmacists must be kept in mind 
when planning marketing efforts. One study done in New Zealand regarding the 
influence of pharmacists on OTC purchases showed that product selection is influenced 
by the guidelines of the pharmacist (Emmerton, 2002). 
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In another study, Kotecki (2002) looked at the influence of pharmacists on OTC 
purchases. Eight over-the-counter medicines were selected and the survey was 
distributed to 526 pharmacies in Indiana. The products selected were food supplements 
and smoking cessation products. It was found that OTC product selection was greatly 
influenced by the healthcare specialists working at the pharmacies. This means that the 
healthcare training and expertise of pharmacists plays a strong role in determining 
consumer product selection preferences (Kotecki, 2002).  
The role of the pharmacist as a self-care consultant is known, but there are also a 
number of societal as well as medical factors that can affect the selection of a particular 
medicine. The experiences of friends and family members and the observable effects of 
medicines are equally effective in influencing the purchase of OTC products. Moreover, 
the self-care revolution has also affected the choice. People are interested in self-care 
therapies, ushering in a new role for pharmacists. Pharmacists can make 
recommendations for OTC medicines based on their knowledge, training and expertise.  
As shown in Figure 3, this study adopted the RoMI research model for evaluating 
investment decisions regarding the sales and marketing of OTC medicines in 
pharmacies in the emerging market of Kuwait. The ultimate goal of organizations is to 
improve their decision making process so as to achieve alignment between marketing 
activities and their impact on corporate goals. The current chapter covers how the ROMI 
model can be practically applied by ensuring that key functions within the organization 
are engaged and that marketing activities are effectively carried out and monitored.  
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3.2   Development of the conceptual framework 
The action research model was used to evaluate the impact of marketing in the field of 
OTC pharmaceuticals in emerging markets. The aim of the study was to measure the 
return on marketing investment. The impact of the marketers’ efforts on practitioners 
and involved organizations was measured and the effect of marketing was evaluated. 
Some practitioners insist that the role of marketing cannot be accurately quantified, 
while others assert that it is possible through action research. However, prior to the 
study, there was an agreement among the researcher’s sales and marketing team that 
marketing should be studied in relation to its outcomes before employing a given 
strategy.  
In the contemporary business environment, organizations need to gain a 
sustained business advantage. However, this is impossible without having information 
about intangible assets. Such assets include innovative capacities, networks, and 
knowledge of corporate activities. This chapter discusses how these assets help in 
determining return on investment and what measurement efforts are needed to build a 
useful framework. A conceptual framework will be offered that will help with historical 
measurements. This framework is relatively new in the field of marketing but it is very 
helpful in understanding which marketing systems can provide high return on 
investment. Two main elements upon which this framework is based include the 
amount of financial expenditures for the marketing process and the financial return 
achieved through this expenditure with the sale of the product. It is also important to 
mention that financial return is not only about sales revenue; it can be correctly 
calculated by subtracting product sales revenue from the cost of goods sold during a 
particular time period and the investment made to achieve the desired result. When a 
high RoMI figure is achieved, it means that the particular area of marketing has 
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provided greater profits for the company. A high RoMI suggests that the company’s 
marketing efforts are very much fruitful (Woodburn, 2006). Different parameters for 
measuring growth were identified before the start of the action plan. Here, marketing 
includes all customer-related activities. The aim of the organization was to measure the 
outcomes of the marketing activities and to create a balance between B2B (business to 
business) and B2C (business to consumer) approaches (Woodburn, 2006). 
3.3  Research Model  
The conceptual model for the action research component was selected based on the 
metrics needed to measure RoMI. Marketing metrics are key performance indicators 
that are either internal or external, and financial or non-numerical; these are considered 
key guides to be utilized by top management (Ambler, 1997). The RoMI model was 
developed by the RoMI Club (Woodburn, 2006), first by identifying and then applying 
key metrics in order to understand the current situation in a given market. This 
information can offer guidance for the future endeavours of the company. First, a 
general overview of the company’s performance measurement is done and marketing 
metrics are described. After the model is proposed, conclusions are drawn regarding 
how helpful these metrics have been in assessing the effectiveness of the company’s 
efforts.  
During the process of Woodburn’s (2006) study, the organizations employing the 
best practices remained the focus of attention. Several parameters related to their 
activities and the way the companies performed in their given environment were also 
analysed.  However, this phase of the research remained very challenging, possibly 
because only a few organizations perform at their best and it was difficult to identify 
practices that were free of flaws. Keeping this in mind, it was ascertained that if any 
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company with exemplary activities could not be found, a new approach and a 
framework for future practices would be created. This was done to assist the 
researchers with studying relevant marketing efforts. It also helped in creating an 
understanding of the final impact of marketing. Then, the data to build business cases 
were generated (Woodburn, 2006). 
On the basis of Woodburn’s (2006) research, a model was developed for 
understanding the value of marketing in improving the company’s structure and 
function. This model proved helpful for identifying customized practices for the 
measurement of marketing activities. Finally, it became possible to determine whether 
the approach was feasible and meaningful for the particular organization. Figure 3 
shows the adapted marketing metrics model (Woodburn, 2006) that was designed to 
help organizations answer the following key questions: 
 What measures are essential for tracking the impact of promotion/marketing-
related activity?  
 What metrics are appropriate for measuring the impact of marketing? 
 What investments are needed to achieve the desired outcome? 
 What key advantages does the organization have that can be utilized to achieve 
corporate goals and how can such impact be measured? 
 What course of action should be invested in and when should it be done in order 
to achieve marketing goals? 
 What is the desired budget for achieving the set goals? 
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Figure 3: The RoMI model (adapted from Woodburn, 2006, p.52) 
 
The model is divided into the following key components:  
 Corporate performance:  Corporate-related forecast and actual results 
 Market segments: To define the objectives of each segment and the outcomes 
achieved after implementation of the plan.  
 Impact factors: To define the framework for tracking market response post-
intervention.  
 Marketing and other actions: Action plan to achieve the set goals.  
 Budget resources: To define the amount of investment needed to deliver the 
strategy.  
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The outflow arrows at the top of Figure 3 reflect what needs to be done to achieve the 
set goals, and the inflow arrows at the bottom reflect what actually happens after the 
intervention takes place. The current study uses this model, in a form of an action 
research approach, to test the hypotheses developed in the following section. A 
modification has been made to the model by adding RoMI as a key metric for the 
outcome, under market segment. Return on marketing investment (ROMI) is the 
contribution attributable to marketing divided by the marketing spending (Farris, 
Bendle, Pfeifer, & Reibstein, 2010). Since there are many sources for how ROMI can be 
calculated, the researcher decided to use the formula developed by Farris et al. (2010), 
who believe that the consensus from usage justifies the following formula:  
 
ROMI =
[Incremental Revenue Attributable to Marketing(USD) ∗Contribution Margin% − Marketing Spending(USD)]
Marketing Spending(USD)
  
 
As shown in Figure 3, the most important factor in the model is corporate revenue/ 
profit because it is considered to be the most important area of the business. At this 
point, internally generated desires are also linked to the external potential of the 
corporation and consideration is given to achievable goals. Another important area of 
the model is the time measurement framework. This is the metric that should be 
measured in relation to its scope and nature, according to the organization’s specific 
requirements, and that is why it is not mentioned in the above figure. Data are gathered 
and the method for collecting these data is also explained. A target is set according the 
planned levels of achievement, while past levels of achievement are noted in order to 
record the results.  
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The basic business elements to be taken into account are: 
 Corporate performance 
 Corporate revenue and profit 
 Corporate achievement  
All the measurement dimensions selected for the present topic are considered at 
each stage of the framework. The measurement concept is applied to the present 
outcomes, past results and expected future targets. The corporate revenue results are 
helpful in determining how successful a business strategy has been. These corporate 
targets can be different, and may require different measurement tools. However, their 
contribution to final performance is of great importance. For instance, if a forecast for 
ambitious growth is made, the marketing should also be ambitious. 
Marketing alone cannot describe a company’s performance and hence various 
targets for company performance can be broken down into segments. These segments 
might include, but are not limited to, revenue, sales and volume. They can also include 
segments to which marketing makes its own contribution. In addition, marketing 
activities cannot be kept separate from sales. As marketing creates demand and sales 
capture this demand, various aspects of marketing growth are interconnected and 
should be studied simultaneously.  
The model suggests that business elements should be justified in three different ways: 
 Future phase: Helps in the quantification and derivation of expectations for the 
business. 
 Past and present phases: To report performance through actual achievement of 
goals and targets.  
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While defining a segment, it is critical to define the number and nature of the 
segment. An awareness of the changing attitudes in one segment is gained. Along with 
this, the behaviour of the segment—for example, whether the number of people in the 
segment is increasing or decreasing—is also determined. The amount spent on services 
or goods in the segment is also defined. Through this, average price margin in 
comparison to the competition is gauged. The entire process of segmentation and the 
measurement of segment characteristics can take a long time. However, important 
trends in a segment can be tracked using the key characteristics of that particular 
segment. For this purpose, data are collected and internal and external market 
information is identified. When sales data are gathered for a particular segment, the 
funding required for that segment and the expected return can also be determined. Data 
manipulation options are also available to enhance the utilization of the obtained 
results.  
  The response of each segment is determined with the help of impact factors. 
These factors are responsible for making essential differentiations in the marketing 
segments. The actions taken by marketers should be based on these impact factors, 
which can help in achieving a competitive advantage. In this context, the competitive 
advantage factor is of critical importance, as it gives the researcher a chance to adopt 
strategies that can aid in identifying advantages compared to other corporations.  
The competitive advantage factor can also become a qualifying factor when all 
competitors reach a point that no one is able to surpass. These factors then become a 
measure of the company’s performance for customers. For instance, if a company is 
unable to deliver a product on time, there are plenty of other options available for the 
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consumers to switch to. This becomes a qualifying factor and cannot be converted back 
into a competitive advantage factor.  
Finally, there are productivity factors. These are the factors implemented by 
suppliers to gain a competitive advantage over others. These factors are concerned with 
increasing sales revenues by increasing productivity. For instance, effective supply 
chain management can ensure that the product is delivered on time or can increase the 
amount of product produced per unit time. It can also increase sales once demand is 
high. Companies that are unable to meet customer demands do not achieve an 
advantage. In order to take advantage of these factors, it is critical to gauge the 
performance of companies in relation to the changes being made so as to avoid potential 
issues.  The above model describes supplier strategies in terms of impact factors that 
can be competitive, qualifying or productive in nature. Once a competitive factor is 
achieved, it might become a qualifying factor as other companies start to adopt the same 
strategy.  
The forecasted result for corporate performance is the main element in business 
performance measurement. Market segments are observed for the measurement of 
business outcomes and the response to the impact factor strategy is analysed. Finally, 
marketing plan actions are taken according to the budget, resources and time. The 
model described above was intended to provide interested companies with a feasible 
approach for proper marketing evaluation. Each marketing action is discussed in detail 
and the impacts of these actions are also discussed. The linkages between various 
marketing actions are closely observed and results are forecasted. It is also possible that 
while pursuing marketing goals based on this model, the company may fall short of its 
ultimate goals. However, at least some success is achievable in every case. Sometimes, 
 
 
78 
better policies and efficient planning might lead to greater success as a result of 
capturing a superior understanding of the market. Through this model, competitive 
advantage is achieved and valuable results are obtained.  
The above has provided an understanding of the action research approach by 
describing it as a source of tension between social, personal, and professional changes. 
It is a phenomenon of deep inquiry that helps the people involved move toward an 
envisioned future. In other words, action research is a reflective study of actions taken 
and the results of those actions. The actions can take place within an organization, at the 
workplace or in the market, and as a result, a deep inquiry into the professional practice 
is performed (Blaxter, Hughes, & Tight, 2010). There is a group of approaches that are 
modified and used by action researchers during the course of study. These 
modifications are made in various directions to fit them into the context of the research. 
For instance, action research for the analysis of social processes is done using the 
collaborative approach, which involves different stakeholders (Cohen, Manion, & 
Morrison, 2000).  
Action research can also be used to seek improvement opportunities. A new 
course of action is defined within the existing setting so that work practices can be 
aligned with the fluctuating needs of the environment. A series of reflective stages are 
adopted during the course of action research. At the end of the research, it becomes 
possible for the researcher and the reader to understand complex patterns of the 
organization related problem. Finally, action research becomes the process by which 
the researcher brings the theory to life with the help of practice.  
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3.4  Application of the ROMI model 
 
The RoMI model is used to calculate return on investment in cases where companies 
need to calculate the outcomes of their marketing efforts. In cases where marketing 
needs to be viewed as a credible discipline, these activities can help greatly. Historically 
privileged outcomes of marketing metrics are applied to test the marketing content 
sequence and to see the effect of influencing factors. This is done in order to find an 
appropriate means of accomplishing the marketing goals. In this context, the RoMI 
model is a useful tool for determining the conditions that can be exploited by a company 
for the sake of value creation. The importance of this model is greater in the marketing 
environment, as it is focused on metrics and not on integrated performance. The model 
helps in creating new evaluative dimensions that allow the identification of factors 
having a positive influence (Jeffery, 2010).  
Jeffery (2010) describes the ways and the means through which RoMI can be 
applied in various settings in which marketing is done. The author presents the example 
of a ‘new product launch.’ Financial RoMI can be applied in the market, even in cases 
where several months-long campaigns are undertaken to generate profits. At the same 
time, this model can produce equally beneficial results for cases where multiple 
campaigns over multiple years are planned. For instance, when RoMI is applied to a new 
website that is being launched and whose marketing campaign is being started, the very 
first step is to develop an understanding of the needs and demands of the business at a 
basic level. This is where primary cost and revenues are taken into account. This step is 
called business discovery and is the first step in determining RoMI. The most important 
aspect of this is benchmarking against rivals within the same industry. On this basis, the 
business drivers found in the market are identified. In some cases, benchmarks are not 
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available; in that case, detailed market research is required. Annual marketing cost, 
revenue generated from different products, inflation, and tax and discount rates are 
measured. After collection of this information, the upside revenue and upside cost of the 
product are calculated. Assumptions are generated for best and worst case revenues. 
Other findings such as tax to discount rate, year-to-year sales, limited market 
penetration and existing sales force marketing are also generated. Afterwards, the new 
product is incorporated and marketing costs are determined, including product 
development and maintenance costs. Product launch cost is also included. A summary of 
these costs, including web portal development and maintenance costs, is made. 
Quantification of these costs is easy but projecting upside revenue from marketing and 
product sales can present a challenge (Jeffery, 2010). 
In most cases, collection of long-term data is difficult. However, RoMI allows the 
measurement of 3- or 5-year straight line depreciation, meaning that expenses are 
calculated for periods of three or five years. The straight line helps in measuring 
expenses every year.  Other costs such as on-going marketing, and operational and 
professional service support can be calculated as they are incurred. 
RoMI is usually calculated for a given time period, but whenever a new product 
is launched the question arises of how much time should be taken into account for 
RoMI, as new products can take many months to have an effect. The time period for 
RoMI must match the time that is used for the analysis (Jeffery, 2010). The action 
research approach can also be applied in other cases, as it can be equally generalized for 
line expansion of an existing product or driving users to a new channel. Similarly, best 
practices can be applied to all marketing campaigns in a generalized manner (Jeffery, 
2010).  
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Woodburn (2006) adds that the RoMI framework has received enough attention 
in the given market environment to help ensure that measurement of the contribution 
of the marketing investment can be done in the right way. This is the framework that 
helps ensure that the entire organization is going in the right direction and that every 
department is on the same page. Moreover, tools and expertise that are being used for 
the measurement process are also maintained in the same way. In order to gain the 
maximum benefits from RoMI, it is critical to ensure that RoMI remains a company-wide 
framework. Every person involved in finalizing data collection needs to be aware of the 
basics of the framework. They must make it a sustainable project by developing an 
infrastructure in a manner that incorporates the organization’s cultural environment. 
Sales, marketing and market segments become vehicles for obtaining market data. 
Executive project managers and staff utilize the data to conduct their analyses and 
change management techniques are shared. Innovative ideas are converted into real 
solutions through communication, and change management is made possible. However, 
companies need to have appropriate visibility to ensure better investments in 
marketing. This study will help in describing the tools, process and techniques that are 
best aligned to the company’s objectives, so that effective marketing can be done. The 
underlying vision for the entire organization must bring together shareholders as well 
as customer satisfaction in order to guarantee the company’s progress.  
Jeffery (2010) sheds light on various aspects of the RoMI framework and states 
that the RoMI framework maintains a simple and straightforward approach. This 
approach can be used in different marketing campaigns at the same time, including line 
extensions, product launches and demand generation. First, business discovery is done 
in order to understand the impact of marketing on new launch campaigns. After that, 
the base case is taken, which helps in defining cost, existing market sales and cash flow 
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in the existing market. Afterwards, the budget for all marketing costs and the product 
launch is defined, including product cost, pre-launch, product maintenance cost and 
customer service charges. The upside revenue impact of the new marketing initiative is 
estimated. Finally, the base cost is subtracted from the upside (Jeffery, 2010).  
The RoMI model is initiated by taking into account corporate revenue and 
corporate profit. This is the stage at which most companies start sensing what can be 
achieved from the business. It is critical to see the potential of the marketplace at this 
point because it can help with finalizing decisions in the subsequent stages. The 
measurement timeframe is created and a link is made between the internally generated 
desires of the company and the external potential. The nature of the measurement is not 
straightforward because there are several ways through which information is collected, 
and planned levels of achievement are determined based on past levels of achievement 
(Jeffery, 2010). All business elements included in the framework help to generate 
corporate value and explain how the business contribution is generated through 
performance. These forecasts derive measurements for future endeavours. To decide 
whether or not these agreements or forecasts should be the same in order to achieve 
better future performance, there is a need to use them differently. If these agreements 
fail to have an effect at a given time, their contribution to company performance is 
questionable and an argument can be made that the marketing initiatives should be 
done differently. It is essential that after making appropriate forecasts, all segments of 
the company should start responding in order to deliver better results. For instance, if 
the forecast predicts ambitious growth for the company, marketing initiatives must be 
ambitious at the same time. Similarly, different strategies are required when marketing 
is done for profit growth and expansion. Marketing makes a clear contribution to 
company performance, but metrics such as revenue generation, sales growth and 
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volume must be identified as factors that are significantly affected by marketing. 
Therefore, separating marketing from sales activities should be avoided because the 
purpose of marketing is to locate and create demand, while the purpose of sales is to 
capture this demand. Both of these elements are interdependent and cannot be used 
separately from one other (Woodburn, 2006). 
The above paragraph states that the RoMI model can be best applied if different 
elements of the business, such as revenue generation, are quantified and measured in 
two timeframes. After this, the ROMI model can be used in three main ways, including 
comparing the future with that of the past in order to measure differences, 
quantification of expectations and the driving of efforts toward it, and finally, comparing 
projections over a defined timeframe with past results to learn from measured 
differences. Quantified corporate expectations serve as the main driver for all business 
activities by creating inter-linkages between them.  
3.4.1 Market segmentation and data collection process for RoMI 
 
Companies need information about their customers in order to understand how to 
interact with them. This information is of great use in determining the future course of 
action. Information that is more valuable can be made available to the management so 
that it can be quantified and utilized for making changes and comparisons. According to 
Wendell Smith (1956, p. 5), “Segmentation is based upon developments on the demand 
side of the market and represents a rational and more precise adjustment of product 
and marketing effort to consumer or user requirements.” According to a study by Halley 
(1968), it is easier to take advantage of the existing market than to create a new market. 
No brand will be accepted by all customers and acceptance depends on whether the 
product is positioned correctly in the marketplace. Marketing can easily be tuned to the 
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marketplace, allowing understanding to be developed about threats and opportunities. 
In this regard, it is important to state that the market is not a homogenous mass. 
Instead, it is divided into various segments. Different parts of the market are segmented 
based on similar needs and wants. This process is called as market segmentation. 
People in one market segment might respond in one way while another segment 
responds entirely differently. Therefore, the market is segmented by taking into account 
the needs of a group of people, such as what they buy and when.  
Here, it is important to note that for non-sales data collected for a particular 
segment, application of this data to another segment can be a profound mistake. 
Customer data collected in a single database are not always a true reflection of the rest 
of the market segments. Therefore, business organizations need to take into account 
special data collection process, after which funding is decided. Woodburn (2006) states 
that data collection from outside the company is a crucial step in making a plan 
successful, because no amount of internal data can compensate for the absence of 
external data. A few customers who are loyal and who decide to buy from the supplier 
cannot be regarded as representatives of the entire market. Such an assumption can be 
misleading in terms of policymaking for future marketing activities. External data 
includes sales rates, contribution, market share and gross margins, and these provide 
the basis upon which forecasts are made and targets are judged.  
Data collection can be made successful with the help of two sets of 
measurements. The first is lagged measurements, which are taken from the actual 
results of the recent past. The other includes the forecasts for the previous and 
following years. Different segments have different responses, so it is sometimes harder 
to determine how each segment will respond to a marketing effort. Management of 
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marketing and sales efforts is done based on this information and data collection 
remains the biggest challenge during the process of marketing measurement.  
3.4.2 Impact factors in the ROMI model 
 
In addition to the abovementioned information about impact factors, they are also a key 
element of the ROMI model. An impact factor is defined as a proposition that can make a 
difference in market segments by leading to different results. Actions taken by suppliers 
should be directly focused on impact factors, as they help in finalizing future marketing 
strategies for a company.  
It is crucial to identify sets of impact factors for each segment because different 
strategies may be needed for each segment. A strategy for one segment might only have 
a small impact in other segments. Explicit strategies are not only powerful in nature but 
also offer a good deal of overlap. This means that impact factors that have an effect on 
one segment can be beneficial for other segments as well. Different types of impact 
factors are highlighted: these are productivity, qualifying and competitive advantage 
factors.  
Competitive advantage factors are those whose value proposition allows a 
supplier to obtain positive differentiation compared to rivals in the same market. These 
are the factors that have as their primary focus the prominent needs of customers. 
Increased market share can be assured if performance is improved for these factors. 
Competitive advantage factors can also become qualifying factors if used for a longer 
period of time. This happens when all competitors in a given market reach the same 
performance level and no one is able to gain an advantage. In most of the cases, this 
level is achieved when customers’ needs and demands are satisfied for a given product 
and do not require further improvement in performance. Considering the example of a 
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market in which five-day delivery is normal, if one company starts to provide next-day 
delivery, it only gains a benefit if customers actually want things the next day. If not, the 
customers’ needs are already satisfied and this factor cannot be converted back into a 
competitive advantage factor; it has now become a qualifying factor (Thomas, 2002). In 
other words, qualifying factors are the least that the customer demands. For example, 
when all companies are delivering in three days, a company that delivers in four days 
can be regarded as having poor performance, as it does not qualify as meeting market 
needs.  
The competitive advantage factors defined above relate to improving sales 
volumes and hence, productivity. Productivity factors include initiatives to reduce the 
cost of production, which can also improve the company’s profits. Production costs can 
be reduced through certain elements, including enhanced communication with 
suppliers, a quick transaction process, and the availability of raw material. In the RoMI 
model, these productivity factors play a central role. They can be used to monitor how 
they improve the business. The marketing management team can identify these factors 
through research and their implementation can be improved (Woodburn, 2006). 
In the case of the RoMI model, the strategies of suppliers are defined by the 
impact factors used to determine the responses of different market segments. Business 
advantages are obtained by those who achieve differentiation in their strategies or who 
are able to produce goods at low cost. Today’s competitive advantage factors become 
tomorrow’s qualifying factors.  
3.4.3 Actions related to marketing 
 
Marketing actions are critical in implementing the selected business strategy of a firm. 
These actions can be measured by looking at progress and fulfilment of business targets. 
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Almost every action requires external and internal costs for its implementation. Most of 
these actions can be categorized broadly into marketing and non-marketing actions. The 
structure of the company determines the way that distinct factors are measured and 
funds allocated to them. The allocation of funds is done based on the marketing action 
that the activities are meant to perform. The budgeting department is expected to 
allocate the funds. A company’s actions can be more appropriately grouped if the budget 
is assigned by aligning the actions with their purpose. Grouping of actions is also done 
by looking at the people involved in fulfilling them and the purposes of those actions. 
For each of the impact factors, a list of actions should be created and useful marketing 
initiatives carried out. If actions are cross-functionally distributed, a progress overview 
should be provided on an occasional basis. The responsibility for such a report is given 
to those responsible for the action, as they are closer to the market impact and thus 
have a clearer overall view of the impact.  
The above paragraphs have shown that marketing strategies should be 
implemented in a manner that is aligned with internal as well as external impact factors. 
All these impact factors have some cost attached to them and the marketing 
management team has the responsibility to identify this cost. Budgeting is done on the 
basis of available resources. Allocation of these resources is finalized by the 
management team responsible for the annual round of budget planning. Preparing the 
budget is a repetitive activity that addresses the future needs of the company. 
Estimating time demands can help avoid manipulation of the budget. Moreover, 
previous budgets that are used for future budgeting can lead to repetitive program 
activity that brings the company further from real business needs. Budgeting based on 
previous records is thus not a best practice; instead, market dynamics should be kept in 
mind so that the company can learn year after year. As a result, the company’s agenda 
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and the costs of various aspects will be much clearer. The company will stop poor 
spending habits and finally, the cost of operations will become clearer. The marketing 
budget can also be linked with the budgets of other functions, and should consider each 
of the identified impact factors.  
3.4.3.1 Action research in the field of marketing  
 
An ever-changing business environment requires marketers to undertake actions that 
can bring competitive advantages. Sometimes, bold actions are not very rewarding and 
at other times they can result in immense benefits for the company. In other words, the 
situation is not always very clear and some study is required before making decisions 
about company activities. Therefore, prior to implementing some actions, it is critical to 
take into account the marketing intelligence database that can help marketers with 
proper decision making. Getting the latest market intelligence requires resources in 
terms of time and money, so larger firms have a greater ability to gather intelligence 
and align their activities with the results (Simmons, Armstrong, & Durkin, 2011). Hence, 
it was essential for the team participating in this research to collect data during the 
early action research workshops and to combine that with the data from the first 
component of this research along with secondary marketing data in order to build a 
useful marketing intelligence dataset.  
Marketers have focused largely on the outcomes of marketing factors that can 
intervene between reward and expenditure at the same time. Lack of awareness of 
these factors can result in a lack of control, which might negatively affect business 
activities. The measurement of factors that may enhance marketing efforts results in 
improvement in returns (Simmons et al., 2011). The company can position and forecast 
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its efforts in a better way. Through such policies, activities generated in a vacuum are 
discouraged and the chances of failure are minimized.  
Action research in marketing helps identify how changes in marketing activities 
affect customer choices. As a result, company management is provided with accurate 
and valuable choices using reliable internal sources of information and secondary 
market data. Sound information also provides a basis for future decision making. 
Programs for marketing performance management and control can be initiated with the 
help of such research. Although previously, only marketing managers were involved in 
marketing research, various other departments such as sales, management, and 
production and supply units also participate in this area now. Informed decisions are 
made based on information shared on all fronts. Therefore, it was essential in this 
research to have participants from both the sales and marketing functions.  
According to Anstead et al. (2008), marketing is a complex phenomenon that is 
driven by customer demand. If a marketing action runs opposite to the demands of the 
customer, it can result in a total loss for that business. Initially, marketers are unaware 
of what the end results of their efforts will be, and this might lead to decisions that 
cause financial losses. Action research in marketing allows the marketer to perform a 
practical analysis of marketing activities to determine whether or not his actions will 
suit the interests of the company. Once the results are favourable, implementation of the 
strategy can be carried out (Anstead et al., 2008).  
Gray et al. (2003) add that marketers can forecast the effects of their operations 
with the help of action research; their expectations can also be quantified according to 
the organizational expectations. The clarity obtained through these initiatives creates 
stability in the organization and employees become able to direct their efforts in a 
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correct way. It is believed that companies that operate based on these principles learn 
to obtain competitive advantages through improved marketing decision making. In line 
with that, it was important for the marketer in the researcher’s organization to 
participate not just in the marketing planning session, but also in the sales planning 
session to benefit from the collective knowledge available in both the sales and 
marketing teams.  
Market segmentation is an important procedure that helps develop an 
understanding of the company’s marketing progress. Action research in this field is 
aimed at tracking performance and comparing it with past data and future projections. 
Marketing segmentation was a key tool that utilized for this research. A dedicated 
workshop session was set for the purpose of identifying segments. In this process, 
organizational aspirations are expressed in terms of goals and the nature of these goals 
and threats are defined. Segmentation is also of great importance in action research 
because the market is not homogenous; it is divided into various individuals, 
companies, groups and patents. This requires subdivision of the market into segments, 
which can create order according to people’s needs and demands. Through 
segmentation, people are placed into different groups and their demands are 
prioritized.  
Through action research, a company can decide how meaningful a part of the 
market is. Activities can be aligned to the purchasing decisions of the customer. 
Meaningful results are obtained through sales analysis of people’s buying preferences. 
Sometimes, one product is not attractive for one segment but carries a great deal of 
value for another segment of the same market. Therefore, market segments should be 
identified in terms of the attitudes, behaviours, needs and demands of potential 
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customers. Suppliers can better address customer drivers if they study these segments 
carefully.  
According to Woodburn (2006), management of marketing cannot be done 
effectively unless segmentation is done in a proper manner. A set of characteristics are 
studied before segmentation of the market is performed. The information that is 
collected is fundamental to developing strategic measurements for the company. The 
external backdrop of the segmented behaviour makes it possible for the supplier to 
understand the expected trends in the market. Action research is also a valuable tool for 
determining the opportunities and threats in a given market segment. Location, 
agreement and numbers are defined in relation to the needs and demands of the 
customer. From the results obtained through the research, segmentation criteria such 
as lifestyle, technological uses and buying attitudes are defined. Then, market segments 
are identified in relation to the projtect’s priorities and goals. In the current research, 
segmentation was as a key tool for defining the metrics of the model used.  
Actions that are taken in order to implement new marketing strategies can help 
assess marketing efforts in terms of their usefulness and progress. Every action should 
be evaluated in terms of the cost required to perform it. Grouping of actions should be 
done on the basis of the individuals or groups involved in fulfilling those actions. For 
instance, some actions are taken on a departmental basis and others might involve 
customers. Such groupings serve to simplify the process, making it easier to measure 
the impact of the actions. Sometimes, more than one department is involved in an 
actions and hence, the involvement of individuals from all the relevant departments is 
needed. This might increase the complexity of the project.  Along with this, the 
resources required for a particular action are identified. The budget is a strong force in 
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determining the success of a program. Therefore, the internal and external costs of an 
action require a good deal of attention. Strategic impact factors should also be measured 
in terms of cost and then appropriate actions taken (Shiv, Carmon, & Ariely, 2005). 
 
3.4.3.2 Role of action research in marketing  
 
Action research is gaining popularity in many fields, including education, marketing and 
human resource management. In this type of research, anecdotal evidence is used to 
establish facts. Companies are now being guided by action research in the adoption 
marketing strategies to facilitate and improve performance.  
How does the researcher create the system used for action research?  
In order to solve a problem in marketing, the researcher must take some important 
steps that create a proper system for resolving issues (Riel, 2010): 
 Identify the problem. 
 Select an investigation procedure. 
 Determine the data collection techniques and interpret the data. 
 Create a plan of action to solve the problem. 
 The researcher must be provided with the authority to implement the 
recommended procedures. 
The teams and groups that are involved in solving any issue must take certain 
steps in action research. The first is identifying the research problem, which must be 
specific and clear, but which can be either predictable or unpredictable. Large-scale and 
complicated problems should be left to more experienced researchers. Since problems 
also involve the consumers, efforts are made to know their views on how to resolve the 
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issues. For this purpose, surveys are developed and provided to the consumers in order 
to evaluate their satisfaction with the organization’s marketing process. The granted 
authorised scholar practitioner in this research played a major role in facilitating the 
study’s flow and the active involvement of the participating team members.  
3.4.4 Resource costs 
 
When an impact factor is identified by the market, external costs are incurred. This 
happens in cases where new equipment and software is purchased. For instance, 
delivery time can be shortened if delivery is done via trucks; the purchase of these 
trucks will require a cost known as an external cost. This brings a competitive 
advantage to the company with regard to this particular market activity. The needs of 
the marketplace can be best fulfilled if investments are made by taking into account the 
specific advantage factor and making it part of the marketing activity. Companies that 
do this are prepared to better respond to the changing needs of the market. The budget 
is tight when resources are required on short notice. Therefore, intelligent budgeting 
can be done by taking into account market needs and the position of the company in the 
market. In other cases, several dangers can be experienced by the business. If the 
provision of budget is not done, the intended marketing strategies are blocked, after 
which different decisions that may prove unsuitable for the company are made 
abruptly. Investment is wasted as the company goes against the market demands.  
 
3.5  Conclusion  
This chapter has identified the measurements that are required in order to apply the 
proposed RoMI framework. The aim of this framework is to develop an understanding 
of the market. Activities within organizations can be maintained with the lowest level of 
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uncertainty through such procedures. Measurements that are made through variable 
costs help in tracing costs. Cause and effect planning is conducted and marketers make 
assumptions according to their understanding of market. Cause and effect planning 
becomes useful in such cases where it is important to measure the return on marketing 
investment. For instance, if someone knows that a discount price promotion is more 
attractive than a banded coupon, investment can be directed toward the former. This 
knowledge cannot be achieved if the appropriate data is not gathered. Moreover, 
repeated updating of this knowledge is of critical importance; otherwise, companies can 
move into lazy spending. However, the RoMI model includes cause-and-effect 
relationships that cannot be measured very easily for some areas. Difficult-to-capture 
systemic information is sometimes required. Exceptions can be made clearer by 
marketers and company management if the different stages of the RoMI model are 
clearly identified.  
If a 2% increase in an impact factor takes place, a positive response may be 
expected. However, in some other cases, management may consider that a positive 
response is achieved at 5%. Quantification of the linkage between actions can decrease 
misunderstanding and differences in perception. Such outcomes can be applied to 
various business cases, leading to better decisions.  One study of market performance 
measurement in an emerging Turkish market indicates that marketing performance 
metrics are mainly production-oriented rather than sufficiently oriented that focus on 
the quality in which the focus is on the volume rather than the quality (Hacioglu, 2013). 
The reason for this is due to the historical attitude of Turkish firms, where production 
has been a key area for growth.  
The most important aspect of the model is data collection. The more data that is 
collected, the greater the chance of improving performance, since learning is enhanced 
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with data gathering. Unfortunately, records on marketing actions are maintained at a 
poor level in some companies and repeated mistakes are made each year. In such 
organizations, since an appropriate mechanism for learning is not encouraged, 
achievement of long-term goals and targets becomes impossible.  
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4.1 Introduction  
 
This study uses a mixed methodological approach to assess the impact on sales and 
return on marketing investment of marketing activities for OTC pharmaceutical 
products at the researcher’s organization. The theoretical and practical importance of 
this research is its goal of developing and implementing an effective intervention to 
measure the impact on sales and RoMI of marketing activities for OTC products. More 
specifically, this study investigates what drivers influence the sale of OTC products at 
pharmacies in different practice settings. To address the research objectives, this study 
uses the quantitative method and an action research (AR) approach.  
4.2 Quantitative component of the study 
In the quantitative component of the study, a survey is used as a simple way to collect 
data, as it offers flexibility, versatility and efficiency (Alreck & Settle, 1985). The 
researcher aimed to simplify the survey to ensure a high level of focus and clarity. The 
quantitative component of the research was accomplished by collecting data from the 
survey shown in Appendix A. The survey was distributed to pharmacists to assess their 
perceptions of the marketing activities conducted for OTC products. The aim was to 
optimise the marketing decision making process for executives managing OTC 
medicines in an emerging market by exploring the perceptions of community, hospital 
and polyclinic pharmacists regarding different types of marketing activities. The reason 
for choosing pharmacists in the private sector was because pharmacists are the sole 
central stakeholder through which prescription flow, marketing activities and discount 
offers occur. For the past decade, the role of the community pharmacist has increasingly 
included involvement in things like customer medical counseling and services. With the 
community pharmacy as a key channel for the majority of pharmaceutical company 
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activities, it was essential to assess the pharmacists’ perceptions of marketing and sales 
activities related to OTC medicines. This is due to the fact that pharmacists are believed 
to be uniquely qualified to serve the public interest in assisting with OTC product 
selection. The first component of the research was of an explanatory nature and was 
aimed at measuring pharmacists’ motives for making favourable recommendations. 
This component measured 18 influential items categorised under medical, social and 
marketing forces. Since the aim of this study was to look at the return on marketing 
investment, it was recommended by the researcher’s sales team to ask about the 
ranking of non-prescription analgesic product sales at the pharmacy. The last section of 
the questionnaire was used to collect sociodemographic data on the characteristics of 
the respondents, as well as on the setup of the pharmacy. Chapter Five explores the 
study sample selection, survey design, results and data analysis in further detail.  
4.2.1 Sampling method 
The study population consisted of pharmacists licensed in the state of Kuwait to 
practice pharmacy in the private market. The reason for excluding governmental sector 
pharmacies from the study was due to the regulations prohibiting any marketing 
activities in governmental pharmacies. A pharmacist database was obtained from the 
Ministry of Health, Pharmacy Licensing Administration. The total number of 
pharmacists licensed for the private market was 1,042 as of December 2013. The 
number of private market pharmacies listed with the Pharmacy Licensing 
Administration was 534 and the number of active pharmacies in terms of operation was 
around 390.  The pharmacies were sorted by their practice setting, based on a market 
survey conducted by the researcher’s sales team in December 2013. There are three 
different known practice settings in the private market: the private hospital pharmacy, 
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the private polyclinic pharmacy and the community pharmacy. The following table 
shows the distribution of pharmacies according to the different practice settings: 
 
Table 2: Distribution of pharmacies according to practice setting 
Practice setting Number of 
pharmacies 
Private hospital pharmacy 11 
Private polyclinic pharmacy 55 
Community pharmacy 324 
Total 390 
 
Determination of the necessary sample size was done using the Macorr© Research 
Solution sample size calculation tool. A confidence level of 95% and a confidence 
interval of 5% were used in order to gain a clear observation of the impact of different 
marketing activities on the sales of analgesic OTC products. The same significance level 
of 5% was also used for the study of Awad & Abahussain (2010), which assessed the 
health promotion and education activities of community pharmacists in Kuwait. In that 
study, the sample size was determined using Java applets to be 186 pharmacists in 
order to achieve a 5% significance level. Based on the Macorr© Research Solution 
sample size calculation tool, the necessary sample size in the current study was 
determined to be 194 pharmacies.  Each pharmacy was asked to have one staff 
pharmacist answer the questionnaire.  
4.2.1.1 Inclusion criteria 
To determine eligibility for participation in the study, the following criteria were set for 
pharmacists in the private sector: 
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 Licensed in the state of Kuwait as a pharmacist for the private market.  
 Active practitioner in a private sector pharmacy in the state of Kuwait.  
 Working as pharmacist at a hospital pharmacy, polyclinic pharmacy or 
community pharmacy.  
 
4.2.2 Survey design and approach 
The survey was designed based on a study by Kotecki (2002), which aimed to 
investigate what factors influence pharmacists’ over-the-counter (OTC) 
recommendations. Kotecki’s (2002) study extended the research of Benrimoj (1991) on 
the factors that influence pharmacists’ purchases and recommendations. 
The decision to design the survey based on the work of Kotecki (2002) was 
mainly because the author explored the factors influencing pharmacists’ OTC 
recommendations. Pharmacists are considered to be vital in the area of the OTC product 
selection. The pharmacist also has the best view of the factors that influence the 
purchase of OTC products, since the prescriptions, promotions, direct consumer 
feedback, OTC product procurement and product displays are all present in the 
pharmacy under the pharmacist’s supervision. Kotecki (2002) measured pharmacists’ 
motives for making favourable recommendations using 19 influential items categorised 
under medical, social and marketing forces. For this study, the number of influential 
factors was reduced to 18, using the same groups: medical forces (3 items), social 
factors (6 items) and marketing factors (9 items). Some of the influential items were 
redefined based on recommendations from the sales team at the researcher’s 
organization and from selected pharmacists currently practicing as community and 
hospital pharmacists. Since the aim of the current study was to look at the return on 
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marketing investment, it was recommended that the pharmacists be asked about the 
sales ranking of non-prescription analgesic products in the pharmacy. The last section 
of the questionnaire was used to collect sociodemographic data on the characteristics of 
the respondents as well as on the setup of the pharmacy. The researcher worked on 
collecting the data for the study.  
4.3 Action research component of the study 
The second component of the research was accomplished using the action research 
(AR) approach. Here, the survey data was analysed and a marketing action plan was 
created for a range of analgesic OTC products from the researcher’s organization.  The 
second component involved a series of meetings conducted by the researcher in the 
presence of the sales team to discuss the results of the survey and how the action plan 
could be designed to achieve the best possible results. The researcher was involved in 
all the meetings. Towards the end of the second component, the implementation of the 
action plan and a continuous evaluation process allowed the researcher and sales team 
to apply corrective actions when needed to ensure that the team could deliver the best 
possible results.  Chapter Six of this study describes the action research inquiry and the 
method applied in greater detail. The AR model was utilized after analysing the data 
collected by the survey. The use of the AR methodology allowed the survey data to be 
made the basis for the action plan developed by the researcher’s sales team. The 
researcher was the managing director at the organization where the research was 
conducted and received permission to conduct the research.  
If applied within a democratic environment, action research is considered to be a 
useful tool for solving an identified problem by involving relevant stakeholders as co-
researchers throughout the research process. This is done through a social 
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transformation process involving interaction in conducting the research, problem 
formulation, operationalization, data gathering, analysis, formation of the action plan, 
implementation of the action plan and action evaluation (Greenwood & Levin, 1998). 
The model requires an appropriate implementation process, as shown in Figures 4 and 
5, which was adapted in the current research to revolve around a series of workshops 
conducted within researcher’s organization.  
The first workshop had two key objectives: first, to identify current organization-
level metrics that were expected to be affected by the marketing activity; and second, to 
develop a set metrics for key identified segments in the researcher’s organization. The 
second workshop’s objective was to identify the metrics reflecting the impact factor in 
order to use impact factor analysis to track the performance of the marketing strategy.  
The third workshop focused on identifying actions necessary to deliver the marketing 
strategy, the budget to deliver the marketing goals and the financial metrics that would 
be used to track the actions and their impact on the set goals. The objective of the fourth 
workshop was to identify the responsibility of all team members involved in the action 
research in terms of who would be collecting the data, producing and tracking metrics 
and who would be responsible for corrective action if a metric indicated actual 
performance below the target. The fifth and sixth workshops were the final workshops, 
where the metrics were reviewed while the implementation was taking place. These 
workshops focused on monitoring the performance of the action plan implementation 
phase. This reflected the final part of the action research cycle, the evaluation. These 
two workshops were added to the model developed by Mouncey (2009) to help the 
researcher cover a complete action research cycle.  
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Figure 4: The marketing metrics model process (adapted from Woodburn, 2006, 
p.63) 
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Figure 5: Final marketing metrics model with four workshops (adapted from 
Mouncey, 2009, p.209) 
 
The purpose of bringing all the metrics together was to show the cause and effect 
relationship across the defined metrics. The objective was to help management assess 
the likely impact of implementing the defined marketing actions (McDonald, 2011). 
Appendices B and C present the template used for the information collected through the 
action research, covering the following items: 
 Actions:  The actions listed as part of the marketing plan and derived from the 
impact factors  
 Metrics: How the likely impact of the actions will be measured.  
 Current:  Reflects the current level of performance  
 Change: The change expected as a result of the action’s impact  
 Segment performance metric: Metric that is expected to be influenced by the 
defined action 
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4.3.1 Action research deployed in this research 
What action research offers to this applied research is the fact that the sales team at the 
researcher’s organization worked together with the researcher. As Lonergan (1990) 
emphasizes, being attentive to the data, intelligent in making an inquiry, reasonable in 
making judgements and responsible in making decisions allows the team to better 
analyse the data and achieve better ROI research. The action research methodology 
applied in this research consisted of assessing the collected survey data, developing a 
joint action plan, implementing the intervention and evaluating the impacts. This was 
done through participatory action research.  
One key challenge was related to the question of whether or not the action 
research conducted at the researcher’s organization would be scientifically rigorous. 
Based on the reviewed literature (Gummesson, 2000; Greenwood & Levin, 1998), action 
research, compared to other scientific research methods, is about taking action, solving 
the problem and contributing to the knowledge. Action research is enacted using the 
scientific method, moving through the stages of problem formulation, 
operationalization, hypothesis formation, data gathering and analysis, action design and 
action evaluation. Because of this, as argued by the reviewed literature, that qualifies 
the approach as a scientifically rigorous research method.  
Assessment of action research is done to confirm the validity and value of the 
research (Cassell & Johnson, 2006). Some authors (Cassell & Johnson, 2006; 
Gummesson, 2000) argue that a main benefit of action research is its ability to correct 
deficiencies discovered through the positivist approach, thus rectifying the past in 
addition to building toward the future. With the aim of finding a better approach for 
achieving higher ROI through various marketing activities, maintaining constant 
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interaction between team members in a democratic atmosphere will create the desire to 
implement the planned action, solve the problem and contribute to the knowledge and 
science (Gummesson, 2000).  
It has been discussed how action research methods can be used to solve 
immediate issues in marketing. Action research is used in various fields of study in 
order to can bring advancement in these areas. The personal involvement, reflection 
and insight developed through this technique are valuable in determining solutions to 
the problem being investigated. Marketers perform this kind of research during their 
studies and also in practice, with deliberate analysis of data and monitoring of the 
impacts of specific actions.  
As discussed in the literature review, the four basic steps of action research are 
planning, acting, observing and reflecting. These steps might be simple or complex, 
depending upon the nature of the problem being discussed. The plan can be modified 
according to the research requirement and all of the steps can be repeated until suitable 
results are obtained. The research method can also be adjusted to identify better 
options. The process might involve a number of research techniques, such as interviews, 
surveys, observations and discussions.  
The active participation of team members in an existing situation can help solve 
problems effectively. This kind of research carries a great deal of importance, as it 
provides the team members with the chance to explore new techniques in practice. 
Activities and strategies that have never been used before are initiated. Various forms of 
research, leading to new social actions, have been conducted in the field of marketing. 
The approach comprises a circle of planning that assists in finding a solution to a given 
problem.  
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Presently, marketing requires a great deal of study in order to bring its activities 
and strategies into line with the business cycle. These strategies can then be used by the 
organization to solve financial issues. Sometimes, a workable approach cannot be found 
unless actions are taken. Avoidance of the problem is not recommended, as it stops the 
organization at a point where it cannot move forward. In this context, business 
organizations that are able to collect systematic data and use this information to build a 
framework of action can move forward in a more objective manner. Doing so provides a 
number of advantages over continuing to operate without knowing the impacts of the 
company’s activities. Finally, an informed company is in a position to improve and adapt 
in a manner that can best meet its needs and demands.  
Action research involves teams or groups of individuals assessing the issues 
faced. In this way, both internal and external communication are enhanced. Teams that 
include stakeholders like employees and customers identify where the problem stems 
from. This improves employee performance and helps them become better 
professionals. Once the employees go through the action research steps, they come to 
know how problems can be assessed and resolved. This is a collaborative process, as it 
involves the employees, the employer and the stakeholders. They share their ideas, 
communicate with one other, inform one another and treat everybody on an equal 
basis. The authoritative approach is discouraged and employees and stakeholders gain 
the opportunity to participate equally and demonstrate their skills (Lewin, 1946).  
Action research is employed in daily situations rather than in an experimental 
setting because the main goal of the research is to find a solution to a real life problem. 
However, such research can first be employed by social scientists in their primary 
research or in pilot studies, followed by the actual action research. This approach can 
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resolve research problems in cases where the situation is not clear. When conditions 
require flexibility, this process can be employed, with the involvement of other 
participants used to improve the outcome (Stringer, 2013). The people who use action 
research in their studies are mainly practitioners who want to improve the 
understanding of their actions and the corresponding results. For instance, social 
change activists who are trying to create an action campaign can utilize this type of 
study. Similarity, people involved in designing marketing campaigns can also use it to 
assess the efficacy of their plans (Chisholm & Elden, 1993). 
4.3.2 Types of action research in marketing 
There are two kinds of action research that work effectively in marketing: practical 
action research and participatory action research. These types are discussed below.  
4.3.2.1 Practical action research  
Practical action research is related to the organization’s internal environment. 
Employees and employers participate in addressing a specific marketing problem at 
their company. The process can be carried out in a business setting such as in offices or 
production units. The aim of this type of action research is to improve business 
practices in the short term and to be aware of and communicate larger issues with the 
employees. The research is performed by a group of individuals, by teams or even by 
larger groups. The groups are provided with a clear and specific focus aimed at solving 
certain issues that interrupt the business process. An action plan is the outcome of this 
type of action research (Valtonen, Korhonen, Rekonen, & Leppanen, 2010). For the 
current research, this type of action research was not preferred, as the purpose of this 
research was to assess the business from the perspective of external environment in 
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terms of the effectiveness of sales and marketing activities, rather than being concerned 
with the internal environment.  
4.3.2.2 Participatory action research 
Participatory action research involves the individuals or groups known as stakeholders. 
Stakeholders play an almost equal role in the process and are meant to act as equal 
partners. They are highly concerned about the internal issues at the organization. They 
also help inform the organization about external business trends, so their participation 
is critical. The aim of participatory action research is to strengthen the company’s 
position in the external environment by having action researchers and participants take 
an active part in business operations and bring about social changes to enhance the 
company’s value in the long term. Stakeholders do not get involved at the start of the 
research. The company first seeks their help, and they become active early in the 
process. Then they collaborate in studying the action plan and finding ways to 
implement it (Berg & Lune, 2004).  
Collaborative research is an essential aspect of action research. It provides 
employees, employers and stakeholders with the means to step forward and take 
systematic and regular action for the sake of resolving significant problems. 
Collaborative research is democratic, as it invites all team members to actively take part 
in the process and values their decisions and ideas. The involvement of employees and 
stakeholders makes the research participatory. Participatory action research 
encourages employees and stakeholders to come up with explanations of their actions 
and then develop plans to best resolve the problem (Berg & Lune, 2004). The current 
study employed this type of action research by having managers and key employees 
from the researcher’s organization participate in the study as co-researchers. 
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4.3.3 Method of inquiry 
The researcher’s organization is specialized in trade related to healthcare products. The 
organization uses of two key models of operation. The first is called the distributor 
model; it takes care of the logistical support in terms of clearance, storage, distribution 
and market access, with key accounts in the market. The second key business model is 
known as sales and marketing, which revolves around the management of the sales and 
marketing function related to certain product lines. The model of interest for this 
research is sales and marketing. The aim is to investigate how the sales and marketing 
team can invest effectively and then monitor the outcomes of the investments made. 
The project of interest within the researcher’s organization is related to sales and 
marketing for pharmaceutical consumer products, particularly an OTC analgesics line.  
This section explores the method of inquiry for the action research component of 
the research and it includes an explanation of the applied action research learning cycle 
enacted through the workshops conducted, the secondary data used and the method 
used to validate the outcome and interpretations.  
Action research is considered a valuable tool for monitoring and evaluating the 
success of a given procedure. The participatory nature of action research helps generate 
a sense of ownership of the evaluation that is done. It also aids in retaining the 
knowledge generated by a given evaluation within the organization. Stakeholders are 
more involved in the process of research and this helps in the maintenance and 
retention of knowledge in communities and organizations (Majgaard, 2010).  
Action research is a process that is based on some fundamental steps. These 
steps have been described by different authors in different ways. Susman (1983) 
provides a step-by-step interpretation of the activities followed during the process of an 
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action research study. The first step of an action research study is identifying the 
problem. This process is also called diagnosis. During this phase, the problem for which 
a solution is being sought is defined. Afterwards, collective brainstorming is used to 
bring forth several possible solutions. Identification of the most suitable solution is 
done with the help of research that includes data collection and analysis. After the data 
is collected and analysed, the findings are interpreted in a detailed manner. This 
determines how useful the studied action was. The problem is then reassessed and the 
process is continued until a suitable solution is found.  
Action research cannot be regarded as a single method for finding a solution to 
an issue. Rather, it is a more holistic process in which several different research tools 
are used. Most of these methods are the same as those used in qualitative research, 
including data collection and analysis, keeping a journal, recording observations and 
conducting structured and unstructured interviews.  
Of all the tools discussed above, the most important and commonly used 
procedure for action research is the research conference. The research conference 
includes many different participants, including customers, decision makers, workers 
and policymakers, who all play a role in the reorganization of the business. During these 
conferences, the problem is identified in groups composed of the various stakeholders. 
The opening sessions provide detailed information regarding the problem and the 
environmental context in which the problem is being faced. All of the content of the 
conferences is created by the participants themselves, and the researchers are only 
there as facilitators to the process. Without criticism from the researchers, the group 
engages in in-depth discussion and the composite picture is checked by the entire 
group. The group then examines the after-effects of all the efforts made in the 
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organization and an overall picture of the desired future state is constructed. Finally, 
consideration is given to action or implementation steps (Chisholm & Elden, 1993).  
According to Lewin (1946), the action research process has three main stages. 
These stages involve a planned change that is cyclic in nature.  This cyclic process of 
change and the stages involved in this are discussed below.  
In the first step, a series of planning sessions is undertaken, where the change 
agent and client work together to identify the issue. During this process, actions related 
to the learning process are undertaken and an analysis of the problem requiring 
behavioural changes in the organization is done. Learning activities are developed with 
the help of feedback obtained through this process. For that purpose, a feedback loop is 
created.  
After the first stage, the second phase is the action phase or the transformation. 
This is the phase that involves the learning process associated with a change in 
behaviour for the client organization. The feedback received in the first phase is utilized 
in the second phase to implement changes to the existing client structure. One 
important aspect of this phase is determining which learning system will best align the 
change with the research objectives. Members and consultants from the client system 
provide their opinions after each joint session. Joint sessions are carried out based on 
the workshop sessions and then actions are taken for bringing the change to the 
organization.  
The third and final stage is the evaluation phase, which leads to actual 
behavioural change in the members of the organization. In this phase, corrective actions 
are taken based on the information gathered from the second phase. This stage also 
involves data gathering, through which progress can be determined and any necessary 
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changes can be made. Further adjustment is done on the basis of learning activities 
conducted during this phase.  
The first cycle of planning and re-evaluation brings basic changes to the 
organization. The entire approach introduced by Lewin (1946) includes the planning, 
action and evaluation phases. The planning stage is also called the period of unfreezing, 
where the discovery of problems is done. This is followed by a change period, when 
problem awareness is created. The final, action stage is the actual stage of change and 
includes trying out new behaviours that can help in addressing systemic problems. 
These stages sometimes overlap one other, as the boundaries are not very well defined 
and a continuous cycle cannot be carried out, as it would lead to unnecessary cost due 
to the possible repetition. The end phase or the period of refreezing is the one wherein 
new behaviours and activities are assessed in terms of their success. Attitudes that have 
proven helpful are reinforced and become part of the system. This shows how action 
research takes a problem-centred approach that can also be client-centred or action-
centred. During this process, diagnostic or active learning is done to bring about a 
solution for a given issue (Lewin, 1946).  
4.3.4 Action learning cycles and the workshops conducted 
The action research cycle adopted in this research comprised four basic steps: 
constructing, planning the action, taking action and evaluating the action, as per Figure 
6 (Coghlan & Brannick, 2014). The cycle included constructing the issue that the 
research intended to tackle and resolve, planning which actions would be taken, 
implementing the plan, and evaluating the result. The cycle captured a number of 
activities carried out in the form of workshops and post-workshop interventions.  
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Figure 6: Action research cycle 
The marketing metrics model used, which is illustrated in Figure 7, consisted of 
four workshops. The model follows a similar path to the action research cycle illustrated 
in Figure 6, which starts with construction, or defining the market and understanding 
the related values, followed by defining the plan through determining the value 
proposition, followed by action in delivering value, and ending with evaluation of the 
action by monitoring value.  
 
Figure 7: Positioning of the marketing metrics model 
The selection of the workshop team, as described in Section 4.3.3.1 below, is vital 
for the success of the action research process in terms of the team’s ability to develop 
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the key metrics, implement the action plan and appreciate the value gained from the 
process through continuous reflection and construction. The workshop process utilized 
for this study is described in detail in the following sections. Another important aspect 
of the team was the request that “criticism should be accepted and no hard feelings be 
taken.” The team wanted to make sure that there was a democratic environment and 
they were convinced that critical active learning was the best way to develop the 
research and action plans. It was not easy to convince the team to actively participate in 
this research and to take it as a serious assessment of the research and action plans. 
Hence, the researcher decided to run the workshops as per the model, in the form of 
business planning sessions and business review sessions that replaced the traditional 
business planning and business review sessions that take place in the researcher’s 
organization on a quarterly basis.  
 First workshop (building the case, defining the market & understanding value): 
As explained by Mouncey (2009), the first workshop had two key objectives. The first 
was to identify business metrics that might be influenced by the marketing activity and 
the second was to identify the key metrics related to the target segment. To achieve this 
objective, the team used the data collected from the quantitative component of the 
study and an analysis was done on the data. Business metrics can be in the form of sales 
targets, desired market share, market position, and gross margin. Metrics related to the 
target segment are critical metrics that are linked to segments found to be attractive for 
the chosen project, whose related consumer profiles match the key strengths and 
advantages of the organization’s products, capabilities and goals. The purpose of this 
workshop was to identify metrics that would enable the organization to track 
performance from the corporate and segment perspectives.  
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 Second, third and fourth workshops (Forming a plan of action, determining value 
proposition)  
As highlighted by Mouncey (2009), the remaining three workshops focused on 
defining the action plan and determining the value proposition. The second workshop 
was conducted to ensure that the strategy formed for achieving the set goals was 
appropriate and that the defined metrics could help track the progress toward the goals. 
The third workshop was focused on identifying the actions needed to implement the 
strategy, the budget required to deliver the action plan and the metrics to be used to 
track the actions, budget funding versus action, and the expected impact. The fourth 
workshop divided responsibility among participants by identifying how each member 
would be involved with each metric.  
 Fifth workshop (Taking action and delivering value) 
The fifth workshop was added to the model developed by Mouncey (2009). It included a 
review of the data generated through the enterprise resource planning (ERP) system 
post implementation, in addition to discussing secondary data like International 
Marketing Statistics (IMS) related to market share and market size. 
 Sixth workshop (Evaluating action and monitoring value) 
The sixth workshop was also added to the model developed by Mouncey (2009). It 
included a business review of the project’s performance after completion of the full 
action plan, in which the defined metrics were used to track and evaluate the 
performance. The team reflected on the results, how they might impact the existing 
plan, and whether modification was needed for the second cycle of the action plan. The 
current research covered only one complete action research cycle. The second, third 
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and further cycles will continue in the same manner as the first in the form of an annual 
business plan formulation workshop and quarterly business review workshops to 
ensure that there is a continuous action learning cycle.  
4.3.4.1 Participants  
The workshop participants were sales team members who were directly involved in 
promoting the analgesic OTC line at the researcher’s organization. The involved 
members included the commercial director, business development officer, sales 
manager, marketing manager, medical sales supervisor and pharmacies sales 
supervisor. The researcher was the managing director of the organization and had been 
acting as a researcher in the group. A key benefit of action research is the authority it 
offers to employees by enabling them to participate in the decision making process 
(Coghlan & Brannick, 2009). This approach is known as participatory action research. 
Another key feature of action research is the importance of group work and active 
participation. For the applied research, it would be impossible to conduct an action 
research study without the support of all participants. Coghlan and Brannick (2009) 
stress the importance of group work in reaching the desired state, as it strengthens the 
commitment level of all involved in the team. It is important to have active participants 
who have been involved in the collaborative inquiry move forward through the different 
phases of the action research. According to Beckhard and Pritchard (1992), the 
participants determine the need for change, the future desired state, and the work to be 
done to reach that desired state. Finally, they manage the transition phase. This requires 
group work at an intergroup level via productive dialogue between team members to 
assess what needs to be changed, mutual needs, and how the future can be shaped 
(Coghlan & Brannick, 2009). 
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4.3.5 Data sources  
A survey was distributed to a selected sample of pharmacists. Secondary data in the 
form of literature, company information and market data were also used. The dialogic 
inquiry action research approach between the researcher and workshop participants 
had an exploratory emphasis (Franco, 2005), describing the views of participants, 
which helped achieve a high level of detail from the collected data. 
4.3.6 Role of the researcher  
The researcher worked with the sales and marketing teams to analyse the survey data 
and the secondary data, and also organized the group conducting the action research, 
acting as an insider. Regarding the dual role of being an insider action researcher and an 
employee, it was politically challenging to act as both the front-line researcher and an 
employee. This challenge was minimized by having other members of the sales team 
supervise the research group. Building credibility was a key element as an insider 
researcher to achieving the research objectives as well as overcoming political 
challenges  (Björkman & Sundgren, 2005). This was done by defining the purpose of the 
action research and communicating the benefits that could be gained by the 
organization and the team. Another key challenge that was faced in conducting the 
action research was related to accessing the secondary data, particularly the informal 
data in the form of personal experiences rather than officially documented information.   
The action researcher must play multiple roles during the course of the research. 
He is the conductor and implementer of the research and also communicates the 
advantages and disadvantages of the research. In other words, the researcher is the 
person who can explain the consequences of ‘wearing different hats.’ In addition, the 
researcher is also a mandatory reporter when the research is complete. The researcher 
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is required to report both the positive and negative aspects of a technique’s 
implementation. As an action researcher, the researcher has the ability to analyse the 
socio-cultural context in which the results are found. During the research process, the 
role of the researcher becomes very challenging when more information is needed to 
respond quickly to a situation.   
When identifying an issue and finding a solution in marketing, it is the 
responsibility of the researcher to identify the problem and then bring it to the attention 
of the stakeholders. It is not necessary for the problem to be related to the researcher; it 
can be associated with the stakeholders. The researcher must support the stakeholders 
in solving their issues, acting as an internal consultant to the organization and 
informing them about the internal situation and activities of the organization (Lewin, 
1946). 
4.3.7 Limitations of the deployed action research methodology  
Upon review of the literature, it was clearly noticed that there is limited literature on 
the documentation of the action research process. This is in line with Herr’s (2014) 
finding that only a few studies have worked on the documentation of action research. In 
addition to that, less than 1% of all published information-system-related research is on 
action research, which means that action research is a relatively undeveloped research 
methodology.  
Regarding the current research, it is acknowledged by the researcher that the 
research has not followed the commonly understood conventions of action research. 
That has cyclical process. According to Susman (1978), action research involves a 
cyclical process comprising the five stages of diagnosis, action planning, action taking, 
evaluation, and specifying learning. After the final stage is completed, the cycle 
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commences again with the diagnosis stage. The long-term aspect of action research is 
crucial in order to ensure the rigor of this research methodology. According to Kock Jr. 
(1997), action research should be conducted in a cyclical format in order for it to 
strengthen the results of the research and achieve a more solid evidence-based 
outcome. Moreover, the iterative pattern of the repeated cycles of action research offers 
expansion of the research scope, helping build up the generality of the research 
outcome. This increases confidence, as the greater the exposure of the research work to 
the real world, the more reliable the data would be. Due to the limitations in time for the 
current research, it was relatively difficult to conduct an additional cycle of action 
research. The duration of this research was limited to 28 months and it was not possible 
to extend this period. In addition, the researcher also carried out quantitative research 
in addition to the action research component, which made it difficult to perform an 
additional cycle. The validity of the quantitative data was enhanced by combining it 
with the action research approach. The validity can be enhanced further if the research 
is done in iterations.  
4.3.8 Personal involvement  
The positivist approach followed in this research came from the understanding of the 
theoretical perspective of positivism. According to Gray (2013), positivism argues that 
that inquiry should be based upon a scientific observation. In the case of this research, 
the inquiry initiated for the action research component was built on the scientific 
quantitative component of the research. Hence, the action research was initiated based 
on an empirical inquiry. It is also important to acknowledge the claims of positivists and 
their fundamental beliefs; based on that understanding, the action researcher should 
respond in a neutral way with minimal bias in giving the opinion (Kock Jr., 1997). In 
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action research, an understanding of positivism can come from the definition given by 
Greenwood (1998), who argues that logical positivism is based on the ontological 
argument that the world can be defined objectively by applying objective techniques to 
acquire the truth and the solution to the problem. In this research, the researcher has 
followed positivistic logic and objectivist ontology by including quantitative 
methodology and applying a survey in order to build a base of truth prior to the action 
research approach. 
  As suggested by David Gray (2013), it is important to have a theoretical 
perspective in research in order to help clarify issues in research design. The research 
philosophy should be acknowledged in order to define which research design will work 
and which will not. In the current research, it was decided among research peers that it 
would be best to first use a quantitative survey component as a scientific query of 
pharmacists’ views on the most effective marketing activities for promoting analgesic 
OTC pharmaceuticals.  
The quantitative methodology in this research was followed by action research 
and as defined by Greenwood and Levin (1998), action research is a joint learning 
process that consists of a set of self-consciously collaborative and democratic strategies 
for generating knowledge and designing actions. Here, the researcher and local 
stakeholders collaborate to generate action and knowledge. Action research focuses on 
doing “with” rather than doing “on,” aiming to enhance the change and generate data for 
the generation of scientific knowledge through broad participation. Therefore, the 
researcher worked closely with participants in the organization in order to generate 
useful knowledge for the organization. Action research rejects the separation between 
thoughts and actions, as it promotes a participatory approach that aims to alter the 
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initial situation. In order to alter the initial situation at the researcher’s organization, it 
was important for the research team to collaborate to identify the ideal methodology for 
determining ROMI and to identify the marketing activities that would bring the best 
results through scientific inquiry.  
Due to the different natures of identified problems, action research follows a 
multidisciplinary approach and uses different methods. Action research must respect 
the multidimensionality of the defined problems in order to utilize local knowledge in a 
systematic manner to enable participants to make smarter business decisions.   
In order to minimize bias, it is important for the researcher to acknowledge the 
personal effect of involvement in the research, which often results in a high degree of 
emotional response, especially in situations that involve conflict and stress (Kock Jr., 
1997). Ignoring this fact might lead to failure in the intervention implemented by the 
action research practitioner. Such consideration has been given by the researcher in this 
research in order to avoid failure due to the researcher’s own behaviour.  
Considering the limitations of this research stated above, it is advisable to carry 
out additional iterations of the action research cycle, which would help overcome any 
possible distortions in the findings of this research caused by the researcher’s over-
involvement. The researcher avoided identification as the managing director and 
instead self-identified as the research facilitator for the sake of avoiding the negative 
consequences of personal over-involvement in the research. This is supported by the 
work of Greenwood (1998), who argues that the key benefit of the action research 
approach is that it opens the conversation to all participants and keeps the conversation 
going by bringing all forces of authority and representatives of different functions 
together in a structured way to make positive contributions.  
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Finally, it is important to visit the statement of Greenwood (1998) that action 
research produces meaningful and valid research results. This defends action research 
against the standard criticism arguing that action research is unscientific. In this case, 
acknowledgement of personal involvement should come hand in hand with the stated 
goal of seeking meaningful and valid research results.  
4.4 Conclusion 
With action planning being a key part of the action research cycle, it was important to 
enhance this phase using the quantitative survey data. This data was meant to help the 
research team solidify the action plan, aim for better engagement within the research 
team and reach a desirable outcome. Since the action research methodology is not 
common, it is also uncommon to find combined research that includes both quantitative 
methodology and action research, as this study does. Chapter Six covers the definition of 
action research, the use and role of action research in marketing, the types of action 
research and the specific type used for this study, the investigation and validation of the 
action research, the intervention that took place through a series of six workshops, and 
the outcome of the research. It was important for the researcher to acknowledge the 
possible effects of personal involvement, the positivistic logic used in the research and 
the fact that the research did not use successive iterations. It is also important to 
acknowledge that the validity of the research outcome can be enhanced by conducting 
further iterations of the action research cycle.  
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5.1  Introduction 
In the initial, quantitative component of this study, the data collected from the 
questionnaire were analysed. The survey, which was distributed to pharmacists, was 
aimed at assessing the efficacy of marketing activities in the pharmacy channel with 
regard to OTC products. The survey consisted of two sections, with the first section 
containing the following questions:  
 What is your gender? 
 How many years of experience as a pharmacist do you have? 
 What is the practice setting of the pharmacy? 
 How many point-of-sale materials (POSMs) are currently available in the 
pharmacy? 
 What is the frequency of pharmacist-patient interactions regarding OTC 
products? 
 What is the potential of the pharmacy in terms of daily revenue? 
 What is the most effective POSM in terms of its impact on analgesic OTC sales? 
The second section of the survey was aimed at investigating the pharmacists’ 
perceptions regarding the impact of POSM, prescriptions and the pharmacist-patient 
relationship on the sale of OTC analgesic products. The second section comprised 7 
questions measured on a 5-point Likert scale. The items were rated from 1 to 5, with 1 
representing “strongly agree” and 5 representing “strongly disagree.” The reason for 
using a 5-point scale was that it offered a few alternatives to the respondents. A smaller 
scale might have affected the reliability of the answers by forcing respondents to give an 
imprecise answer regarding the statement being investigated (Creswell, 2003). A larger 
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scale, on the other hand, might have led to more ambiguity regarding the meaning of the 
answer (Creswell, 2003).  
5.2  Results and data analysis 
The survey was distributed to 194 pharmacies in Kuwait, and of these, 141 pharmacists 
agreed to participate in the research. Due to the poor mail service in Kuwait and the lack 
of a database with pharmacists’ email addresses, the researcher distributed the survey 
to all participants in person. The purpose of the research was explained to all 
participants and they were asked to fill in the survey completely. Table 3 shows the 
demographic information for the participants, including sex, years of experience in 
practice, the practice setting of the pharmacy and number of POSMs. The majority of 
respondents (60.6%) were male, most (50.7%) had experience of longer than 10 years, 
and 30% had work experience between 6 and 10 years. The pharmacy practice settings 
of the respondents fairly reflect the proportion of different settings in the state of 
Kuwait, with the vast majority (82.9%) working at community pharmacies, 4% at 
hospital pharmacies and 14.3% at polyclinic pharmacies. Another key element for this 
study was the level of pharmacy activity in terms of marketing; that was reflected by the 
number of POSMs present in the pharmacy. The result showed that 28.3% of 
pharmacies had more than 10 POSMs, 23.2% had 8 to 10 POSMs, and 34.8% had 4-7 
POSMs.   
 
Table 3: Demographic information for the participants  
What is your gender? 
Answer Options Response 
Percent 
Response 
Count 
Female 39.4% 54 
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Male 60.6% 83 
answered question 137 
skipped question 4 
How many years have you practiced as a licensed pharmacist? 
Answer Options Response 
Percent 
Response 
Count 
Less than a year 2.1% 3 
1-5 years 17.1% 24 
6-10 years 30.0% 42 
More than 10 years 50.7% 71 
answered question 140 
skipped question 1 
What is your current practice setting? 
Answer Options Response 
Percent 
Response 
Count 
Community pharmacy 82.9% 116 
Hospital pharmacy 2.9% 4 
Polyclinic pharmacy 14.3% 20 
answered question 140 
skipped question 1 
How many point-of-sale materials (POSMs), e.g. counter top, stand, 
banner, are currently present in the pharmacy? 
Answer Options Response 
Percent 
Response 
Count 
Nil 0.7% 1 
1-3 13.0% 18 
4-7 34.8% 48 
8-10 23.2% 32 
More than 10 28.3% 39 
answered question 138 
skipped question 3 
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skipped question 25 
 
The pharmacists were asked whether they provide favourable recommendations 
to walk-in customers for key OTC product/medication categories, including analgesics, 
vitamins and nutritional supplements, home diagnostic devices for blood pressure and 
blood glucose, dieting/weight reduction medication and smoking cessation products. All 
participants answered this question. As can be seen in Table 4, analgesics and 
vitamins/nutritional supplements were the categories with the highest number of 
pharmacists giving favourable recommendations, with 139 out of 141 pharmacists. 
Dieting/weight reduction medications came in third, with 127 pharmacists providing 
recommendations, and the OTC classes with the least recommendations were home 
diagnostic devices for blood pressure/blood glucose and smoking cessation products.    
Table 4: Results showing whether the pharmacist provides favorable 
recommendations for OTC products/medications to customers 
Section 1: Do you provide favourable recommendations for OTC 
products/medications to customers walking in to your pharmacy for the 
following product categories: 
Yes or No 
Answer Options Yes No Response Count 
Analgesics 139 2 141 
Vitamins and 
nutritional 
supplements 
139 2 141 
Home diagnostic 
devices for blood 
pressure, blood 
glucose 
103 37 140 
Dieting/Weight 
reduction 
127 13 140 
Smoking 
cessation 
95 44 139 
 
 
129 
products 
     
  Question Totals 
answered question 141 
skipped question 0 
 
The revenue potential and pharmacy environment were measured by asking 
about the level of interaction with the customers, the total number of prescriptions 
received per day and the classification of the pharmacy in terms of sales per day. The 
results are shown in Table 5. Since most of the respondents were in a community 
pharmacy setting, the number of prescriptions received per day for all respondents was 
on the low side, with 43.2% receiving less than 10 prescriptions per day and 44.6% 
receiving 10 to 50 prescriptions per day. On the other hand, the level of interaction with 
patients was on the high side, with 73.8% of respondents identifying that they interact 
with patients regarding OTC products more than 10 times per day. The distribution of 
pharmacy classes reflects the overall classification of pharmacies in Kuwait in terms of 
revenue, with 39.7% of respondents achieving sales greater than 1000kd per day and 
46.6% achieving sales greater than 500kd per day. The low revenue potential 
pharmacies represent the minority of the respondents, with 13.8%.  
Table 5: The revenue potential and environment of the pharmacy 
On average, how often do patients interact with you regarding OTC 
products per day? 
Answer Options Response 
Percent 
Response 
Count 
Nil 0.7% 1 
Less than 5 times 11.3% 16 
5 – 10 times 14.2% 20 
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More than 10 times 73.8% 104 
answered question 141 
skipped question 0 
On average, what is the total number of prescriptions you receive per 
day? 
Answer Options Response 
Percent 
Response 
Count 
Less than 10 43.2% 60 
10 to 50 44.6% 62 
51 to 100 8.6% 12 
More than 100 3.6% 5 
answered question 139 
skipped question 2 
Describe the classification of your pharmacy in terms of revenue? 
Answer Options Response 
Percent 
Response 
Count 
Class a (sells more than 1000kd/day) 39.7% 46 
Class b (sells more than 500kd/day) 46.6% 54 
Class c (sells less than 500kd/day) 13.8% 16 
answered question 116 
skipped question 25 
 
The collected data were analysed using SPSS 22.0 and several analytical tools 
were employed, including mean, standard deviation, t-test and ANOVA. Table 6 presents 
the mean and standard deviations for 18 possible different forces that can affect the 
recommendations and sales of OTC products. The forces were categorized into medical, 
social and marketing forces. The pharmacist’s personal experience (M=4.63), positive 
feedback from customers regarding the product (M=4.49), the formulation/active 
ingredient of the product (M=4.41), the percentage bonus (i.e. free-of-charge goods 
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supplied with the product) (M=4.25) and stock pressure (M=4.23) were found to be the 
most significant influencers of OTC product sales and recommendations. Moderately 
important forces influencing the sales and recommendation of OTC products were cost 
of the product to the consumer (M=3.98), physicians’ recommendations of the product 
through prescription (M=3.89), the mark-up on the product, reflecting the profit margin 
for the pharmacy (M=3.86), the manufacturer’s reputation (M=3.86), and information 
from general medicinal guidelines (M=3.84). The least influential forces included what 
other pharmacists recommend (M=3.39), the market share held by the product (3.46), 
and availability through the pharmacy outlet only (M=3.56). 
As shown in Table 6, Cronbach’s alpha tests were conducted and the variable for 
the medical forces was 0.69, for the social forces jt was 0.74, and for the marketing 
forces it was 0.73, indicating that the group items had acceptable internal consistency 
(George & Mallery, 2003; Kline, 2000). 
Table 6: Cronbach’s Alpha results for the three categories of forces 
 
Scale: Medical Forces 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based 
on 
Standardized 
Items N Items 
.687 .692 3 
 
Scale: Social Forces 
Reliability Statistics 
Cronbach's 
Alpha 
Cronbach's 
Alpha Based 
on 
Standardized 
Items N Items 
.737 .740 6 
 
Scale: Marketing Forces 
Reliability Statistics 
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Cronbach's 
Alpha 
Cronbach's 
Alpha Based 
on 
Standardized 
Items N Items 
.735 .738 9 
 
As shown in Table 7, the mean scores for the three categories of influential forces 
showed no significant difference between them. Medical forces had the highest mean 
score (M=3.98) followed by social forces (M=3.97) and marketing forces (M=3.88).  
Table 7: Mean and standard deviation for the three categories of influential forces 
  Mean N Std. 
Deviation 
Medical Forces   
The formulation/ 
active ingredient of 
the product 
4.41 141.00 0.80 
Scientific 
evidence/clinical 
studies 
3.70 141.00 1.07 
Information from 
general medical 
guidelines 
3.84 141.00 0.96 
Average  3.98 141.00 0.94 
Social Forces   
My personal 
experience with 
the product 
4.63 140.00 0.76 
Positive feedback 
from customers 
4.49 140.00 0.77 
Physicians' 
recommendations 
of the product 
through 
prescriptions 
3.89 141.00 0.98 
Cost of the product 
to consumers 
3.98 141.00 0.99 
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What other 
pharmacists 
recommend 
3.39 140.00 1.08 
Market share held 
by the product  
3.46 140.00 1.04 
Average  3.97 140.33 0.94 
Marketing Forces   
It was formerly a 
prescription 
product 
3.79 140.00 1.12 
The manufacturer's 
reputation 
3.86 139.00 1.05 
Available only 
through pharmacy 
outlet 
3.56 140.00 1.11 
General 
advertisement of 
the product 
3.77 140.00 1.01 
The sales 
representative’s 
influence 
3.80 138.00 1.01 
The display 
materials 
3.80 139.00 1.01 
The mark-up of the 
product 
3.86 139.00 1.06 
The percentage of 
the bonus related 
to the product 
4.25 141.00 0.98 
Stock 
pressure/inventory 
4.23 141.00 0.97 
Average  3.88 139.67 1.04 
 
Next, the pharmacists were asked to rank the most effective drivers for OTC 
analgesic product sales in the pharmacy. As seen in Table 8, the results showed that the 
pharmacists’ recommendations are the most influential driver of OTC analgesic product 
sales, with an average score of 1.95. This result is related to the finding for social forces, 
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in which the pharmacist’s personal experience with the product was the most 
influential force affecting OTC product sales and recommendations (see Table 7).  The 
free of charge good/mark upwas the second most influential driver, with an average 
score of 2.38, followed by prescriptions, which had an average score of 2.65. Point of 
sales materials were the least effective driver, with an average score of 3.03. The 
ranking results are presented graphically in Figure 8. 
Table 8: Influential forces affecting OTC products sales and recommendations 
Section III: Rank the most effective driver for analgesics OTC product sales in your pharmacy 
(Please rank in order of importance from 1 to 4, where 1 is most important to you and 4 is 
least important.) 
Answer Options 1 2 3 4 Rating 
Average 
Response 
Count 
Point of sales material 12 27 36 55 3.03 130 
Prescription 24 35 34 37 2.65 130 
Pharmacist's 
recommendation 
55 38 26 11 1.95 130 
Free of charge 
goods/mark-up 
provided 
39 30 34 27 2.38 130 
answered question 130 
skipped question 11 
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Figure 8: Ranking of the most effective drivers for OTC analgesic product sales in 
the pharmacies 
 
ANOVA and t-tests were conducted to determine whether the medical, social and 
marketing forces differed significantly depending on the respondents’ gender, their 
work experience, the practice setting of the pharmacy, the amount of point-of-sale 
material available in the pharmacy, the level of interaction between the patients and 
pharmacist, the number of prescriptions received per day and the class of pharmacy in 
terms of daily revenue. The results are shown in Table 9. Medical forces scored higher 
with female participants (M=4.41) in comparison to social forces (M=4.05) and 
marketing forces (M=3.92). The t-test value was 1.54, reflecting a significant difference 
between the mean scores between males and females for the medical forces, with male 
participants giving a mean score of 3.89. The medical forces also achieved a high mean 
score, despite the difference in the work experience, where one-way analysis of 
variance showed a value of 0.44. The lowest mean score was found under the marketing 
forces with participants that had work experience of between 1-5 years. Surprisingly, 
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50
Point of sales material
Prescription
Pharmacist's
recommendation
Free of charge
goods/mark up provided
Section III: Rank the most effective driver for analgesics OTC products sales in 
your pharmacy <Please rank the following in order of importance from 1 to 4 
where 1 is most important to you and 4 is least important to you>
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the mean of the medical forces in the community pharmacy practice setting was the 
highest (M=4.17) compared to the polyclinic practice setting (M=3.86) and the hospital 
practice setting (M=3.75). The hospital practice setting had the highest mean score of 
4.20 for the social forces, compared to the polyclinic pharmacy practice setting 
(M=4.09) and the community pharmacy practice setting (M=3.94). All pharmacies had 
POSMs when the survey was conducted, with at least 1-3 POSMs in each pharmacy. The 
level of interaction of pharmacists with patients was on the passive side, with the 
minimal interaction level being 1-5 times daily. Pharmacies that receive more than 100 
prescriptions daily had the highest influence of social forces on sales (M=4.1). Class A 
pharmacies achieved the highest mean score for the medical forces (M=4.12) and 
marketing forces (M=3.93), and class C pharmacies achieved the highest score for the 
social forces (M=4.02). Overall, medical forces were more influential for female 
pharmacists, pharmacists who had practiced less than a year, the community pharmacy 
practice setting, pharmacies with one to three POSMs, pharmacists who interacted with 
patients between 5 and 10 times daily, pharmacies that received 10-50 prescriptions 
per day, and class A pharmacies. Social forces were higher influences for female 
pharmacists, pharmacists who had practiced less than a year, the hospital pharmacy 
practical setting, pharmacies with one to three POSMs, pharmacists who interacted with 
patients more than 10 times daily, pharmacies that received more than 100 
prescriptions per day and class C pharmacies. Marketing forces were higher influences 
for female pharmacists, pharmacists who had practiced less than a year, the polyclinic 
pharmacy practice setting, pharmacies with one to thee POSMs, pharmacists who 
interacted with patients less than 5 times daily, pharmacies that received 51 to 100 
prescriptions per day and class A pharmacies.   
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Table 9: Mean (M), Standard deviation (STD), t-test (t) and ANOVA (F) 
 Mean (M), Standard deviation (STD), t-test (t) and ANOVA (F) 
Item Medical Social Marketing 
Gender    
Male M=3.89 (STD=1) M=3.92 (STD=0.99) M=3.84 (STD=1.11) 
Female M=4.41 (STD=0.85) M=4.05 (STD=0.85) M=3.92 (STD=0.91) 
 t=1.54 t=0.49 t=0.46 
 p=1.170 p=0.110 p=0.030 
Experience     
Less than a year M=4.11 (STD=1.27) M=4.22 (STD=0.45) M=4.4 (STD=0.62) 
1-5 years M=3.95 (STD=1.12) M=4 (STD=1.08) M=3.66 (STD=1.13) 
6-10 years M=3.92 (STD=0.99) M=4.04 (STD=0.85) M=3.96 (STD=0.99) 
More than 10 years M=4 (STD=0.82) M=3.91 (STD=0.93) M=3.87 (STD=1.03) 
 F=0.44 F=1.16 F=1.06 
 p=0.728  p=.452 p=0.428 
Practice setting     
Community 
pharmacy 
M=4.17 (STD=0.94) M=3.94 (STD=0.94) M=3.90 (STD=1.05) 
Hospital Pharmacy M=3.75 (STD=0.65) M=4.20 (STD=0.75) M=3.70 (STD=0.84) 
Polyclinic 
Pharmacy 
M=3.86 (STD=0.99) M=4.09 (STD=0.95) M=4 (STD=1.08) 
 F=0.59 F=0.98 F=0.99 
 p=0.644 p=0.445 p=0.428 
Number of POSMs    
Nil M=4 (STD=NA) M=4.5 (STD=NA) M=3.77 (STD=NA) 
1-3 M=4.34 (STD=0.75) M=4.12 (STD=0.86) M=3.99 (STD=0.98) 
4-7 M=3.80 (STD=1.04) M=4 (STD=0.95) M= 3.96 
(STD=1.03) 
8-10 M=3.88 (STD=1.02) M=3.85 (STD=0.98) M= 3.77 
(STD=1.08) 
More than 10 M=4.07 (STD=0.80) M=3.94 (STD=0.89) M= 3.80 
(STD=1.02) 
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 F=1.381 F=1.198 F=1.005 
 p=0.264 p=0.452 p=0.452 
Level of interaction    
Nil M=4.33 (STD=NA) M=3.66 (STD=NA) M=3.44 (STD=NA) 
Less than 5 times M=3.87 (STD=0.88) M=3.99 (STD=0.81) M= 4.04 
(STD=0.80) 
5-10 times M=4.13 (STD=0.83) M=3.96 (STD=0.97) M= 3.92 
(STD=0.90) 
More than 10 times M=3.96 (STD=0.97) M=4 (STD=0.81) M= 3.85 
(STD=1.07) 
 F=0.816 F=1.183 F=1.624 
 p=0.493 p=0.502 p=0.285 
No. of prescriptions    
Less than 10 M=3.88 (STD=0.99) M=3.97 (STD=0.86) M=3.86 (STD=0.98) 
10-50 M=4.08 (STD=0.89) M=3.97 (STD=1.01) M= 3.88 
(STD=1.09) 
51-100 M=3.94 (STD=1.05) M=3.91 (STD=0.87) M= 3.99 
(STD=1.02) 
More than 100 M=3.86 (STD=0.62) M=4.1 (STD=0.75) M= 3.68 
(STD=0.81) 
 F=0.851 F=1.059 F=0.862 
 p=0.503 p=0.442 p=0.515 
Class of Pharmacy    
Class a  M=4.12 (STD=0.86) M=3.99 (STD=0.94) M= 3.93 
(STD=1.06) 
Class b M=3.93 (STD=0.90) M=3.92 (STD=0.94) M= 3.85 
(STD=0.97) 
Class c  M=3.95 (STD=0.92) M=4.02 (STD=0.91) M= 3.72 
(STD=1.03) 
 F=0.843 F=0.518 F=0.985 
 p=0.524 p=0.651 p=0.485 
 
 
 
 
139 
5.3  Discussion 
Since the objective of this study was to assess the return on marketing investment and 
marketing efficiency for OTC pharmaceutical products, it was vital to understand how 
competition forms, why certain marketing tools are used over others and how that is 
reflected inside the pharmacy. The reason for choosing pharmacists who worked in the 
hospital, polyclinic and community pharmacy settings was because all types of 
marketing activities are present in those pharmacies. For example, if the marketing 
authorisation holder for the OTC product, who owns the product’s intellectual property, 
decides to intensify marketing activities through the expert channel (i.e. detailing with 
physicians), the return on their investment in marketing should be reflected in the 
number of prescriptions generated by physicians and hence, this is how the return on 
marketing investment should be measured. In another example, if the marketing 
authorisation holder decides to intensify marketing activities through POSMs, 
consumers will find the POSMs inside the pharmacy. Therefore, the majority of 
marketing activities related to the OTC pharmaceutical products will fall inside the 
border of the pharmacy. Thus, it is important to assess pharmacists’ opinions of the 
marketing forces related to OTC pharmaceutical products.  
Regarding OTC medications, it is important to continuously assess how this 
category of medication is evolving with time, how it is impacting public health and how 
the marketing authorisation holder for the OTC products is contributing toward 
increasing public awareness of OTC products. One study showed that OTC medications 
account for an annual savings of 4.2 million USD for the treatment of headaches, 4.6 
million USD for indigestion and heartburn and 3 million USD for common cold 
symptoms (Lowe & Ryan-Wenger, 1999). Advertising and promotional activities 
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encourage the promotion of self-diagnosis and self-care in the public arena (Lowe & 
Ryan-Wenger, 1999), which is positively reflected by savings on general healthcare 
costs.  
According to a study by Lowe & Ryan-Wenger (1999) conducted in the world’s 
largest pharmaceutical market, the United States, retail sales of OTC products for the 
treatment of common diseases and symptoms increased from 1.9 billion USD in 1964 to 
16.6 billion USD in 1997. That means that every dollar spent on OTC products saved 
2.47 USD in healthcare costs, which has encouraged the growth of the OTC market along 
with its horizontal expansion into new categories (Lowe & Ryan-Wenger, 1999). A study 
by Awad and Abahussain (2010) conducted in Kuwait regarding the health promotion 
and education activities of community pharmacists showed that the majority of 
pharmacists in the study had a positive attitude toward encouraging health promotion 
and believed that lack of time was the biggest barrier to health promotion.  
It was encouraging to find that pharmacists are active in providing favourable 
recommendations for different types of OTC products/medications. The overall result 
was 603 affirmative answers to whether favourable recommendations were given, 
versus 98 negative answers. The result varied from one category of OTC product to 
another. Looking at analgesic OTC products, which include pain killers and headache 
relief products, and vitamins and nutritional supplements, 98% of pharmacists 
confirmed that they give favourable recommendations for OTC analgesics, vitamins and 
nutritional supplements.  
OTC dieting and weight reduction products achieved the second highest score, 
with 73% of pharmacists providing favourable recommendations. A study by Gordon, 
Watson, and Avenell (2011) evaluated the effectiveness and cost effectiveness of 
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community pharmacy weight management interventions and found that while 
community pharmacy weight management interventions can produce significant weight 
loss from baseline, the effect was not significant enough to justify the investment in the 
intervention. In the current study, 127 pharmacists out of 140 stated that they give 
positive recommendation for weight management products. This was higher than for 
blood glucose and blood pressure measurement devices, as well as smoking cessation 
products. It is not surprising that weight management products did not get a higher 
score than analgesics and vitamins, and there could be many reasons for that result. One 
possible reason can be found from a study done in the UK, which confirmed that 
pharmacies were not the preferred point of contact for advice on weight management, 
compared to other locations like gyms, leisure centres, primary care centres and 
dieticians (George, Lovelady, Connolly, Parmar, & Davies, 2010).  
Generally, the contribution of the pharmacist in encouraging the use of blood 
pressure monitors is limited. A study by Chambers et al. (2002) showed that this limited 
contribution is mainly due to poor communication between physicians and pharmacists. 
Pharmacists’ positive contribution toward encouraging the use of blood measurement 
devices would help facilitate the diagnosis and control of high blood pressure. In the 
current study, the pharmacists reported that they do not give as favourable 
recommendations for blood pressure self-monitoring devices and blood glucose devices 
as they do for OTC analgesics, vitamins and diet medications. The communication 
between pharmacists and physicians is considered to be poor due to limited 
communication channels, e.g. poor filing systems, limited email correspondence and 
lack of meetings between healthcare professionals. Thus, it is not surprising to find that 
the result of this study is similar to the findings of Chambers et al. (2002).   
 
 
142 
Pharmacy access is available for both healthy and sick customers. A study by 
Bauld, Chesterman, Ferguson, and Judge (2009) found that for smoking cessation, the 
pharmacy treats many more smokers that speciality group services, reflecting the 
greater accessibility of the pharmacy. As shown in Table 4, smoking cessation products 
are not highly recommended by pharmacists, and the study by Bauld et al. (2009) 
showed that pharmacy services were less effective than specialist-led group-based 
services, despite access to pharmacies being much higher. Bauld et al.’s (2009) finding 
can be seen as being reflected in the fewer pharmacists who reported giving positive 
recommendations for OTC smoking cessation medications. This topic would need 
further study in order to find ways to increase the effectiveness of pharmacy-based 
services, which would then reflect positively on the impact of promotional activities for 
OTC smoking cessation products.  
According to the commonly accepted rules for internal consistency based on 
Cronbach’s alpha (D. George & Mallery, 2003; Kline, 2000), the results for the medical, 
social and marketing force variables shown in Table 10 indicate that all three forces had 
acceptable internal consistency, despite the fact that medical forces had a Cronbach’s 
alpha of 0.69, reflecting an acceptable internal consistency rather than good. However, 
the variable was not eliminated, as it stands above the acceptance value of 0.6.  
Table 10:  Internal consistency based on Cronbach's alpha 
Cronbach's alpha Internal consistency 
α ≥ 0.9 Excellent (High-Stakes testing) 
0.7 ≤ α < 0.9 Good (Low-Stakes testing) 
0.6 ≤ α < 0.7 Acceptable 
0.5 ≤ α < 0.6 Poor 
α < 0.5 Unacceptable 
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The averages of the categories of forces affecting OTC product recommendations 
and sales were not significant from one another, but the averages of the individual 
forces did significantly differ. The highest influencers were found to be the pharmacists’ 
personal experience with the product, followed by the formulation/active ingredients of 
the products, and positive feedback from the customers. These findings suggest that the 
clinical evidence is as important an influencer as pharmacists’ own experience with the 
product and recommendations from the customers. The personal experience of the 
pharmacist seems to influence the recommendation given to the patient as significantly 
as a clinical study. Howard, Tsourounis, and Kapusnik-Uner (2001) found that the 
personal use of dietary supplements by pharmacists leads to a two-fold increase in the 
likelihood of the pharmacist recommending a dietary supplement to a patient. Hence, 
pharmacists do not only utilize their university education in making recommendations 
for OTC products; they are likely to place a high weight on their own personal 
experience.  
It was interesting to note that out of the marketing forces, bonuses related to the 
product and stock/inventory pressure achieved the highest score among all marketing 
forces, with mean scores of 4.25 and 4.23, respectively. Additionally, the overall 
marketing forces mean had the lowest score compared to the overall mean scores for 
medical forces and social forces. This might indicate that, in general, pharmacist 
behaviors in this part of the world are more biased toward a direct benefit to the 
pharmacy. In other words, marketing forces do not bring an immediate result but 
require time in order to create brand awareness and sales. Or, as indicated by Kotecki’s 
(2002) similar findings, the result suggests that pharmacists as healthcare professionals 
are qualified to serve the public interest objectively rather than considering monetary 
factors, and that they consider themselves a reliable source of OTC product information. 
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This data is further validated by the second component of the research—the 
RoMI from the marketing interventions analyzed through action research. Interestingly, 
the average mean of the stock/inventory pressure achieved a high score in this study 
compared to Kotecki’s (2002), which found stock pressure to be the least influential 
marketing force, suggesting that pharmacists are not more likely to recommend 
products that have been purchased in bulk. In this study, on the other hand, pharmacists 
reported that having high stock influences them to recommend products. Presumably, 
the high stock forces them to push products to avoid shouldering the cost of expired 
stock or having the cash flow cycle of the pharmacy be affected by high stocks of slow-
moving items.   
According to IMS data from 2013, analgesics maintained the leading position 
among all OTC products in the Kuwaiti market, and this was led by the drug 
paracetamol. Many products are available in the market with similar active ingredients 
but in different pharmaceutical forms, combinations and strengths. The analgesics 
category is of great interest to the researcher for many reasons, one of them being the 
fact that analgesics cover a wide range of customer segments, including adults, pregnant 
women, parents, the elderly, children and infants. In light of that, one question was 
dedicated to exploring the most effective driver for analgesic OTC product sales in the 
pharmacy, and a large portion of the second component was dedicated to assessing 
marketing interventions related to analgesic OTC products. It was interesting to find 
that pharmacists’ recommendations were considered the most influential driver of OTC 
analgesic sales. This can be supported by the finding of a relatively high level of 
interaction between pharmacists and patients, with all pharmacists reporting at least 1-
5 daily interactions.  
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When looking at the overall scores, pharmacists’ recommendations came first, 
followed by free-of-charge goods/mark-up provided, prescriptions, and finally, point of 
sales materials, despite the fact that all pharmacies had at least 1-3 POSMs when the 
survey was conducted. The result may suggest a biased effect, as pharmacists can reject 
the POSMs’ allocation in the pharmacy outlet despite the fact that all participants have 
POSMs in their pharmacy without acknowledging a significant effect. This finding is 
similar to the finding for driving forces, where social and scientific forces had a higher 
group average than marketing forces. It is worth noting that despite the fact that the 
OTC market in Kuwait is considered small, presently accounting for only about 15.5% of 
total pharmaceutical spending, BMI (2011) expects spending in this sector to increase 
from KWD28mn (US$99mn) in 2010 to KWD41mn (US$146mn) by 2015. Furthermore, 
from the data collected by the IMS (2012) related to the market in Kuwait, prescriptions 
are the main driver for pharmaceutical product revenue, dominating the vast majority 
of sales. In the current study, prescriptions were the 3rd most effective driver for OTC 
products, which is supported Weeks et al.’s (2001) finding that healthcare consumers 
rely mainly on physicians for information and Cockburn and Pit’s (1997a) finding that 
the prescribers themselves are the strongest determinants of which drug is chosen, 
even when patients have prior expectations about the choice of medication.  
A significant difference was found between males and females for the medical 
forces (t-test value of 1.54), for which the male participants gave a mean score of 3.89. 
Interestingly, this finding is similar to that of Kotecki (2002), who found that female 
participants scored higher for both medical and social forces. The medical forces 
achieved a high mean score, despite the difference in the work experience, which means 
that medical detailing is essential to pharmacists regardless of how many years of 
experience they have. One-way analysis of variance showed a value of 0.44, which may 
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suggest that pharmacists as healthcare professionals are qualified to serve the public 
interest in an objective manner rather than considering the monetary factors, and that 
they consider themselves a good source of OTC product information. The lowest mean 
score for the marketing forces was with participants that had work experience between 
1-5 years. This may suggest that pharmacists with less work experience might not have 
yet have sensed the impact of marketing forces on building the brand and creating 
demand for OTC products. 
It was interesting to note that the mean of the medical forces for the community 
pharmacy practice setting was higher (M=4.17) than for the polyclinic practice setting 
(M=3.86) and hospital practice setting (M=3.75). The hospital practice setting achieved 
the highest mean score of 4.20 for the social forces, compared to the polyclinic 
pharmacy practice setting (M=4.09) and the community pharmacy practice setting 
(M=3.94). This may suggest that prescriptions dominate OTC product sales in the 
polyclinic and hospital pharmacy settings. This is in agreement with the finding of 
Weeks et al. (2001), who found that healthcare consumers rely mainly on physicians for 
information. It also agrees with Cockburn and Pit’s (1997a) finding that the prescribers 
themselves are the strongest determinants of which drug is prescribed, even when the 
patients have prior expectations about the choice of medication. This is unlike the case 
of the community pharmacy, where access to physicians is lower and the pharmacy is 
used as a primary source of information on general symptoms and OTC products.  
Pharmacies that receive more than 100 prescriptions on daily basis showed the 
highest influence of social forces on sales (M=4.1). Class A pharmacies achieved the 
highest mean score for the medical forces (M=4.12) and marketing forces (M=3.93) and 
class C pharmacies achieved the highest score for the social forces (M=4.02). This may 
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indicate that the higher the number of customers, the higher the interaction, leading to a 
greater influence from the social forces.   
 Overall, medical forces were more influential for female pharmacists, 
pharmacists who had practiced less than a year, the community pharmacy practice 
setting, pharmacies with one to three POSMs, pharmacists who interacted with patients 
between 5 and 10 times daily, pharmacies that received 10-50 prescriptions per day 
and class A pharmacies. This may suggest that education-based influence is higher with 
fresh graduates than with more experienced pharmacists.  
Social forces were higher influences for female pharmacists, pharmacists who 
had practiced less than a year, the hospital pharmacy setting, pharmacies with one to 
three POSMs, pharmacists who interacted with patients more than 10 times daily, 
pharmacies that received more than 100 prescriptions per day and class C pharmacies. 
This suggests that the higher the level of interaction with the patient, the stronger the 
social force influence.  
Marketing forces were higher influences for female pharmacists, pharmacists 
who had practiced less than a year, the polyclinic pharmacy practice setting, pharmacies 
with one to thee POSMs, pharmacists who interacted with patients’ less than 5 times 
daily, pharmacies that received 51 to 100 prescriptions per day and class A pharmacies.  
This may suggest that when there is less interaction and a high flow of customers, 
marketing forces will have a stronger influence by communicating directly to 
consumers and creating demand for OTC products in the pharmacy.  
This data was further validated by the findings of the second component of the 
research, in which action research was conducted to analyze the impact on sales and 
RoMI of marketing interventions carried out by the researcher’s organization.  
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5.4  Conclusion 
Growth of the OTC product market is occurring every day. This has had a positive 
influence on healthcare costs and has encouraged self-care and health promotion. At the 
same time, marketers are trying to take advantage of this growing market by carefully 
selecting how to invest in the promotion of OTC products. The quantitative, survey 
component of the study has provided insights about what drives the sale of OTC 
products from the pharmacist’s perspective, and what the most effective factors are that 
can help in promoting and selling OTC products inside the pharmacy. The pharmacy 
was a key channel for conducting this study because all pharmaceutical company efforts 
meet in that setting. If the pharmaceutical company decides to promote a product 
through medical experts, the resulting prescriptions will be processed through the 
pharmacy. POSMs will be placed inside the pharmacy if the pharmaceutical company 
wants to use direct communication tools with consumers, and finally, pharmacists’ 
interactions with consumers take place in the pharmacy. It is important to combine the 
findings and conclusions of the study’s first component with the second component of 
action research, which will be further described in the following chapter. Such a 
combination is used to effectively assess the factors driving OTC product sales and to 
determine the best driver for delivering optimal RoMI.  
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Chapter 6 
Deploying action research 
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6.1  Introduction 
 
To help decrease risk in marketing investment and improve the marketing decision 
making process, working toward solving business problems is one of the main roles 
adopted by a marketing researcher. However, new practices within sales and marketing, 
as well as within business development, have left traditional market investigation 
behind. These disciplines are moving in the direction of greater involvement of front-
line staff and customers in the co-creation of value for companies. As a result, an 
increasingly participatory attitude towards employees and customers is being reflected. 
Various authors have illustrated how market researchers can assist in and improve this 
co-creation process for both commercial and not-for-profit organizations. Action 
research provides the tools and methods to enhance the level of customer satisfaction. 
The process of action research involves experimentation with other teams in order to 
find solutions to problems encountered in community practices.    
Marketing is a phenomenon that connects customers, sellers and end users in a 
manner that is beneficial for all stakeholders. During the action research process, 
information is collected to define and identify various kinds of opportunities and issues 
in the area of marketing. This helps improve the understanding of various marketing 
procedures and their potential impact on the revenue of a company. At the end of the 
research, the results are analysed in order to improve the implementation of the entire 
process (Donnelly, Simmons, Armstrong, & Fearne, 2012).   
To reduce failure and attain success, marketing departments can employ action 
research. Action research helps solve problems in a market, such as competition, 
product failure, gaining consumer attraction and satisfying stakeholder interests. It can 
also help decrease failure by motivating the employees to improve their communication 
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both inside and outside of the organization. However, high commitment is needed on 
the part of those conducting the action research. It is also necessary for all involved 
researchers to be seriously committed to improving performance and solving problems. 
They need to be fully engaged in the research in order to achieve the desired outcomes.  
Action research is a process that is carried out during a procedure or an activity 
to improve the methods and approaches already in use. This type of research was first 
used in the field of education and then became popular in various other fields. There are 
a number of marketing devices that must be checked for effectiveness and the entire 
process can be used to prepare a model for use in a business. During the process of 
action research, hypotheses are first developed and then they are evaluated. Therefore, 
the two main procedures that underpin action research are evaluation of a hypothesis 
and analysis of that hypothesis on the basis of the available literature (Webster Jr, 
1992).  
According to Ladkin (2004), action research relies on a protracted epistemology 
that assimilates theory and practice. It is grounded in the phenomenology of daily 
involvement (Ladkin, 2004). Another distinctive characteristic of action research is that 
it includes numerous perspectives. Therefore, action research is a participatory as well 
as a democratic process that pursues research by and for individuals, to restore the 
balance of influence over knowledge formation. Market orientation is supposed to 
facilitate better business performance. It helps in understanding trends fitting the 
requirements of the customer, according to the fluctuating market trends (Martin, 
Martin, & Minnillo, 2009). Analysis of behavioural viewpoints through action research, 
with an emphasis on idea generation, diffusion and receptiveness, contributes to market 
intelligence, ultimately benefitting the marketer.  
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According to Barton (1994), action research provides a chance to control vital 
marketing procedures, aiding in the development of a system with the right people and 
right data. However, the information is not always as good as expected. Planned 
marketing forecasting can benefit firms and yet, few firms are able to devise an action 
research marketing concept effectively. In a constantly changing business environment, 
executives cannot manage operations according to environmental changes if they are 
unable to obtain information by properly connecting front-liners to the external 
environment (Bartlett & Ghoshal, 1995). Thus, the primary role of managers in action 
planning is to sense environmental changes and deliver up-to-date market data that can 
be used by top executives to make decisions (Webster Jr., 1992). 
Action research also has a tendency to challenge the traditional and social 
sciences, as it moves beyond reflective knowledge. It aids in the creation of ideas 
through critical thinking. The process involves the creation of samples, the emergence 
of structure and knowledge, and the theorization of data. Knowledge is gained through 
the implementation of a procedure, or, in other words, actions are taken to validate a 
particular phenomenon. The entire process revolves around developing a well-informed 
action so as to understand how a process should be conducted.  
In this chapter, there is a description of the role of action research in the field of 
marketing and types of action research used in marketing. The chapter describes the 
participatory action research approach that was tailored to this research and how the 
intervention took place through a series of six workshops.  
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6.2  Investigation and validation of action research  
 
The philosophical view of people’s ever-expanding cycles of action-reflection-theorizing 
underpins action research. It is a social construction that takes the view that reality is 
generally created by people’s ideas and perspectives (Berg & Lune, 2004). Some 
researchers, including Berg and Lune (2004), perceive that developing realism by going 
through these cycles creates the basis of action research. For instance, about fifty years 
ago, McLuhan (1964) projected the idea of a global village; currently, people around the 
world are associated with one another through electronic means, creating virtual 
societies. After a new invention is emerges, it becomes less intimidating with the 
passage of time. Patterns, training, and additional support can encourage its acceptance, 
eventually turning adopters into assimilators. The phenomenon of adoption does not 
take an excess amount of time when the results are desirable or according to 
expectations. In many cases, innovation comes forth when people are unwilling to adopt 
the change. Sometimes, when an institution has incorporated and integrated a given 
idea, systems might still be unwilling to develop acceptors. Then, the upsurge of change 
can transform late adopters into critical accepters (Bruner, 2003). As acceptors increase 
in number and use the invention more and more, a learning point is reached and the 
invention becomes part of the developing culture. 
Research on invention tells us that there might be an association between an 
training and competence levels in an organization, and obstacles may arise during the 
course of adoption (Berg & Lune, 2004). In this context, the main obstacle is an 
embedded organizational philosophy. According to Mast and Zaltman (2005), 
supervisors frequently waste efforts on unproductive advertising, and setting up and 
executing the marketing strategy. There is a need to allow sufficient time for the 
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invention to be assimilated into the target culture. Research conducted at Harvard on 
novel product marketing found that people often make buying decisions based on word 
of mouth (Mast & Zaltman, 2005). The same study found that testimonials were more 
effective for marketing novel products than media advertisements and other 
techniques. People communicate when they are enthusiastic or feel good about 
something, but they likewise want to express their negative viewpoints. This shows that 
the product must be conveyed reliably in order to gain positive recommendations from 
satisfied consumers. Recommendations are equally relevant for the marketing of over-
the-counter medicinal products. 
Acceptance of novelty appears to occur more readily once the innovative product 
integrates into the culture of a place (Savenye & Robinson, 1996). Fullan (2007) adds 
that increased exposure to a product and familiarity with it reduces confrontation, thus 
improving its acceptability. As the invention becomes less threatening over time, 
acceptors become more eager to use and recommend it to others. At the same time, they 
begin to use the invention more often and integrate it into their lives. This inspires their 
peers to adopt it. By this point, acceptors require support and inspiration as they 
embrace and integrate the invention into their daily lives (Savenye & Robinson, 1996). 
Acceptors must feel that the benefits of the invention exceed its cost. Finally, the effort 
devoted to producing and distributing the invention will be worth the outlay. 
Action investigation is similar to a procedure used by many researchers. Lewin 
(1946), a famous organizational investigator, termed that procedure field research. The 
process involves project documentation, examination, planning, perceiving, assessing, 
amending, and then evaluating the cycle once more. Action investigation has proven to 
be a useful application of technical methods and an additional form of self-controlled 
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investigation that helps in dealing with daily problems. Assimilating theory into practice 
is the most vital part of action investigation. The term action investigation or action 
research developed out of kindergarten through twelfth grade classroom investigations 
that were directed informally by educators who wanted speedy solutions to classroom 
issues (Gay & Airasian, 2003).   
The effort required before action investigation can begin is more challenging.  In 
a conventional study, the researcher knows ahead of time which writings are pertinent 
to the study and he can thus form an idea of what the study is going to achieve.  In most 
systems of action investigation, however, the pertinent literature is only made clear 
through the data the researcher gathers. For these reasons, action research is much 
more difficult to report, especially for thesis efforts. The researcher must validate the 
entire methodology prior to the research.  At the same time, it is important to recognize 
that even if the assessors do not agree with the method, they have to see and accept that 
an acceptable justification has been delivered in the course of the research.  
6.3 Personal involvement  
The personal involvement of the researcher in the research process cannot be ignored, 
and it was acknowledged by the researcher throughout the entire research process. 
Action research requires the researcher’s involvement and the bias of the researcher 
can be controlled by the acknowledgement of possible bias. The industry influence on 
the scholar practitioner is a key feature distinguishing this type of research from 
traditional research approaches. With the iterative nature of action research, the effects 
of personal over-involvement can be minimized, as suggested by Kock Jr. (1997), 
through the successive iterations. Disconfirmation of the evidence using further 
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successful iterations can correct any distortion of truth coming from previously 
conducted iterations where researcher over-involvement was an issue.  
6.4 Intervention  
Action research has important elements that must be in place to protect participants 
from being threatened by corporate management. These elements, as suggested by 
Coghlan and Brannick (2009), include democracy, justice, freedom and participation. 
The literature provides a few useful suggestions about how to overcome political 
threats. For example, it is advisable to inform the sponsor—in my case, corporate 
management—about the progress of the action research on regular basis, as well as to 
be smart in communicating the benefits of the research (Roth, Shani, & Leary, 2007). 
Buchanan and Boddy (2008) also suggest establishing solid personal relationships with 
key decision makers in the organization by becoming a ‘political entrepreneur.’ They 
suggest managing the political stage at two levels: first, through actively participating in 
planning, processing, implementing and monitoring the change process; and second, 
through having the proper skills to conduct the action research, having skills that match 
the proposed strategy, properly preparing the team to conduct the research through 
back-staging, proper planning and implementation, building strong relationships with 
corporate management and knowing how to deal with decision makers.  The 
intervention that took place in the current study was in alignment with those 
suggestions. The researcher collaborated with team members to implement the action 
plan developed based on the analysis of the data obtained through applied research.  
It is helpful to know about the five areas of interest for incorporating 
organizational planning and implementation, as described by Coghlan and Rashford 
(1990). These are framing the corporate picture, naming the corporate words, doing 
 
 
157 
corporate analysis, choosing and implementing corporate actions and evaluating 
corporate outcomes. The wisdom here ensures that for any action taken, the action is 
evaluated and revisited if further modification is needed. This continuous evaluation 
process drives the active learning to be achieved by adopting action research. Such 
continuous learning should be used with the intervention in the business plan 
formulation process enacted at the researcher’s organization.  
6.5  Story and outcomes  
The story and outcomes are considered the heart of this research, as they reflect the 
course of events that took place through the series of workshops as well as through the 
sales and marketing activities implemented as part of the action research. The 
researcher decided to undertake this research as part of his organization’s annual 
business plan formulation and business review processes. The rationale for doing this 
was to make the participants feel like they were working within their comfort zones in a 
regular company process. During the action research process, it was important for the 
researcher to take account the sense-making and sense-giving done with the 
participants, especially throughout the process of collecting the story. According to 
Rouleau (2005), sense-making is defined as the way managers create sense for 
themselves through their attempts to understand and interpret the information 
collected related to a strategic change. Rouleau (2005) defines sense-giving as 
managers’ attempt to communicate their ideas and thoughts to others and influence 
others regarding the planned change. According to Coghlan and Brannick (2014), the 
sense-making process can take three forms for the action researcher. The first is the 
reflective pause, in which the researcher pauses at a point to reflect on events that 
surprised or disappointed the researcher. The second is going back to the story and 
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reflecting on how to interpret it. The third form is making sense of the overall 
interpretation of the story.  The outcome of the six workshops is summarised in the 
following sections.  
6.5.1 Outcome of the first workshop 
 
The first workshop took place at the end of fiscal year 2013. As discussed earlier, the 
key objective of the first workshop was to define the corporate goals and business 
metrics that could be used to evaluate the marketing activity. In this workshop, the 
participants discussed how the organization would handle the consumer line in general 
and the analgesics line in particular. This was done from the focus of entering the 
private market business, a key segment that had not been of interest in the past. The 
organization decided to invest in rebranding the analgesic line, which is a generic OTC 
line, to gain a solid lead position in the market over the next five years. At the corporate 
level, the organisation set a desired growth rate of 45% in revenue for 2014, a target 
revenue of 600,000 USD, a target gross margin of 240,000 USD and a net profit of 
108,000 USD for the analgesics line. The targets set at the corporate level were based on 
the market size for the analgesics line in the private market, which was defined by the 
IMS data for 2013 to be around 9,000,000 USD, with an expected growth of 5%.  
The team defined three target segments for the analgesics line: community 
pharmacies, polyclinic pharmacies and hospital pharmacies. The defined segment 
profiles are summarised in Table 11.  
 
Table 11: Segment profiles 
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Important 
drivers  
Segment 1: 
Community 
pharmacies 
Segment 2: 
Polyclinic 
pharmacies 
Segment 3: 
Hospital 
pharmacies  
What do they 
buy? 
Consumer 
products more 
than prescription 
products 
Prescription 
products more 
than consumer 
products  
Prescription 
products more 
than consumer 
products  
Who buys? Healthy and non-
healthy patients 
Mainly non-
healthy consumers  
Mainly non-
healthy consumers  
Number of 
pharmacies 
324 55 11 
Segment 
proportion of the 
total market in 
number of 
pharmacies  
0.83 0.14 0.03 
Segment 
proportion of the 
total market in 
value 
0.35 0.21 0.44 
Physician 
prescription 
influence  
low High high 
Pharmacist 
recommendation 
influence 
high Low low 
Direct marketing 
to consumer 
influence 
high high  Medium  
Spending 
contribution on 
medical 
marketing 
30% 20% 44% 
Spending 
contribution on 
POSM marketing 
56% 24% 20% 
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Impact factor for 
medical 
marketing 
20% 30% 35% 
Impact factor for 
POSM marketing 
30% 15% 10% 
 
Since the organization decided to move the analgesic consumer line from its 
comfort zone of the tender business to a focus on the private market, it was critical for 
the team to define a set of metrics that could help management track performance. This 
would ensure positive and desired progress toward achieving the corporate goals. The 
team defined key metrics, shown in Table 12 that could be greatly influenced by the 
planned marketing activities, along with set targets. As described in Table 11, the 
community pharmacy has access to both healthy and non-healthy consumers, unlike the 
polyclinic and hospital pharmacies. Community pharmacies represent the vast majority 
of pharmacies in Kuwait in terms of number. However, that does not reflect the 
potential of the pharmacies in terms of revenue, as the hospital pharmacies represent 
44% of the revenue stream related to pharmaceutical products despite only making up 
3% of total pharmacies. Due to the high flow of prescriptions coming from hospitals and 
polyclinics, the team decided to set the influence of prescriptions as high for polyclinics 
and hospitals. Based on the survey, and as shown in the rankings of the most effective 
drivers of OTC analgesic product sales in pharmacies (see Figure 6), pharmacists believe 
that their own recommendations are the most effective driver of OTC sales. Thus, the 
team ascribed high influence to pharmacists’ recommendations for community 
pharmacies compared to polyclinic pharmacies and hospital pharmacies. According to 
the survey and the mean scores for the three categories of influential forces shown in 
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Figure 9, the team decided to set the influence of direct-to-consumer marketing as high 
for both polyclinic pharmacies and community pharmacies compared to hospital 
pharmacies. The team decided to distribute the spending across the three different 
segments based on the identified influence levels. Spending contribution for medical 
marketing represented the majority of spending in the hospital pharmacy segment due 
to the high revenue potential and number of physician prescriptions. The spending 
contribution for POSM marketing was the highest for the community pharmacy 
segment, followed by the polyclinic pharmacies and the hospital pharmacies. The 
impact factors were calculated based on the team’s assumptions of the revenue that 
would be generated with and without the marketing activity. Using this information, the 
ROMI calculation shown below defines the incremental revenue attributable to 
marketing for each marketing activity in each segment.  
ROMI =
[Incremental Revenue Attributable to Marketing(USD) ∗Contribution Margin% − Marketing Spending(USD)]
Marketing Spending(USD)
  
 
The second objective of the first workshop was to identify sets of metrics related to the 
target segments. The team decided to set the metrics and targets as shown in Table 12.   
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Table 12: Metrics for each target segment 
Metric (title) How 
measured/source 
Actual Target 
Segment metrics 
Desired Market Share vs. 
Actual market leader 
%/ IMS  8% vs. 82%  
Sales Value vs. Competitor 
(market leader) 
Value/IMS  $885,000 vs. $6.1m  
Revenue segment 1: 
community pharmacies 
ERP system   $310,000 
Revenue segment 2: 
polyclinic pharmacies 
ERP system   $185,000 
Revenue segment 3: 
hospital pharmacies 
ERP system   $390,000 
Gross Margin segment 1: 
community pharmacies 
ERP system  $124,000 
Gross Margin segment 2: 
polyclinic pharmacies 
ERP system  $74,000 
Gross Margin segment 3: 
hospital pharmacies 
ERP system  $156,000 
ROMI (Medical Marketing) 
segment 1: community 
pharmacies 
ERP system   3% 
ROMI (Medical Marketing) 
segment 2: polyclinic 
pharmacies 
ERP system   4% 
ROMI (Medical marketing) 
segment 3: hospital 
pharmacies 
ERP system   12% 
ROMI (POSM marketing) 
segment 1: community 
pharmacies 
ERP system   107% 
ROMI (POSM marketing) 
segment 2: polyclinic 
pharmacies 
ERP system   48% 
ROMI (POSM marketing) 
segment 3: hospital 
pharmacies 
ERP system   212% 
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The team decided to define the corporate metrics as follows: the desired market 
share versus the market leader, sales value versus the market leader, revenue target for 
each defined segment, and the ROMI target for each defined segment for both medical 
marketing and POSM marketing. The target ROMI was defined by applying the above 
mathematical formula for ROMI. It was important for the team to first define the 
incremental sales of the marketing activity for each defined segment, allowing the ROMI 
calculation. The determination of the market leader in the category of OTC analgesic 
medications was done according to AC Neilson’s report for the year 2013, when the 
market leader had a more than 80% share of the market. As such, the competitor was 
set as the benchmark against which to monitor performance. It was also important to 
monitor market share as a key metric. The market is monitored by the IMS, which was a 
key secondary source of data. The target revenue and gross margin are normal metrics 
that the sales team was accustomed to using in all scenarios related to sales activities. 
The ROMI calculation was a new metric that was being introduced to the team for the 
first time. At first, it was difficult for the team to accept its use and it was also difficult 
for the team to make the calculation of incremental sales related to the marketing 
activities. In the end, however, the team began to realise how important the exercise 
was, as it enabled them to reflect on how each marketing activity would be reflected in 
the metrics for each defined segment. The other important factor was for the team to 
appreciate the marketing spending for each marketing activity in each segment. This 
gave them a thorough understanding of the amount to be spent and allowed them to 
carefully calculate the desired ROMI. The team also concluded that having more 
historical ROMI data in the coming years would enhance their learning about how to 
increase the efficacy of the marketing decision making process.   
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6.5.2 Outcome of the second workshop 
The second workshop dealt with developing the strategies to help the team achieve the 
desired goals and determining what the team needed to focus on. The question that 
needed to be answered at this workshop, as defined by Mouncey (2009), was ‘What 
impact factors will impact the performance?’ 
The team decided to investigate the impact of four different drivers: POSMs, 
medical detailing to influence prescription writing, the pharmacist’s recommendation, 
and free-of-charge goods supplied with the products as a promotional tool.  It was a 
challenge for the team to agree on the analytical outcome of the data collected from the 
survey and how this could influence the intervention plan. According to Mouncey 
(2009), impact factors need to be divided into three types: qualifying factors, 
competitive advantage factors and productivity factors. Qualifying factors are those that 
bring products to the minimal acceptable level from the customer’s perspective. In our 
project, the customers were physicians, pharmacists and consumers. According to 
industry norms, the team believed that having all the different driving factors (POSMs, 
medical detailing and supply of FOC goods) was essential and a minimum requirement 
to compete in the market. The competitive advantage factor meets the customer’s needs 
and demands; doing so over time is crucial in order to gain a competitive advantage in 
the market, which would be reflected in the project’s performance. The qualifying and 
competitive advantage factors aim to increase the project’s revenue and market share, 
whilst the third type of impact factor, the productivity factor, aims to improve the 
profitability of the project. The focus of the productivity factor is on the team’s decision-
making process, how the team is structured, and how the strategy is formed to deliver 
 
 
165 
results and performance. In line with that, the team selected the following impact 
factors:  
 Detailing activities for physicians and pharmacists  
 Implementation of POSMs by the marketing department according to the 
defined planograms  
 Supply of FOC goods 
As noted, the above three impact factors were considered minimal requirements 
to be competitive in the market, but what provides the competitive advantage is the 
effective implementation of the marketing activities to improve visibility and brand 
awareness, in addition to the marketing and sales coverage of the detailing activities 
and supply of FOC goods. Smart spending through close monitoring of the ROMI is what 
improves the productivity factor; that can be done by selecting the physicians to be 
covered in the detailing activities, how much to spend for the POSM activities and what 
percentage of FOC goods should be supplied to pharmacies as a bonus. The following 
table presents the gap analysis of the impact factors by strategy.  
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Table 13: Gap analysis of impact factors by strategy 
Impact factor and 
actions  
Metric Actual  Target Segment performance 
metric 
Actual  Target 
Consumer factor: Promotional activities related to point of sale materials  
Improve visibility  Number of 
POSMs 
implemented 
 35 counter- 
top and 30 
floor stands  
Market share vs. 
market leader 
 8% vs. 82% 
Improve brand 
awareness 
Cost of POSM 
implemented 
 $17,000 Sales value vs. market 
leader 
 $885,000 vs. $6.1m  
Improve coverage    Revenue for segment   $575,000 polyclinic and 
hospitals 
    Gross margin for 
segment  
 $286,000 
    ROMI for segment   107% in community 
pharmacies, 48% in 
polyclinic pharmacies, 
212% in hospital 
pharmacies  
Expert Factor: Medical detailing with physicians and pharmacists 
Full coverage of 
pharmacies 
Number of visits  3422 Market share vs. 
market leader 
 8% vs. 82% 
Coverage of all class A 
and B general 
practitioners 
Cost of medical 
representative 
visits  
 $82,000 Sales value vs. market 
leader  
 $885,000 vs. $6.1m  
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Using medical 
marketing aids 
Medical Aids 
(Drop-card and 
brochures) 
 $3000 Revenue for segment   $354,000 
 Scientific 
gatherings 
 $6000 Gross margin for 
segment  
  
    ROMI for segment   58% in community 
pharmacies, 11% in 
polyclinic pharmacies and 
86% in hospital 
pharmacies 
Retail Factor: Supply of free-of-charge goods to pharmacies 
Full coverage of 
pharmacies 
% of FOC goods 
supplied versus 
revenue  
 60% Market share vs. 
market leader 
 8% vs. 82% 
Reduction in the 
percentage of the FOC 
goods to be supplied 
versus last year 
Cost of FOC 
goods supplied 
versus revenue 
 $244,000 Sales value vs. market 
leader 
 $885,000 vs. $6.1m  
Achieve growth in the 
revenue and gross 
margin in all segments 
Cost of FOC 
goods supplied 
versus gross 
margin 
 $244,000 vs. 
$477,000 
Revenue for segment   $885,000 
    Gross margin for 
segment  
 $354,000 
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 Table 14 summarizes the metrics chosen to assess the outcome of the defined 
impact factors. For the consumer factor, the team decided to focus on pharmacies in the 
community and polyclinic segments, in which there was a high influence of direct 
marketing to consumers. The team also decided to implement some of the POSMs in a 
few outlets in the polyclinic and hospital pharmacy segments. The target revenue 
related to this impact factor was set at $477,000, while the target gross profit was set at 
$286,000. As defined in Table 14, the target ROMIs for this impact factor were based on 
POSM marketing to improve feasibility and brand awareness.  The target revenue and 
gross margin for the expert and retail impact factors were generalized with the total of 
all three segments. The team decided to cover all three segments with medical detailing 
activities since physicians have the highest influence on prescriptions in both the 
polyclinic and hospital pharmacy segments while the pharmacist, as per the survey 
findings, have the highest influence on the consumer’s decision in community 
pharmacies.  The target revenue and gross margin for the retail impact factor, which is 
related to the supply of FOC goods, was also generalized, as the FOC goods are supplied 
to all three segments.  
6.5.3 Outcome of the third workshop 
  
The aim of the third workshop was to link the marketing actions with their relevant 
costs and performance measurements, in order to measure the impact of the defined 
action plan on the budget and the outcome. In other words, it was about building the 
assumption of cause and effect. Since the project was of a consumer nature, It was 
important for the team to assess the causes and effects of the marketing activities 
related to the consumer impact factor. Since the project was well diversified, it was 
therefore difficult for the team to generalize the impact, unlike with the expert and 
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retail factors. Setting the budget for each element of the action plan and the expected 
outcomes in the form of revenue and net profit was already a regular process at the 
researcher’s organization. It was important to identify the linkages of all key metrics; 
these are summarized in Table 14. 
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Table 14: Marketing actions for the consumer impact factor 
Marketing 
action 
Metrics Quantity  Budget ($) Actual 
Related 
incremental 
revenue 
Target 
Related 
incremental 
revenue 
Segment performance 
metric 
Actual  Target 
Consumer factor: Promotional activities related to point of sales materials  
Indoor 
activity 
(POSM) 
Floor stand 30 $13,650   $125,000 Market Share vs. 
competitors 
 8% vs. 83% 
  Counter top 35 $3,350   $50,000 Sales Value vs. 
competitors  
 $885,000 vs. $6.1m  
  Cost of POSMs 
implemented in 
community 
pharmacy segment 
  $12,000    $75,000 Revenue for community 
pharmacies segment, 
Revenue for polyclinic 
pharmacies segment,  
Revenue for hospital 
pharmacies segment    
 $310k, $135k, 
$390k 
 Cost of POSMs 
implemented in 
polyclinic pharmacy 
segment 
   $2,500    Gross margin for 
community pharmacy 
segment, Gross margin 
for polyclinic pharmacy 
segment, Gross margin 
for hospital pharmacy 
segment  
 $124k, $74k, $156k 
 Cost of POSMs 
implemented in 
hospital pharmacy 
segment 
   $2,500    ROMI of segment   107% in community 
pharmacies, 48% in 
polyclinic 
pharmacies and 
212% in hospital 
pharmacies  
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The team defined the indoor activities for the selected line as including floor 
stands and counter tops as POSM locations. The team also defined incremental revenue 
for POSMs that could directly impact sales, like floor stands, counter tops and gondolas. 
It was decided that the general target for community pharmacies would be the key 
indicator for the window display rollups, as these POSMs do not have as much of a 
direct impact on sales as they do on product branding, which was a key strategy for the 
brand for the defined year. The total cost of the indoor activity was estimated to be 
17,000 USD and this amount also included also the estimated space rental at each 
pharmacy outlet. When calculating the incremental sales, the team considered two 
factors: the revenue expected without the indoor marketing activity; and the revenue 
expected with the indoor marketing activity. The team chose the following formula to 
calculate the incremental revenue for the indoor marketing activity: 
𝐼𝑛𝑐𝑟𝑒𝑚𝑒𝑛𝑡𝑎𝑙 𝑟𝑒𝑣𝑒𝑛𝑢𝑒 𝑓𝑜𝑟 𝑖𝑛𝑑𝑜𝑜𝑟 𝑚𝑎𝑟𝑘𝑒𝑡𝑖𝑛𝑔 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦
=  𝑟𝑒𝑣𝑒𝑛𝑢𝑒 𝑤𝑖𝑡ℎ 𝑖𝑛𝑑𝑜𝑜𝑟 𝑚𝑎𝑟𝑘𝑒𝑡𝑖𝑛𝑔 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 −  𝑟𝑒𝑣𝑒𝑛𝑢𝑒 𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑖𝑛𝑑𝑜𝑜𝑟 𝑚𝑎𝑟𝑘𝑒𝑡𝑖𝑛𝑔 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦  
 The workshop was found to be useful for the team, as it was the first time that all 
participants calculated the incremental revenue for the indoor marketing activities. The 
team faced some difficulties in doing the calculation, but with the help of the marketing 
team, they were able to create their own formula to calculate how each POSM could 
impact the revenue. They did this by considering the potential of the community 
pharmacy, the space rental, the seeding orders and the repeat orders. It was clearly 
defined that the marketing team would be responsible for finalizing the design of the 
POSMs as well as for choosing the locations for implementation. The sales team would 
be responsible for implementing the plan defined by the marketing team. 
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6.5.4 Outcome of the fourth workshop 
 
The fourth workshop aimed to bring the previous efforts together by reviewing the 
corporate goals and market segments from the first workshop, the defined impact 
factors from the second workshop and the correlation between the budget and action 
plan from the third workshop. The team decided to follow the audit process suggested 
by Mouncey (2009) by covering the following list of points: 
 Is the team implementing the authorized action plan? 
According to company policy, the approved business plan empowers the sales manager 
to take the actions necessary to implement the plan without needing to consult with 
management. A quarterly business review is carried out at the organization to ensure 
that the business outcomes are occurring according to the plan, and in the case of any 
major deviation, management interference in the project would be valid.  
 Does the action plan have a sponsor in senior management? 
The researcher is the organization’s managing director and has given full authority to 
the sales manager to execute the action plan without interference. Interference will only 
be used in the case of non-compliance with organizational policy or in the case of a 
deviation of more than 10% from the set targets.  
 Have the resources needed to execute the action plan been allocated?  
The action plan was approved prior to the commencement of the new fiscal year. Thus, 
the required resources in terms of manpower, marketing budget and other requested 
expenses and resources have been allocated for the project.  
 Which corporate goals could be influenced by the marketing strategy? 
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Smart spending is a key corporate goal that has evolved dramatically within the 
organization as a result of the action research.  
 Have the responsibilities been distributed to members who will monitor each 
metric? 
Each team member has clearly defined responsibilities, as do the sales manager and 
researcher. This is key for tracking the performance of the metrics, which have been 
incorporated into the organisation’s ERP system. The following table describes the 
frequency and responsibility for data collection related to the defined metrics. 
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Table 15: The frequency and responsibility of collecting & monitoring data related to the set metrics 
Metric (title) How 
measured/source 
Frequency 
of collecting 
the data 
Who measures Who monitors Who acts  
Desired Market Share vs. 
competitor (market leader) 
%/ IMS Quarterly Business 
development 
department 
Management 
  
  
Sales 
Team 
 Sales Value vs. competitor 
(market leader) 
Value/IMS Quarterly Business 
development 
department  
Revenue for segment 1: 
community pharmacies 
ERP system  Monthly Account and finance 
department 
Revenue for segment 2: 
polyclinic pharmacies 
ERP system   Account and finance 
department 
Revenue for segment 3: 
hospital pharmacies 
ERP system   Account and finance 
department 
Gross Margin for segment 1: 
community pharmacies 
ERP system  Account and finance 
department 
Gross Margin for segment 2: 
polyclinic pharmacies 
ERP system  Account and finance 
department 
Gross Margin for segment 3: 
hospital pharmacies 
ERP system  Account and finance 
department 
ROMI (Medical Marketing) 
for segment 1: community 
pharmacies 
ERP system   Account and finance 
department 
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ROMI (Medical Marketing) 
for segment 2: polyclinic 
pharmacies 
ERP system   Commercial director 
& marketing 
department 
ROMI (Medical marketing) 
for segment 3: hospital 
pharmacies 
ERP system   Commercial director 
& marketing 
department 
ROMI (POSM marketing) for 
segment 1: community 
pharmacies 
ERP system   Commercial director 
& marketing 
department  
ROMI (POSM marketing) for 
segment 2: polyclinic 
pharmacies 
ERP system   Commercial director 
& marketing 
department  
ROMI (POSM marketing) for 
segment 3: hospital 
pharmacies 
ERP system   Commercial director 
& marketing 
department 
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6.5.5 Outcome of the fifth workshop 
The research team conducted several business review sessions throughout the year to 
ensure that the implementation plan was being carried out according to plan with no 
major obstacles, and that the field force had an acceptable understanding of their 
obligations with regard to the implementation of the action plan. Many difficulties were 
reported during the business review meetings. Details about these difficulties are 
provided in the conclusion of this chapter and in Chapter Eight.  
A key challenge identified by Mouncey (2009), who created the RoMI model 
adapted for this research, is the ability to find a reliable data source for tracking 
performance. One measure for minimizing the risk of unreliable data in the current 
study was its size. The study was carried out only on the analgesics lines, with a defined 
marketing spend to ensure that the framework for measuring the RoMI and impact on 
sales was clearly defined. The purpose of the fifth workshop was to look at the data that 
had been collected and reviewed during the business review meetings. The team made 
sure that all the collected data had been validated, compared the findings with the first 
component of the study, and confirmed that the secondary data came from defined 
sources.  
The following tables represent the data collected after the close of the fiscal year.
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Table 16: Data collected for gap analysis of impact factors 
Metric (title) How measured/source Actual Target 
Segment metrics 
Desired market share vs. 
market leader 
%/ IMS 7% vs. 81% 8% vs. 82%  
Sales value vs. market leader Value/IMS $765,000 vs. $5.9m $885,000 vs. $6.1m  
Revenue for segment 1: 
community pharmacies 
ERP system  $322,000 $310,000 
Revenue for segment 2: 
polyclinic pharmacies 
ERP system  $135,000 $185,000 
Revenue for segment 3: 
hospital pharmacies 
ERP system  $308,000 $390,000 
Gross Margin for segment 1: 
community pharmacies 
ERP system $136,800 $124,000 
Gross Margin for segment 2: 
polyclinic pharmacies 
ERP system $57,375 $74,000 
Gross Margin for segment 3: 
hospital pharmacies 
ERP system $129,360 $156,000 
ROMI (Medical Marketing) for 
segment 1: community 
pharmacies 
ERP system   7% 3% 
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ROMI (Medical Marketing) for 
segment 2: polyclinic 
pharmacies 
ERP system   30% 4% 
ROMI (Medical marketing) for 
segment 3: hospital 
pharmacies 
ERP system   -57% 12% 
ROMI (POSM marketing) for 
segment 1: community 
pharmacies 
ERP system   105% 107% 
ROMI (POSM marketing) for 
segment 2: polyclinic 
pharmacies 
ERP system  8% 48% 
ROMI (POSM marketing) for 
segment 3: hospital 
pharmacies 
ERP system  146% 212% 
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Table 17: Data collected for impact factors 
Impact factor 
and actions  
Metrics Actual  Target Segment 
performance 
metric 
Actual  Target 
Consumer factor: Promotional activities related to point of sales materials  
Improve 
visibility  
Number of POSMs 
implemented 
33 counter top 
and 30 floor 
stands  
35 counter top 
and 30 floor 
stands  
Market share 
vs. competitor 
7% vs. 82% 8% Vs. 82% 
Improve brand 
awareness 
Cost of POSMs 
implemented 
$17,000 $17,000 Sales value vs. 
competitor  
$765,000 vs. $5.9m $885,000 Vs. $6.1m  
Improve 
coverage 
Cost of POSMs 
implemented in 
community 
pharmacies segment 
$12,000 $12,000 Revenue for 
segment  
$322k, $135k, 
$308k 
$310k, $185k, 
$390k 
 Cost of POSMs 
implemented in 
polyclinic 
pharmacies segment 
$2,500 $2,500 Gross margin 
for segment  
$136k, $57k, $129k $124k, $74k, $156k 
 Cost of POSMs 
implemented in 
hospital pharmacies 
segment 
$2,500 $2,500 ROMI for 
segment  
105% in 
community 
pharmacies, 8% in 
polyclinic 
pharmacies and 
146% in hospital 
pharmacies  
107% in 
community 
pharmacies, 48% in 
polyclinic 
pharmacies and 
212% in hospital 
pharmacies  
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Expert Factor: Medical detailing with physicians and pharmacists 
Full coverage 
of pharmacies  
Number of visits 3198 3422 Market share 
vs. competitor 
7% vs. 82% 8% vs. 82% 
Coverage of all 
class A and B 
general 
practitioners 
Cost of medical 
representative visits  
$82,000 $82,000 Sales value vs. 
competitor 
$765,000 vs. $5.9m $885,000 vs. $6.1m  
Using medical 
marketing aids 
Medical Aids (Drop-
card and brochures) 
$3000 $3000 Revenue for 
segment  
$443,000 $575,000 polyclinic 
and hospitals 
 Scientific gatherings $6700 $6000 Gross margin 
for segment  
$186,735 $230,000 
    ROMI for 
segment  
7% in community 
pharmacies, 30% in 
polyclinic 
pharmacies and -
57% in hospital 
pharmacies 
3% in community 
pharmacies, 4% in 
polyclinic 
pharmacies and 
12% in hospital 
pharmacies 
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Retail Factor: Supply of free of charge goods to pharmacies 
Full universal 
coverage of 
pharmacies 
% of FOC goods 
supplied versus 
revenue  
55% 60% Market share 
vs. competitor 
7% vs. 81% 8% vs. 82% 
Reduction in 
the percentage 
of the FOC 
goods to be 
supplied 
versus last 
year 
Cost of FOC goods 
supplied versus 
revenue 
$231,800 $244,000 Sales value vs. 
competitor  
$765,000 vs. $5.9m $885,000 vs. $6.1m  
Achieve 
growth in the 
revenue and 
gross margin in 
all segments 
Cost of FOC goods 
supplied versus 
gross margin 
$231,800 vs. 
$323,000 
$244,000 vs. 
$477,000 
Revenue for 
segment  
$765,000 $885,000 
    Gross margin 
for segment  
$323,535 $354,000 
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6.5.6 Outcome of the sixth workshop 
 
In the sixth workshop, the participants reviewed the outcome of the intervention plan 
and discussed the findings. The team found it useful to employ the ROMI model 
throughout the process, as it helped them identify new key performance indicators that 
allowed them to analyse the business situation and devise a more effective action plan.  
The team found additional metrics to add to the previously identified ones:  
1. The registration timeline, if applicable  
2. Necessary regulatory approvals  
3. Supply chain process  
4. Distribution efficiency  
5. Classification of the outlet 
6. Demographic factors 
7. Sales team stability  
8. Listing of the products in the hospitals’ formularies  
The team identified the above key metrics because it was thought that they could 
dramatically affect the outcome of the intervention plan, especially since the products 
are pharmaceuticals, which require special storage and distribution practices. The only 
two metrics from the above eight that actually affected the intervention plan were 
metrics related to the supply chain and the listing of the products in the hospitals’ 
formularies. There was a delay from the factory in supplying the goods to the market 
and that made the team unable to generate sales for the defined products for around 45 
days. The delay in listing the products in the hospital formularies did not significantly 
affect the overall outcome. 
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The revenue achieved was 15.6% below the target. This affected the goal of 
achieving 8% market share; only 7% market share was achieved. The main factor 
behind the decline in sales was the delay related to the supply of the goods to the 
market. The revenue achieved per segment was positive for the community pharmacies, 
as the team managed to achieve good coverage and hence, exceeded the set target. 
Revenue targets were not achieved for either the polyclinic or hospital segments, 
mainly due to the delay of supply of goods as well as the delay in listing the products on 
some key hospitals’ formularies. The gross margin/revenue ratio for all three segments 
was higher than the target, but was less in value than the set target due to the lower 
revenue achieved.  
In assessing the impact on sales of consumer factors related to the indoor 
marketing activities, it was noted that the implementation of the activities had 97% 
success, with 63 out of the 65 materials being implemented successfully and the 
remaining 2 not being implemented due to damage to the counter-top materials. The 
impact on sales was significant in the community pharmacies, as the majority of the 
implemented POSMs were in the community pharmacies and 70% of the POSMs’ cost 
was invested in this segment. Thus, the impact on sales was outstanding, with the 
community pharmacy segment being the only segment in which the team managed to 
achieve its targets. Regarding the RoMI, one notable finding was with the ROMI 
achieved through the hospital pharmacies. Even though it was below the set target, the 
hospital pharmacy is the most valuable segment in terms of revenue stream compared 
to other segments in the private sector. The key learning outcome out of this experience 
was that the successful implementation of POSMs in the hospital segment would result 
in an extremely high RoMI. However, the challenge here is the difficulty of implementing 
POSMs in the hospital segment. Reasons for this difficulty include the limited number of 
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hospital pharmacies, limited space availability and tough competition. Successfully 
implementing indoor marketing activities in hospital pharmacies was considered by the 
sales team to be a good achievement. A disappointing result came from the polyclinic 
pharmacy segment in terms of the RoMI related to the implementation of indoor 
activities. A significantly lower figure than the set target was achieved (8% vs. 48%). 
The research team justified this result as being because the pharmacies selected had 
low potential and none were classified as class A pharmacies.   
When assessing the impact on sales as a result of the medical activities, it is fair 
to conclude that the impact was positive as a result of the sales achieved in the hospital 
pharmacy segment. It is important to note that the team made a tremendous effort to 
list one key product in 7 hospitals, and considering the impact of the delay in supply, the 
result of 12.4% under the target revenue can be seen as a positive result. The RoMIs 
achieved through the polyclinic and hospital pharmacy segments were interesting to 
note, with the polyclinic pharmacies achieving a 30% ROMI versus a target of 4%, and 
the hospital pharmacies achieving a -57% ROMI versus a target of 12%. The research 
team explained this significant variation in ROMI between segments as being due to the 
high attention given to listing a product and increasing prescriptions of that product in 
the hospital pharmacy segment. The same reason explains the low impact on sales 
achieved in the polyclinic pharmacy segment. It worth noting that the coverage of the 
medical team must have had a positive impact on sales in the community pharmacy 
sector and that is in line with the finding from the first component of this research, in 
which the pharmacists’ recommendations were considered the most influential driver 
of OTC product sales in pharmacies. As a result, the resulting ROMI for the community 
pharmacy segment was higher than the set target.  
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Regarding the free-of-charge goods, the sales team decided to decrease the FOC 
goods supplied to the pharmacies by 5%. As a result, the gross margin exceeded the set 
target of 40%, with 42%, mainly in the community pharmacies and polyclinic 
pharmacies. The impact on sales was insignificant. The key finding here is that gradually 
reducing the FOC goods supplied to the market is a wise thing to do rather than enacting 
a sharp decrease, in order to avoid a negative impact on sales. The sales team was not 
able to reduce the FOC goods supplied to hospital pharmacies due to the limited number 
of hospital pharmacies and the low bargaining power of the team based on limited 
historical data.  
6.6 Conclusion 
The main components of action research are creating the action, seeing the results and 
undergoing a transformation on the basis of these results. Transformation comes 
through thinking and acting in a particular manner. With the passage of time, the 
researcher can implement changes in the wider social arena, involving even more 
stakeholders. The research takes shape as it is performed by the people involved. 
Greater understanding is achieved at each point and with time, ways to improve 
practices are developed (Creswell, 2003).  
Some important points regarding the course of action research are highlighted below: 
 Practice and inquiry: These are done to effect a change in a given scenario by 
taking into account a purposeful action. Emphasis on rigorous approaches and 
methodologies, which are required to validate assumptions, is maintained.  
 Converting theory into practice: Theories are used to generate practices. This 
begins with the study of human interactions, values and needs. Patterns of 
change are informed by social needs and demands.  
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 Inside and outside expertise: Inside expertise is used to develop an 
understanding of the problem through action research. Then, methods are 
employed to empower the user. Outside expertise is also called upon to guide the 
process of change.  
 Individual and group processes: Action research is a phenomenon in which the 
researcher explores research questions to investigate a process. At times, a 
group of researchers works to identify a common question and then undertakes 
the investigation. 
 Problem-based approach: In a problem-based approach, the problem is 
identified and progressive problem solving is undertaken. Multiple cycles of 
inquiry can be employed in order to remove confusion. 
 Transformation of identity and effecting social change: The main outcome of 
action research is meant to be change in a social context by influencing the 
processes by which people think and feel.  
 Shared knowledge and shared practices: After the results are obtained, action 
researchers share their practices and findings in a more general and applicable 
manner.  
Regarding the action research component of this study, the entire experience 
was unique, not only for the research itself, but for all co-researchers (team members) 
who participated in the research. It was a positive learning process in which the 
learning outcome significantly impacted the know-how of the research team. This was a 
result of the positive impact on the business achieved due to the project. The team 
decided to extend the practice to all other potential projects managed by the 
organization, and that decision has already been put into place through a request that 
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the business development team include the defined model in the business plan template 
for all potential projects. The business development team will also consider the addition 
of the new metrics agreed upon in the sixth workshop. Applying the defined model to 
new projects will increase the size of future studies, which will proportionally reduce 
the impact of the small study size in this study. The team also identified a new factor to 
be considered for other projects—the stock pressure tool of promotion. It was found in 
the quantitative component of this study that the influence of inventory pressure was 
higher than was previously found by Kotecki (2002); in Kotecki’s study, pharmacists 
who purchased products in bulk were less likely to recommend the product to the 
customer. The geographical distribution of pharmacies was not considered in this study, 
but the team decided to include this consideration in future studies. They will also 
consider retail avenues other than pharmacies, including supermarkets and grocery 
stores. It is also important to note that the study did not consider the classification of 
the pharmacies as a key metric prior to the implementation, in order to avoid a low 
ROMI, similar to what was found in polyclinic pharmacies after the implementation of 
the POSMs. As a result, the team agreed that more attention will be given to the visit 
plans of the medical representatives and the classes of the physicians to be visited. The 
team will not over-visit Class A physicians while neglecting clinics with lower potential. 
This action research did not consider the demographic factors of the healthcare 
professionals, despite the fact that the survey clearly found that medical forces 
influence female pharmacists to a higher degree. It was interesting that the coverage of 
the medical team had a positive impact on sales in the community pharmacy sector, as 
this is in alignment with the finding from the survey that the pharmacists’ 
recommendations are considered to be the most influential driver of the sales of OTC 
products in pharmacies.  It is important to note that the expected ROMI coming from 
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medical activities and indoor marketing activities in community pharmacies cannot be 
as high as the expected ROMI coming from the polyclinic and hospital pharmacies. The 
reason for this is the high number of community pharmacies versus other pharmacy 
settings, as well as the low average per-pharmacy revenue stream coming from the 
community pharmacy segment compared to the average per-pharmacy revenue stream 
coming from the polyclinic and hospital pharmacy segments. In conclusion, the team 
managed to overcome many major obstacles that caused them to consume a large 
amount of time, such as the difficulty in doing the ROMI and incremental revenue 
calculations.  
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7.1  Introduction 
This study aimed to assess the return on marketing investment and the impact on sales 
of various marketing activities for OTC pharmaceutical products. The goal was to help 
improve the sales and marketing decision-making process. Quantitative and action 
research components were used to meet the objectives of this research, test the defined 
hypotheses and answer the research questions. The aim was to address the gaps in the 
existing practice regarding the measurement of marketing’s impact on sales and return 
on marketing investment by executives in the pharmaceutical industry. This chapter 
elaborates on the overall conclusions of the study and how the findings can be taken 
extended through future research.  
7.2  Main findings  
The study answered all the research questions, with the following key findings:  
The action research component found that the impact of indoor promotional 
activities on revenue was positive for the community pharmacies. It was interesting to 
find that successful implementation of POSMs in the hospital segment would result in a 
high ROMI while a low ROMI would be achieved for POSMs in the polyclinic pharmacy 
segment. The ROMI achieved through medical marketing activities was around 30% for 
polyclinic pharmacies, while these activities had a -57% ROMI at hospital pharmacies. 
The team found that the coverage of the medical sales team with healthcare 
professionals had a positive impact on sales in the community pharmacies, which was in 
line with the survey finding that pharmacists’ recommendations are considered the 
most influential driver of OTC product sales in pharmacies. Also in line with those 
findings, the medical marketing ROMI for the community pharmacy segment was higher 
than the set target. Furthermore, the average ROMI achieved through indoor 
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promotional activities was 86.3%, while the average ROMI achieved through medical 
detailing was -6.6%.  
In the survey, 98% of pharmacists confirmed that they provide favourable 
recommendations for OTC products, including analgesics. In terms of pharmacists’ 
opinions of the factors driving sales, the marketing forces achieved the lowest score 
overall compared to the medical and social forces. This might indicate that the behavior 
of pharmacists is based on what directly benefits the pharmacy. In addition, 
pharmacists’ recommendations were rated as the biggest driver of OTC analgesic sales 
in the pharmacy, followed by free-of-charge goods/mark-up provided, and 
prescriptions, with point-of-sale materials receiving the lowest score. This finding can 
be considered as being in line with the action research finding that the reduction of FOC 
goods supplied to pharmacies had no significant impact on sales.  
As per the first component of the study, the highest influencer of revenue was 
found to be the pharmacists’ personal experience with the product, suggesting that 
pharmacists’ own experience with the product is as influential as the clinical evidence. 
Additionally, pharmacists’ recommendations were found to be the most influential sales 
driver, meaning that medical detailing of pharmacists is a crucial marketing activity. 
This was supported by the study’s second component, in which the medical detailing of 
pharmacists at community pharmacies led to a 7% ROMI, while the target was 3%. The 
polyclinic pharmacies achieved a 30% ROMI, while the set target was 4%, showing the 
high influence of pharmacists in the polyclinic pharmacies.  
Of the marketing forces assessed, the percentage bonus related to the product 
and stock/inventory pressure achieved the highest scores in terms of impact on 
revenue, achieving mean scores of 4.25 and 4.23, respectively, on the survey. The 
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finding from the action research found that reduction of FOC goods supplied to 
pharmacies had no significant impact.  
7.3  Research and managerial implications of the findings  
Regarding the implications of this research, several key learnings can be 
identified. The first is that the use of action research in the workplace is clearly 
beneficial for scholar practitioners who aim to create simple and customized models 
that can be used in practice. Executives are too busy to study complex models; these can 
only be implemented by hiring leading consultancy firms at a high cost and are thus not 
suitable for ordinary workplace problems. Although the literature contains plenty of 
theories that are impossible to implement without external support, an important way 
to identify solutions to workplace problems is to create a link between academia and 
business practice. Tenkasi and Hay (2004) assert that theory and practice together lead 
to an actionable study that can act as a bridge between the worlds of business and 
academia. Two outcomes are generated from this: one is the organizational result and 
the other one is the theoretical knowledge gained. However, there is still a lack of clarity 
as to how these dual outcomes can be achieved. The scholar-practitioner serves as a link 
through which desired results are obtained (Tenkasi & Hay, 2004: 114).  
According to Tenkasi and Hay (2004), actionable scientific knowledge is the only 
means that can help successfully span the science that provides a rigorous base for 
action research. Such knowledge meets the criteria for information required by the 
scientific community and by the business needs of an organization. Management science 
calls for relevance and rigor that affect knowledge change practices, which are different 
modes of knowledge practices generated from practical issues arising in a business. A 
useful, actionable study not only advances knowledge about practical business 
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problems but also provides a better understanding of business solutions (Tenkasi & 
Hay, 2004).   
The second key learning from this study is about the ability to play the dual role 
of executive and scholar-practitioner. It was a key challenge for the researcher to play 
that role while being an executive and guiding the other co-researcher to play a similar 
role. In order to become a scholar-practitioner in a particular field of study, it is critical 
to embed theory within a practical approach. Superficial knowledge does not make one 
a true scholar-practitioner; it is a role that requires true engagement, both as a scholar 
and as a practitioner. A third important learning was regarding the industry’s influence 
on the researcher, as the practical support provided to the scholar-practitioner is an 
important factor. Industry support can take the form of sponsorship of case study 
research within a corporation. A company can even allow a practitioner who is 
employed full time to carry out academic activities on a part-time basis. The industry 
can support the scholar-practitioner by offering opportunities to practice and apply 
management theories.  
Scholar-practitioners can face a tough challenge in managing their professional 
and educational goals at the same time. Therefore, industries can support them by 
offering part-time jobs that allow them to balance study with the chance to undertake 
research based on factual knowledge. In this research, being an insider in the 
organization allowed the researcher to complete the study successfully. Scientific 
knowledge is usually based on empirical skills. However, in the scholar-practitioner 
approach, the focus is maintained on objective and subjective skills and the self-
observations of the participants. The problem is identified and the hypothesis is 
formulated. Appropriate evidence is sought to support or disprove that hypothesis. 
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Finally, the overall opinion formed is publically shared and the conclusions are 
presented to peers. If all these steps are followed, better outcomes can be achieved. 
Otherwise, application of the model may be in vain.  
From the perspective of practical managerial implications, the study’s purpose 
was to explore the impact on revenue and ROMI of different marketing elements. 
Analysis of the data identified several key practical managerial implications that can be 
considered as central takeaways for executives responsible for the marketing of OTC 
medicines in emerging markets similar to Kuwait. First, detailing as part of medical 
marketing is an essential tool that can be used intensively in community pharmacies to 
increase pharmacists’ awareness of OTC medicines. Many executives neglect 
pharmacists in the community pharmacy segment, instead putting sole focus on 
prescribers in their medical marketing.  The expectation of ROMI for medical marketing 
in the community pharmacy segment should be reasonable, reflecting steady 
improvement in pharmacists’ awareness levels.  
Second, introducing POSMs to the hospital pharmacy segment, where possible, 
should achieve a significantly high ROMI if an attractive location and rent can be 
secured at the outlet; this is due to the high flow of patients visiting the hospital 
pharmacy. The number of hospital pharmacies is considered to be limited in 
comparison to other types of pharmacy practice settings and securing a location in a 
hospital pharmacy would be a key achievement that would contribute toward a high 
impact on revenue and ROMI.   
Third, the majority of executives managing OTC medicines in emerging markets 
are likely to be hesitant to make significant changes to marketing tactics due to the 
traditional nature of those markets and the fear of sudden unexpected reactions to a 
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major shift in marketing approach. Reducing the bonus being supplied to pharmacies 
might be difficult for many executives to do. The finding of this study, however, suggests 
that bonus goods provided to pharmacies have an insignificant influence on sales. 
Hence, investment in other marketing elements, such as medical marketing in the form 
of workshops, detailing, conference sponsorship and POSMs, would be more effective. 
At the same time, however, bonuses may have a role that was not looked at in this study, 
in areas like listing and promotional offers.    
7.4  Contributions made to the researcher’s organization 
This research work contributed to the researcher’s organization in many key business 
aspects. First, the introduction of the multidimensional practice of measuring ROMI by 
bringing both a quantitative approach and action research methodology created a 
decision making process to be followed by the organization’s executives. Second, 
bringing theory to practice while carrying out a research in the workplace provided a 
key contribution to the organization. This is something that was done for the first time 
by all research participants and gave them the confidence to carry out further research 
in the organization, with the aim of improving business practice and creating new 
knowledge to solve workplace problems. Conducting the research in an action research 
form greatly contributed to the research team’s increased confidence with carrying out 
research. This is due to the participatory nature and democratic process of action 
research, which balanced the influence of team members and led to knowledge 
formation. Third, the ability to transfer knowledge among research peers was crucial in 
the ability to find solutions to the identified problem of measuring the ROMI, which 
represents a relatively common challenge among all key players in the industry. Fourth, 
the researcher’s organization is a mid-sized company for whom hiring a reputable 
consultancy firm to help with complex problems would be very expensive. The team 
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believed that they could solve a complex problem by thinking collectively in a rigorous 
manner; such an achievement can be considered a solid foundation to be used by other 
players in the industry and to be replicated on other projects within the researcher’s 
organization. Finally, a key empirical implication is the ability to generalize the findings 
of this research, such that they are not limited to the specific project tackled. The ability 
to transfer knowledge has made the research team confident in the quality of the 
cumulative knowledge built into this research. This cumulative knowledge aims to 
collect the empirical evidence to apply to other workplace problems that have a similar 
context. As a result, the researcher agreed with the business development team to apply 
the same ROMI model to all the other trading projects in order to gain the long-term 
perspective of the applied ROMI model and to continuously contribute toward 
improving the cumulative empirical evidence from the research and the future 
application of the ROMI model in the researcher’s organization.    
7.5  Conclusion  
 
The scientific rigor of the scholar-practitioner model can be called into question in many 
cases. However, according to the researcher and his executive peers, the actual impact 
brought about by the scholar practitioner as a result of the research—in particular the 
action research component—is what needs to be questioned. The scholar-practitioner 
model is widely accepted and may be considered a key learning process that encourages 
critical thinking and innovation. The final essential aspect of the scholar-practitioner 
model is ensuring a democratic environment and minimizing bias throughout the 
model’s formation and the analysis process. 
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8.1  Introduction 
Many key limitations were encountered by the researcher in this study. One was the 
time constraint, which restricted the ability of the researcher to play the dual role on 
certain occasions. The research skills of the co-researchers presented another key 
challenge that consumed a great deal of the researcher’s time. There are limited number 
of studies covering OTC medicines in an emerging market, despite the significant 
importance and complexity of the subject. Many of the identified aspects of this market 
can be further studied by scholars and marketers, especially regarding the interactions 
among the marketing elements and their impact on sales, listing capabilities, market 
share and ROMI.   
8.2  Limitations 
Some key limitations were identified based on the findings of this study. One limitation 
is the possible bias resulting from pharmacists favouring their own recommendations 
as the main driver of OTC product sales. This result was further validated through the 
action research component of this study, but the survey can be directed to other 
stakeholders in future studies. Another key limitation is that the survey only targeted 
pharmacists practicing in three settings: the community pharmacy, the hospital 
pharmacy and the polyclinic pharmacy. The study did not target medical doctors, who 
are targeted by pharmaceutical companies to promote OTC products through 
prescriptions. Another limitation is that a key segment, the consumer segment, was not 
approached. The consumer segment is influenced either by direct communication 
through POSMs or by indirect communication through expert recommendations from 
healthcare professionals like pharmacists and medical doctors.  
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While the pharmacists were completing the survey with the help of the 
researcher, they were often distracted by consumers walking into the pharmacy to ask 
questions or make requests. In some cases, the pharmacists were not able to answer all 
of the survey questions due to such distractions. Because the study had a marketing 
focus and pharmacists are more oriented toward scientific subjects, having the 
pharmacists understand the terms used in the survey was a challenge. The researcher 
needed to explain in detail the meanings of the terms used, which probably influenced 
the answers of the respondents. It would have been ideal if the study had covered the 
full population of pharmacies in Kuwait. However, due to time constraints, the 
researcher only covered the determined sample size, which took around 100 days.  
A key limitation that was identified, particularly at the early stage of the action 
research component, was gaining the active participation of the co-researchers. The 
acceptance of such participation was initially low, as the co-researchers had a negative 
perception of the participation due to their busy schedules, low expectations of the 
outcome, and the time required. The size of the study was small and that is also a key 
limitation to achieving a reliable finding. Many other limitations have been identified 
and discussed in the conclusions of Chapters 5 and 6.  
There are numerous challenges in action research. The library work is more 
demanding than in traditional research, in which the literature relevant to the research 
is known ahead of time. In contrast, in action research, the interpretation of data 
determines the course of the research. In other words, the researcher first collects data 
and then he consults the literature to assess the findings.  
Another challenge encountered in action research is its reporting protocol, which 
is considered to be more complex than that of conventional research. For action 
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research, it is important to elaborate on the overall purpose of the phenomenon and 
justify the approach. This needs to be done in a manner such that even if others do not 
agree with the approach, they can acknowledge the rationale behind the research.  
 Following on the above two challenges, another problem in action research is 
encountered while documenting or writing up the results in the form of a thesis. During 
the thesis writing, more compelling justification is required regarding what the 
researcher aims to do. To provide such justification, the researcher must write the 
thesis in two stages. He first needs to describe the methods, interpretations and results, 
and then he needs to explain why these methods were appropriate for the given 
situation. If qualitative data was used in the research process, even more space is 
needed to report it.   
Prior to implementing a new initiative, various concerns are presented and one 
may not be sure how to effectively perform a task. In order to sort out these concerns 
and arrive at a practical solution to the problem, the context in which the problem is 
being solved or the solution is being applied must be analysed. The starting point in 
action research is to sort out a given issue to the extent that its solution can be 
generated. However, the most important aspect of the phenomenon is that the 
researcher is honest, rigorous and open.  
The value of action research is great because it is a procedure of interactive 
inquiry in which collaborative analysis is undertaken to create an understanding of the 
nature and cause of a research issue. At the same time, predictions about personal and 
organizational changes are made. During this process, many methods are utilized to 
adjust the balance toward a greater focus on action, thus creating a reflective 
understanding of a particular action. At various stages of action research, tensions can 
 
 
201 
arise amongst participants with different viewpoints. For instance, those who are more 
driven by the aim of the study and those who are more driven by their own agenda 
might have different aims than the aim of the study. At the same time, differences may 
arise between those who are more interested in organizational transformation and 
those who want to attain instrumental goals and targets. 
8.3  Future research  
A key practical implication that is worth noting is the ability to complete the action 
research process in an actual workplace setting. Completing the full process on a 
rigorous and continual basis would facilitate the learning process, the ability to find a 
solution for the problem through establishing a bridge between academia and practice, 
and the ability to generate innovative and creative ideas through critical thinking. The 
focus on OTC medications has a key implication considering the savings that self-
medication can bring to any nation, along with improvements in public welfare. A useful 
practical implication is that action research improves the ability of pharmaceutical 
industry executives to find the most practical, systematic approach to improving 
decision making related to sales and marketing investments in the OTC business.  
Pharmaceutical marketing is regarded as an important source of information and 
data, where new concepts are generated and information is progressively layered. The 
patient-centred approach has gained popularity, in which the person receiving 
treatment remains the focus of attention for the physician and the pharmacist. 
Information systems built to improve the understanding of drug products will play a 
central role in pharmaceutical marketing in the coming years. This information will 
result in the useful application of knowledge in the healthcare system. Transfer of 
information and knowledge to the practice occurs on a regular basis. It allows 
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practitioners to make informed choices, through which the physician can align the drug 
therapy to individual patients’ needs (Chesney & Christensen, 2004).  
Within that context, the process of pharmaceutical marketing remains the most 
comprehensive information system for updating physicians about the pharmaceutical 
aspects of a drug. Hazards, efficacy, safety, and also techniques for the use of particular 
products are shared with the practitioner. Information is communicated to 
sophisticated users who can ascertain the appropriate use of the medicine. The cost is 
offset by the savings resulting from appropriate use of the medication and this helps in 
achieving a better position in price competition.  
Doing a study in a particular region in the world, with its unique features and 
characteristics, uncovers valuable practical implications. Since this study was done in an 
emerging market, it can help pharmaceutical executives adapt their global market 
approach to specific regions. R. Smith (2005) predicts that the pharmaceutical industry 
will shift from a mass market to a targeted market.  This will help companies reach their 
desired audiences more efficiently. An entirely new model of marketing will replace the 
previous one, supporting investment in specific areas. These areas will be identified on 
the basis of market demand. The pharmaceutical workforce will become smaller and 
more agile to match the new dynamics. Incremental innovation in marketing techniques 
will be needed to meet the needs and demands of patients. Only those brands that 
provide cost value and that can impart the benefits of incremental innovation will 
survive. The market will be led by the brands that offer a whole healthcare package to 
patients and that have the capability to meet the changing needs. This means that 
pharmaceutical companies will need to change their marketing and sales techniques in 
the coming years in order to sustain their business.   
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The bargaining power of both suppliers and buyers is increasing with time. The 
pharmaceutical industry will need to work harder on achieving cost savings. This will 
require improved collaboration with marketers, suppliers, payers and providers. In 
such an environment, the pharmaceutical companies will need to prove that their 
medicines actually work and that people are receiving value for their money. Currently, 
the shift towards OTC products is increasing. This has given rise to increased attention 
on the part of the general public to the outcomes of drug therapy. Companies should 
also share their risk management practices, as well as safety and efficacy rules, to make 
their products more viable in the long run (Cockburn, 2004). 
In order to remain successful in a particular environment, companies need to 
understand the marketing rules of a given economy. For instance, in the developing 
world, rules and regulations are entirely different from those of developed countries. 
Therefore, any company planning to take the plunge into a new market will need to 
devise strategies that fit the local needs and demands of the market.  
All of the changing trends mentioned above, which are either regulatory or 
economic in nature, will require effective analysis before a strategy for pharmaceutical 
marketing can be finalized. A company with sufficient knowledge about the local and 
international business environment can shape and re-shape its strategies in a manner 
that is effective and useful.  
According to Law, Majumdar, and Soumerai (2008), the social, economic and 
demographic context in which the pharmaceutical industry is operating compels it to 
move towards change. Seven main trends are currently affecting the pharma sector. 
These trends are diverse, including the burden of chronic disease, the need for new 
forms of healthcare, the increasing influence of policymakers and payers, regulatory 
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burdens, emerging markets, and a focus on prevention rather than treatment (Law et 
al., 2008).  
The economic and social value of treatments for chronic disease will rise 
according to the nature of the diseases. However, the pharmaceutical industry must 
reduce its prices and rely on sales volume for such products, as most countries cannot 
currently afford them. Healthcare policymakers and payers exert a large influence on 
the prescriptions written by doctors. Treatment protocols have replaced individual 
prescriptions. The target audience of the pharmaceutical industry, which includes 
healthcare professionals and consumers, has become more powerful and associated. 
Now, the industry needs to work harder to reduce costs and to form productive 
collaborations with healthcare payers and providers. The industry also needs to 
enhance patient compliance. Therefore, the pharmaceutical market has taken a data-
driven approach to prove that their medicines are working, providing cost value, and 
giving better results than alternative forms of intervention.  
Emerging markets refer to the markets of the developing world. In these 
markets, the demand for medicines is growing rapidly and is also varying with the 
passage of time. Developing countries possess diverse economic and clinical 
characteristics, healthcare systems, and attitudes towards the protection of IP 
(intellectual property). All these factors can affect the future of pharmaceutical 
marketing in these environments. Regulators are becoming more averse to risk. The 
leading national and multinational pharmaceutical agencies have become more 
conscious about offering innovative and diverse medicines.  
Pharmaceutical companies need to engage in research and development in 
addition to developing their marketing capabilities. Improved marketing capabilities 
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will help increase health awareness, product knowledge and accessibility, from both the 
healthcare professional and consumer perspectives. It is essential for pharmaceutical 
companies to come up with marketing models that are customized to the industry, in 
order to overcome tough challenges and high complexity. The customization of 
marketing strategies should not just be industry specific; it is essential to customize 
marketing strategies according to the market’s specific nature and characteristics, 
seeking the highest possible impact on revenue and ROMI.  
8.4  Conclusion 
It can be concluded that in the coming years, pharmaceutical industry management will 
need to work on an entirely new model of sales and marketing. The sales team should 
be trained to launch a product, spread positive information about it and enact price 
controls. The competitive demands of pharmaceutical sales, regulatory burdens, chronic 
diseases and the increased influence of policymakers are inducing some dramatic 
changes that can affect the growth of the overall market. All of these factors should be 
considered and an entirely new model of pharmaceutical marketing should be 
constructed that can fulfil the needs and demands of patients in the coming years.  
The above context reflects the high pressure being built at a fast pace, increasing 
the necessity to improve the sales and marketing decision-making process. Thus, more 
research can help pharmaceutical executives find best model for measuring marketing’s 
impact on sales and the return on marketing investment. 
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Reflection on my experience as a scholar-
practitioner 
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9.1  Introduction 
This thesis reflects my personal experience as a scholar-practitioner conducting a 
research in my workplace. This chapter explains how my learning evolved throughout 
the research process. As indicated previously, I took account of the sense-making and 
sense-giving within the coherent format within the organization to enable an effective 
interactive dialogue among research participants and to enhance the learning in 
practice. I use this chapter to reflect on my learning during the 28 months spent 
carrying out this research at my organization and, in particular, the 12 months of 
conducting action research, when my organizational team members participated in the 
research.  
9.2  The research journey 
I joined the organization as a managing director and co-partner in 2013 and the 
research was conducted in the same year. I had previous experience in the field at a 
different organization that is also in the healthcare industry. Over a period of 7 years, I 
held several executive positions in the industry. The difficulties that I encountered 
during my previous experience with increasing efficiency through smart spending were 
brought with me to my new organization. These difficulties were recognized by myself 
and my other peer executives, and as a result, we constrained our marketing spending. I 
recall a sales manager stating, “On several occasions, we worked with the marketing 
team on a campaign that got rejected by the management due to its high cost without 
considering the possible return on investment.” A pharmacy sales supervisor once 
indicated the following: “Sometimes we get frustrated, as we are asked to repeat certain 
marketing activities that we believe are not useful but we do not have solid proof that 
can support our argument.” Furthermore, a brand development manager once stated, 
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“There is no tracking of our performance and the sales team gets more credit for our 
work more than we do.”  I wanted to prevent such problems from reoccurring by 
tackling the measurement of marketing spend in my workplace through research. The 
team and I were aware that the research process would take time and that it would 
require a high level of collaboration to agree on a model to help the organization 
quantify the projected ROMI and to be a key tool for tracking marketing performance.  
With the help of my CEO, partners and executive team, I managed to obtain 
consent to proceed with this research. It was accepted because it would not distract the 
team from their daily work activities and at the same time would serve to extract 
innovative ideas from the team members to help in the measurement of the marketing 
spend.  As indicated in Chapter 6, I arranged a series of workshops with the research 
team, as per the identified ROMI action research model developed by Mouncey (2009).  
The dual role that I played throughout the research was quite challenging, since I had to 
carry out the research work and facilitate democratic dialogue by enabling the 
participants to openly discuss their views and thoughts without consideration of the 
authority levels of the other participants. I decided to conduct the series of workshops 
as part of the regular business plan review meeting and business reviews. The reason 
for that was because I didn’t want the team to feel that they were doing something 
completely new, which could possibly have increased their resistance to actively 
participating. The only difference from the regular practice was that, first, I asked the 
business development manager to introduce the ROMI model into the business plan 
template that the team used every year to formalize their business plan. The ROMI 
model was introduced into the OTC project in our organization and in particular, the 
analgesic line, as described in previous chapters. Second, I shared the survey results 
with the team and asked them to use it as a basis for the formation of the business plan, 
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in order to determine the impact factors as per the ROMI model. We ran several sample 
calculations of the ROMI model prior to the implementation of the action plan to 
familiarize the team with the model. That helped significantly with improving their 
understanding of the model. Being the researcher and the managing director at the 
same time gave the team a high confidence level due to the authority my dual role 
provided. 
The end result can be considered positive, as all participants agreed that they 
learned something new and it was the first time our organization implemented a model 
to measure the ROMI. Some participants still doubted the accuracy of the ROMI model 
and suggested limiting its application to the OTC line and waiting for three years to 
evaluate the efficacy and the accuracy of the model. In addition, they suggested taking 
this time to utilize the long-term perspective in order to gain a better understanding of 
the business and achieve better returns. This critique from some of the participants is in 
line with the findings of many researchers, who have stated that an evidence-based 
result that is maintained over a period of three years can build trust in the ROMI model. 
The overall experience was positive and the since the workshops were part of the 
business plan and business review meetings, the team felt that the research can have an 
ongoing nature and that their participation in these meetings will continuously generate 
ideas, evaluation and rigorous action plans.   
9.3  Assimilating theory into practice 
Bringing theory and practice together is challenging task and requires an actionable 
study that can act as a bridge between the worlds of business and academia. Being a 
researcher and an industry practitioner at the same time gave me a great privilege, as I 
had access to both theory and support from the industry. I decided to follow an action 
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research approach for the second component of this research in order to experience the 
problem first hand. The questions raised in this research made it possible for the ROMI 
model, as a theory, to be applied in practice. Throughout the entire research process, it 
was in my mind that action research does not necessary mean that I should expect a 
successful outcome and hence, I considered that the least outcome I should aim for was 
to use the action research as a process that could be used by the organization to 
produce local knowledge that could be used to solve work-related problems.  
Many studies have tackled the possibility of bringing theory to practice and the 
process by which the scholar-practitioner explores management learning and 
education. Many arguments have been presented in the literature, and Ramsey (2014) 
describes how ongoing learning in organizations helps managers achieve better work 
performance through an espousal of the theory of learning-in-practice.  
Ramsey (2014) explores three different arguments to reflect on the development 
of the scholarship of practice and these arguments promote, first, the epistemology of 
practice as per the research work of Cook and Brown (Cook, 1999), second, Aristotle’s 
intellectual virtue of phronesis (Kraut, 2008) and third, social poetics per the work of 
Shotter (2001).  
The work of Cook and Brown (Cook, 1999) explains that knowing interacts with 
the world, is shaped by that interaction and is also generative. Hence, practitioners 
develop knowing in action and that is what leads to the production of new knowledge 
and innovation.  To the best of my understanding, effective interaction generates 
knowledge transfer, which in turn generates new knowledge with a high possibility of a 
new theory emerging that can be used to explore similar problems. Aristotle argues that 
the social science of phronesis, the practical wisdom used to develop action, generates 
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universal and sustainable knowledge.  Hence, action research is considered to be a type 
of social science research and thus requires a dialogical approach to practice by which 
the action taken can provide a rigorous contribution. This is in agreement with what has 
been explored in this research and transferred to the co-researchers. Action research 
brings a rigorous base to the practice by giving sense to the research team regarding the 
importance of establishing a link between academia and business practice.  
Ramsey (2014) identified the learnings from his own action research as falling within 
three domains: first, the engagement with ideas, second, the practice of inquiry and 
finally, the navigation of relations. In the current research, Engagement with ideas was 
achieved through experiencing the ideas throughout the action research process in this 
research and assessing what would be appropriate to apply in practice and what would 
not be.  It was essential that the engagement with ideas be embedded with evaluative 
inquiry by asking for feedback after each workshop and asking members from outside 
the research group to provide feedback on the ideas generated and ongoing reflections. 
This was done after each workshop until the first action research cycle was completed, 
as per the work of Mouncey (2009).  What made me not follow the most common action 
research approach of using iterative cycles was the fact that there was not enough time 
to do so within the constraints of the academic research.  
It is essential to establish linkages and cause-effect relationships between ideas, 
opportunities and problems arising throughout the ongoing action research process. In 
my research, a reflective pause was carried out at the start of each workshop, during 
which the research team would reflect on what they had learned so far and how to 
relate their learnings to the situations they had experienced. According to Gibbs (1988), 
reflection starts with the description of what happened, following by identification of 
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how the experience was perceived. This is followed by evaluating how useful the 
occurrence was, what sense has been made out of it and what could have been done 
differently. In the final, crucial stage, the team defines the course of actions to be 
followed.  
As stated by Pedler (2012), critical action learning has three key roles. The first 
defines the problem, the second helps others with their problems and third, facilitates 
the solution making process. This is done through an action learning cycle that starts 
with the action, followed by learning from the experience, followed by reflection on that 
learning, and ending with reframing the plan prior to taking action. The cycle has an 
ongoing nature, as the cycle starts again after finishing. Evaluation of the critical action 
learning is done by assessing the empirical value of the work, the work outcome and the 
contributions to knowledge. As a researcher, I totally believe that the action research 
approach done in this research has contributed significantly toward enhancing the 
critical action learning experience in all the conducted workshops.  
The focus of this research was on practice-centred learning. Shotter (2001) 
defines three key features for practice centred learning: first, it involves the physical 
practice; second, action learnings are generative, creating the world rather than 
expressing it; and third, action learning is spontaneous, with no predefined form, in 
order to emerge relationally. Hence, the research was meant to be physical by having it 
conducted in the actual workplace where there is physical interaction with the real 
world. The team was aware that the aim of the research was to be able to generalize the 
findings for use by other projects. Finally, the research team was encouraged to 
participate freely and criticize openly, with no restrictions on their knowledge and idea 
generation process.  In addition to what stated by Shotter (2001), I found it important to 
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develop the skills of the participants, as mindfulness skills are crucial for critical action 
learning in practice. Having the key features of the action research in the learning set is 
important to achieve the above defined three roles of action learning.   
9.4  Conclusion  
The whole purpose of conducting the research in my workplace was to enhance the 
learning experience through active knowledge transfer in order to create new 
knowledge and solutions to workplace problems in a rigorous manner. I wanted to 
develop a set of actions that would be the fruits of cooperation between peer 
participants rather than created through the sole efforts of the researcher.  
A series of workshops was used to initially develop knowledge through the 
sense-making process of reflecting on events or arguments and then figuring out how to 
interpret them. From my experience in this research work, the sense-making process 
did not just include the analysis of the experienced event within the workplace but it 
also included the action aimed toward gaining a better understanding of the 
experienced event. Due to this process, the organizational managers can now apply new 
skills of interpretation, investigation and evaluation of challenges encountered in the 
workplace and manage the process of inquiry effectively. As indicated by Ramsey 
(2014), such skills can help these managers turn vague suggestions into rigorous 
scholarly practice.  
I wanted the executive team to differentiate between their learnings from daily 
business experience and the learnings from the workplace research experience. As 
indicated by Becket (2000), the epistemology of practice not only leads to the 
development of know-how, but also leads to know-why by questioning the 
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intentionality and purposefulness of the practice. I believe this is a key difference that 
distinguishes learning from practice and learning from scholarly practice.  
The key challenge that I experienced in this research was the need to obtain 
positive empirical implications of this research. I made sure to encourage the team to 
value the collective knowledge being gained and to enhance the knowledge transfer 
among peers in order to accumulate empirical evidence that would make the findings of 
the action research generalizable, at least at the organizational level, where they could 
be cross-utilized by other projects. Another key challenge I experienced throughout the 
action research process was documenting the action research. This was a difficult 
challenge because there is more in the literature about action research itself than there 
is documentation of the action research, as noted by Gary Anderson and Kathryn Herr 
(Herr, 2014).  
If I were to repeat this action research in the future, I would be sure to complete 
the full action research process by carrying out multiple cycles. This would enable me 
and my research peers to build evidence from the previous iterations of the action 
research cycle and achieve stronger and more generalizable results. 
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APPENDIX A – Survey  
 
  
Dear Pharmacist,  
 
Please try to answer the following survey, keeping in mind marketing and promotional 
activities conducted for OTC products that you come across every day.  
 
 
 
 
 
 
Section I: Do you provide favorable recommendations for OTC products/medications to 
customers walking in to your pharmacy for the following product categories?  
 
Category Yes No 
Analgesics    
Vitamins and nutritional 
supplements 
  
Home diagnostic devices for 
blood pressure, blood glucose.  
  
Dieting/Weight reduction   
Smoking cessation products    
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Section II: Please select the option that best describes your opinion on how the 
following factors affect your OTC product recommendations and sales. 
 
Statement 
Strongly 
Agree 
Agree Neutral Disagree 
Strongly 
Disagree 
Medical Forces      
The formulation/Active 
ingredients of the products 
     
Scientific evidence/clinical studies      
Information from general medical 
guidelines 
     
Social Forces      
My personal experience on the 
product 
     
Positive feedback from consumers      
Physicians’ recommendations of 
the product through prescription 
     
Cost of the products to consumers       
What other pharmacists’ 
recommend 
     
Market share of the product in the 
market 
     
Marketing Forces       
It was formerly a prescription 
product 
     
The manufacturer’s reputation      
Available only through pharmacy 
outlet 
     
General advertisement of the 
product 
     
The sales representative’s 
influence 
     
The display materials       
The mark-up of the product      
The percentage of the bonus 
related to the product 
     
Stock pressure/inventory      
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Section III: Rank the most effective driver for OTC analgesic product sales in your 
pharmacy (Please rank the following in order of importance from 1 to 4, where 1 
is most important to you and 4 is least important to you) 
 
Driver Factor  
Point of sales material   
Prescription   
Pharmacist’s recommendation    
Free of charge goods/mark up 
provided   
 
 
Section IV 
What is your gender? 
o Male 
o Female  
 
What is the number of years in practice as 
licensed pharmacist? 
o Less than a year 
o 1-5 years  
o 6-10 years  
o More than 10 years  
What is your current practice setting? 
o Community Pharmacy  
o Hospital Pharmacy 
o Polyclinic Pharmacy 
 
 
 
What is the number of Points of Sales 
Material, e.g. counter top, stand, banner, are 
currently available in the Pharmacy?   
o Nil 
o 1-3 
o 4-7 
o 8-10 
o More than 10 
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Service and Environment 
On an average, how often does the 
patient interact with you regarding OTC 
products per day? 
o Nil 
o Less than 5 times 
o 5 – 10 times  
o More than 10 times  
On an average, what is the total number of 
prescription you receive per day? 
o Less than 10 
o 10 to 50 
o 51 to 100 
o More than 100 
Describe the classification of your 
pharmacies in terms of revenue? 
o Class a (sells more than 
1000kd/day) 
o Class b (sells more than 
500kd/day) 
o Class c (sells less than 500kd/day) 
 
 
 
 
Additional Comments 
 
 
 
 
About You (optional) 
Name  
Pharmacy 
na 
 
Phone  
Email  
 
Thank you for your participation! 
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APPENDIX B – Linkage of metrics  
 
 
Metric (title) How measured/source Current Target 
Segment metrics 
Market Share vs. 
competitor 
%/ IMS   
Sales Vale vs. 
competitor  
Value/IMS   
Revenue of 
segment  
ERP system    
Gross margin of 
segment  
ERP system   
ROMI of segment  ERP system    
Impact factor metrics 
Consumer factors Number & cost of promotional 
materials implemented based 
on survey results / sales team 
and survey 
  
Expert factors Number and cost of visits of 
medical representatives based 
on survey results / CRM 
  
Retail factors % of FOC goods supplied  based 
on survey results and cost/ERP 
  
Marketing Action metrics 
Detailing activities See table 12 for linkages of impact factors to segment 
performance  
Implementation of 
POSM  
Supply of FOC 
goods 
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APPENDIX C – Linkage of actions effect on impact factors to 
segment performance  
 
 
Impact 
factor and 
actions  
Metrics Current  Change Segment 
performance 
metric 
Current  Change 
Consumer factor: Promotional activities related to point of sales materials  
Improve 
visibility and 
brand 
awareness  
Number of 
POSM 
implemented 
  Market Share vs. 
competitor 
  
 Cost of POSM 
implemented 
  Sales Volume vs. 
competitor  
  
    Revenue of 
segment  
  
    Gross margin of 
segment  
  
    ROMI of segment    
Expert Factor: Medical detailing with physicians and pharmacists 
 Number of 
visits 
  Market Share vs. 
competitor 
  
 Cost of medical 
representatives 
visits  
  Sales Volume vs. 
competitor  
  
    Revenue of 
segment  
  
    Gross margin of 
segment  
  
    ROMI of segment    
Retail Factor: Supply of free of charge goods to pharmacies 
 % of FOC goods 
supplied versus 
revenue  
  Market Share vs. 
competitor 
  
 Cost of FOC 
goods supplied 
versus revenue 
  Sales Volume vs. 
competitor  
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 Cost of FOC 
goods supplied 
versus gross 
margin 
  Revenue of 
segment  
  
    Gross margin of 
segment  
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